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The ability of RNA to store genetic information and to catalyze biochemical 
transformations led to the speculation of the existence of RNA world before the evolution 
of contemporary ribonucleoprotein (RNP) world. Recent discovery of RNA molecules 
containing metabolic cofactors including coenzyme A and its various thioesters at their 5’ 
end further supported the RNA world hypothesis as these CoA-linked RNA molecules 
could be the molecular fossils with very ancient origin. As both RNA and Coenzyme A 
are believed to have co-existed since last universal common ancestor (LUCA) or even 
before, the CoA-RNA conjugates in current biology may reveal fundamental molecular 
secrets involved in evolution. Furthermore, these CoA-RNA conjugates may not be just 
remnants of evolution, rather may have an important functional significance in 
contemporary metabolism and gene regulation. The successful characterization of these 
conjugates will expand our knowledge in RNA function and CoA function. However, the 
sequence, metabolism and biological role of these RNA species are still unknown. The 
aim of this study is to capture CoA-RNA sequences form E. coli total RNA to uncover 
their sequences and to investigate their biogenesis. 
The successful characterization of CoA-RNA requires a specific protocol to capture 
them. The development of such protocol requires an easy access to synthetic CoA-RNA. 
While our lab previously developed a method to incorporate CoA into RNA co-
transcriptionally by using dephospho CoA as a transcription initiator, the limited 
availability of dephospoCoA restricts an easy access to synthetic CoA-RNA. In the first 
section, a simple and easy method for the synthesis of dephospho CoA and its oxidized 
dimer was developed. Two enzymes of CoA biosynthetic pathway, PanK and PPAT were 
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cloned in a single plasmid, and purified in a single enzyme preparation. The synthesis of 
dephsphoCoA was achieved by the enzyme cocktail and pure product was obtained by a 
simple reverse phase column chromatography. The method was extended further to 
synthesize various dephosphoCoA analogs including amino dephosphoCoA and biotin 
dephosphoCoA. 
In the second section, two strategies were investigated for their application in CoA-RNA 
capture. In first strategy, various acyl-CoA ligases including acetyl CoA synthetase 
(ACS), Malonyl CoA synthetase (MatB), Succinyl CoA synthetase (SucCD), medium 
chain fatty acyl CoA synthetase (FadK) and Long chain fatty acyl CoA synthetase were 
cloned, expressed and tested their ability to accept biotinylated fatty acid and CoA-RNA 
as substrates. In the second strategy, various pantetheine and phosphopantetheine analogs 
with biotin as a purification handle, [14-C] acetate as a reporter tag, and variable number 
of positive charges to mediate cellular uptake were synthesized. During the synthesis of 
such analogs, a novel method for the selective protection of secondary alcohols in 
presence of their primary counterparts was developed. 
In the third section of this work, a mechanism of CoA-RNA biogenesis was explored. 
Synthesized phosphopantetheine analog was used to investigate whether CoA-RNA can 
be generated post-transcriptionally. We found that a CoA biosynthetic enzyme, PPAT 
(coaD), can accept ATP-RNA as its substrate and yields CoA-RNA. our results showed 
that the suitability of ATP initiated RNA to serve as a PPAT substrate is determined by 
its 5’ structure. An RNA having at least four unstructured nucleotides at the 5’ end can 
participate in PPAT catalyzed phosphopantetheine transfer reaction. Furthermore, the rate 
of the reaction was independent to the number of 5’ unstructured nucleotides at least for 
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the range of 4-10. These findings established the post-transcriptional transfer of 4’-
phosphopantetheine to ATP-RNA as another mode of CoA-RNA biogenesis besides 
previously characterized RNAP mediated co-transcriptional incorporation. 
Collectively, we have developed an easy and simple method to prepare dephospho CoA 
and its analogs, investigated chemo-enzymatic strategies for CoA-RNA capture and, 
discovered a post-transcriptional mechanism of CoA-RNA biogenesis. Our results 
suggest that the existence of CoA-RNA in extant biology may be evolutionary. Future 
studies may lead to development of specific CoA-RNA capture and will expand our 
understandings on how ribozyme catalysis of the RNA world was transformed into 
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CHAPTER I - INTRODUCTION 
1.1 RNA world and origin of life 
One of the most fundamental question that science is trying to answer is how life 
originated in this planet from an inanimate matter. The direct answer to the question how 
chemistry leaded to the biology may never be found as we currently have no way of 
knowing what exactly happened some 4 billion years ago. The most logical way to tackle 
this problem is by synthesizing life from the scratch in a laboratory. However even if we 
invent a synthetic life, it doesn’t necessarily mean that the same sequences of events led 
to the origin of life on early earth. This realization shifted the emphasis of original 
question from “how did life arise” to “how might life arise” [1]. This subtle but important 
distinction extended the research focus from historical emergence of life on earth to the 
possible mechanisms of origin of life in early earth, in a laboratory, and elsewhere in the 
universe. 
The first step in searching the answer to “how might life arise?” is to define requirements 
to be considered as ‘living’. There is no straight answer to this question because the great 
diversity of life led to the difference in opinion of scientists and philosophers on the 
essential properties of life. However, the working definition of life as defined by NASA 
is a self-sustainable chemical system that can undergo Darwinian evolution [2]. The self-
sustainability of a chemical system is determined by its ability to grow and divide 
continuously with an input of just small molecules and energy. The Darwinian evolution 
requires a genetic system capable of imperfect replication to create a genetic variation in 
the next generation. The phenotypic expression of variations acquired from imperfect 
replication of genetic polymer creates a difference in fitness of the replicates allowing the 
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fittest to survive and propagate the phenotype. So, a chemical system having an ability to 
grow and replicate imperfectly without an intervention from the components of pre-
existing living system fits in this definition of ‘life’. 
All the life forms today as we know it follows the central dogma of molecular biology 
where the genetic information encoded in DNA is transcribed to RNA which is then 
translated into protein. The contemporary life form based on the central dogma is very 
complex as it requires at least three biopolymers (DNA, RNA, and protein) and the 
associated machineries of replication, transcription and translation. This complexity and 
interdependence of contemporary biochemistry implies that the possibility of existence of 
simpler system before the evolution took a current shape of DNA→RNA→protein. RNA 
world is one of the hypothetical and conceptual system where RNA or something 
chemically very similar entity acted as a precursor to current complex system and 
dominated both the genotype and the phenotype. 
The realization of RNA’s ability to kick-start biology from chemistry was first made by 
Francis Crick [3] and Leslie Orgel [4] in 1968. The remarkable discovery of catalytic 
RNAs- self-splicing introns by Tom Cech’s group [5] and Ribonuclease P by Sidney 
Altman’s group [6] inspired the active investigation on the broad catalytic role of RNA. 
These experimental evidences of the catalytic role of RNA in contemporary biology led 
to the hypothesis of the existence of ‘the RNA world’ by Gilbert in 1986 [6]. The idea of 
conceptual ‘RNA world’ is further corroborated after the crystal structure of the ribosome 
was solved which revealed that the peptide bond formation reaction in ribosomal core is 
still in fact catalyzed by RNA [7-9]. Furthermore, the development of in vitro selection 
technique independently by Jack Szostak’s group at Harvard [10] and Larry Gold’s group 
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at university of Colorado Boulder [11] in 1990 opened the ways to isolate RNA 
molecules in vitro having ligand binding properties (aptamers) and catalytic activities 
(ribozymes) from a random RNA library. By using the in vitro selection technique, 
investigators have generated a rich repertoire of ribozymes able to perform various 
biologically relevant chemistries including thioester bond formation [12], 
Aminoacylation [13] and many others with impressive catalytic abilities. The selection of 
such impressive ribozymes further supports the notion that RNA might have served as a 
versatile catalyst in a hypothetical RNA world before the emergence of protein-based 
enzymes. 
1.2 RNA functions in contemporary biology 
In addition to a ‘hypothesized’ role of RNA during origin and evolution of life, 
this molecule is central to life processes in contemporary biology. Since the introduction 
of central dogma of life, RNA has been sitting at its center, relaying the information 
stored on DNA to proteins. For example, messenger RNA (mRNA) is an obligate 
intermediate for the protein translation required by all known life forms. In eukaryotic 
organisms, the information on the gene is transcribed into RNA in the nucleus which then 
moves to the cytoplasm in order to get translated. Once in the cytosol, several features on 
functional mRNA, for example, 5’ Cap, 3’ Poly A tail, and untranslated regions at both 
ends regulate the assembly of protein synthesis machinery or ribosome and its movement 
along the mRNA strand. A ribosome reads the base sequence in the form of three-base 
triplets and translates the information into its corresponding amino acid with the help of 
another RNA molecule called transfer RNA (tRNA). The rate of mRNA production and 
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its fidelity determines the rate of translation, abundance of a protein and its structure as 
determined by the primary sequence information. 
While mRNA is a recognized in central dogma and it is undoubtably a key player of life, 
most of the cellular RNA is not mRNA. Two other classes of RNAs— tRNA and 
ribosomal RNA (rRNA) constitute the majority (~ 90%) of cellular RNA [14]. The 
protein synthesis process requires an adaptor molecule to translate the information on 
mRNA and tRNA serves in this capacity. The unique structure of tRNA in conjunction 
with the number of modified nucleotides it carries makes it able to place the correct 
amino acid encoded by the triplet codon in the ribosome during translation. The 
biological role of tRNA is not limited to putting correct amino acid during proteins 
synthesis. It is interesting to realize that tRNA is involved in lipid modification via 
aminoacylation [15]. The aminoacylation of lipids affect the membrane biochemistry and 
is involved in adaptation to stress and other environmental changes. The change in 
membrane property by tRNA-dependent aminoacylation is found to increase the bacterial 
virulence and decreased susceptibility to cationic antimicrobial peptides[15]. 
Furthermore, in Acidithiolacillus genus, tRNA is found to be involved in horizonal gene 
transfer process, expanding the existing functional role of tRNA from protein synthesis to 
bacterial conjugation [16].  
The most abundant RNA in living organism is rRNA. Ribosome is a complex of rRNA 
(~60% by mass) and protein (~40% by mass), where the catalytic activity of peptide bond 
formation resides within the RNA component of the complex. In prokaryotes, there are 
three rRNAs in ribosome assembly: 5s rRNA (120 nt) & 23s rRNA (2906 nt) comprising 
large ribosomal subunit (50S) and 16s rRNA (1542 nt) in small subunit (30S). All three 
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types of rRNAs are encoded by a single gene and organized as a co-transcribed operon 
[17]. An eukaryotic ribosome contains four different types of rRNAs: 5S (121 nt), 5.8S 
(156 nt) and 28S (5070 nt) in large ribosomal subunit and 18S (1869 nt) in small subunit 
[18]. rRNAs in eukaryotes are transcribed as long polycistronic pre-ribosomal RNA 
which are processed in nucleolus to form three of the four rRNAs. 
The three major classes of RNA-mRNA, tRNA and rRNA- comprise only a part of the 
RNA functions in contemporary living organisms. The diversity and importance of RNA 
in a cell is being continuously expanded with added insights and new discoveries in RNA 
function. The recent discoveries of various classes of non-coding RNAs (ncRNAs) 
extended the functional capacity of RNA beyond its active role in translation. These 
ncRNAs are present in both prokaryotes and eukaryotes and are found to interact with 
DNA, RNA and proteins to alter and regulate gene expression and to modulate the 
immune functions during various diseases and development. The examples of non-coding 
RNA include microRNAs (miRNAs), small-interfering RNAs (siRNAs), piwi-interacting 
RNAs (piRNAs), circular RNAs (CircRNAs), short RNAs (sRNAs) and long non-coding 
RNAs (lncRNAs). 
miRNAs are the member of small non-coding RNAs having an average length of 22 
nucleotides. They are generally transcribed from intron sequences of DNA into primary 
miRNAs and processed into pre-miRNAs and mature miRNAs [19]. The intragenic 
region encoding miRNA is transcribed by RNA polymerase II (polII) independently into 
a >1 kb single stranded RNA containing a stem-loop structure [20]. These primary 
transcripts are processed by the microprocessor complex containing two RNA binding 
proteins: DiGeorge Syndrome Critical Region 8 (DGCR8) and Drosha [21]. The stem-
 
6 
loop structure on the primary transcript plays a role as recognition motif for Drosha, a 
ribonuclease III enzyme, and gets cleaved at the base of hairpin structure resulting the 
formation of a 2-nucleotide overhang at 3’ end of pre-miRNA [22]. The complex of 
exportin5/RanGTP exports the pre-miRNA into the cytoplasm[23]. The RNaseIII 
endonuclease Dicer removes the terminal loop of pre-miRNA in the cytoplasm yielding a 
mature miRNA duplex [24]. Both the strands- designated as 5p or 3p based on their 
directionality during processing- can be associated with the argonaute (AGO) family of 
proteins to form the RNA induced silencing complex (RISC) [19]. The selection of which 
strand to load on the RISC complex is made by the thermodynamic stability at the 5’ ends 
of duplex and the presence of U at 5’ end [34]. The strand having uracil at 5’ end or 
lower 5’ stability get preferentially loaded into the RISC complex and is called guide 
strand. The unloaded strand, also called as passenger strand, is unwound and degraded by 
various cellular machineries.  
The biogenesis of miRNA independent of conventional DGCR8, Drosha, Exportin5, and 
Dicer also exists which is often regarded as non-canonical pathway for miRNA 
biogenesis. They can be grouped into two categories Drosha/DGCR8 independent 
pathways and Dicer independent pathways [19]. One example of Drosha/DGCR8 
independent pathway is mitrons, which are pri-miRNAs produced during splicing of the 
primary mRNA transcripts [25]. Some pri-miRNA transcripts are capped at 5’ end with 
m7G and these transcripts do not follow the canonical miRNA biogenesis pathway [26]. 
Existence of multiple pathways for the export and processing of miRNAs signifies their 
diverse cellular roles. Once mature miRNA is formed regardless of the biogenesis 
pathway, it interacts with AGO proteins to form the active RISC complex.  
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Most studies to date have shown that miRNAs induce the translational repression by 
interacting with 3’ untranslated regions (3’ UTRs) of mRNA [27]. The degree of miRNA 
complementary to miRNA response elements (MREs) in mRNA determines how the 
translation of target mRNA is silenced. A perfect complementarity between miRNA and 
MRE induces target mRNA cleavage by AGO2 endonuclease activity while a partial 
complementarity between miRNA and MRE acts through the formation of miRISC 
complex that recruits many other partners to promote mRNA decapping and 
deadenylation [50]. In addition to 3’ UTRs, the promoter region, coding region and 5’ 
UTR are also found to contain miRNA binding site [28]. The role of miRNA is not 
limited to silencing translation; miRNA binding to the promoter region may induce the 
protein expression as well [45]. An interesting aspect of miRNA-based gene regulation is 
that a single mRNA is regulated by multiple miRNAs and one miRNA can target 
multiple mRNAs, increasing the targeting range and complexity of the processes. 
Small interfering RNAs (siRNAs) are another class of small non-coding RNAs found in 
eukaryotes. They are double stranded having length of 20-25 base pairs and an overhang 
of 2 nucleotides. The first observation of post-transcriptional gene silencing by small 
RNAs was made by Cogoni and Jorgensen in plants and fungi [29, 30]. Fire and Mello 
first reported the RNA silencing by RNA interference in animals using C. elegans as a 
model system [31]. The result of miRNA and siRNA action is quite similar: both cleave 
the target mRNA by complementary base-pairing via their association with AGO 
proteins. However, they differ in their origin, and to some extent, in mechanism of action. 
While miRNAs are endogenous and derived from the intergenic regions, siRNAs may be 
endogenous or exogenously derived from viral RNAs as it is evolved as a form of 
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antiviral defense mechanism. Viral infection in a cell results in abundant transcription of 
viral genome. The long dsRNAs resulting from viral reproduction serves as a substrate 
for Dicer enzyme and get processed into siRNA [32]. The siRNA generated such way 
selectively targets and degrades the viral RNA and acts as a host defense mechanism. 
Furthermore, miRNA does not need perfect complementarity to MRE region of mRNA in 
order to function, but siRNA features perfect base pairing with target mRNA. The 
selective mRNA targeting and degradation by siRNA has been used to study gene 
functions as a gene of interest can be selectively knocked down temporarily by RNA 
interference. Moreover, the ability of siRNAs to selectively target mRNA of interest for 
its degradation has proven beneficial to develop novel therapeutics for various genetic 
diseases previously non-targetable by small-molecule drugs.  
PIWI interacting RNAs (piRNAs) are another class of non-coding RNAs that are slightly 
longer (24-31 nt) than miRNAs and siRNAs. They are generated via dicer independent 
manner from their precursor transcripts which are expressed form intergenic regions 
called piRNA clusters [33]. piRNAs interact with PIWI subfamily of proteins that are 
mainly present in germ cell lines during development and forms a specific RISCs known 
as piRISCs. These RNA species are shown to regulate the activity of the transposons and 
preserve genome for normal gametogenesis and reproduction. There are two major 
pathways for piRNA biogenesis: the primary processing pathway and the secondary 
piRNA amplification pathway also known as ping pong cycle [33]. The primary 
processing pathway exists in both germline & surrounding somatic cells and starts with 
the transcription of long primary transcripts from piRNA clusters in the genome 
[34].These long transcripts are exported into the cytoplasm and processed by an 
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endonuclease Zucchini and further matured by perinuclear granules called yb bodies on 
the surface of mitochondria [35, 36]. However, many aspects of mitochondrial 
involvement in piRNA processing remains to be investigated. The maturation is 
completed after 2’-O-methylation at the 3’ piRNA end by DmHen1/pimet 
methyltransferase complex [37] followed by the formation of piwi-piRNA complex 
which is transported to nucleus for the transcriptional regulation of a target gene. The 
secondary pathway or ping pong cycle for piRNA biogenesis takes place in special non-
membranous perinuclear structure known as nuage [38]. In this pathway, the slicer 
activity of AGO3 and Aub cleave the sense and antisense transposon transcripts 
generating piRNAs and silencing the transposons [39]. These small regulatory RNAs 
appear to be similar to siRNA and miRNA as they interact with nucleases to regulate the 
gene expression. They are relatively new to the scientific community and the detail 
picture of biogenesis and function of piRNAs beyond germline and development is yet to 
be clear. 
Circular RNAs (circRNAs) are another class of RNA having covalently joined ends and 
generated by a process called back splicing or exon skipping. In this process, the 5’ splice 
donor attacks on an upstream 3’ splice site leading to 3’→5’ phosphodiester bond and 
generates a circRNA molecule. These RNAs are involved in the regulation of gene 
expression by functioning as miRNA sponges [40, 41]. CircRNAs are found to contain 
multiple binding sites for miRNAs and hence inhibit the miRNA-dependent translation 
suppression by capturing them. For example, a circular RNA CDR1as has 73 binding 
sites for miR-7 microRNA seed sequence [41] suggesting this circRNA is involved in the 
regulation of miR-7 level and activity. In addition to their role in miRNA activity 
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regulation, circRNAs may act as a template for translation [42]. As they do not contain 5’ 
cap, the translation is cap-independent. Some of the translated circRNAs are shown to 
contain internal ribosome entry site (IRES) to mediate the translation process [43]. While 
not much is known about the function of protein product generated by circRNA 
translation, one example is found to have significance in the progression of glioblastoma 
[44]. A circular RNA Circ-FBXW7 encodes a 21 kDa protein whose upregulation in 
cancer cells inhibited cell proliferation and cell cycle acceleration [44]. These RNA 
molecules are also new to the scientific community like piRNAs and there is much to 
investigate about their roles in biology. 
Bacteria do not contain miRNA, siRNA, or piRNA but a large number of small RNA 
regulators are present in them to guide various cellular processes in both trans-acting and 
cis-acting manner. These bacterial transcripts are ~ 50-300 nucleotides in length, function 
analogously to miRNA and siRNA in eukaryotes, and often referred to as sRNA [45]. 
Many of these sRNAs block the translation by short and imperfect base pairing at or near 
the ribosome binding site (RBS) [46]. Some sRNAs also enhance the ribosome binding to 
mRNA by preventing the secondary structure formation which is usually inhibitory. The 
action of sRNA in bacteria is mediated by an RNA binding protein Hfq, which is 
analogous to eukaryotic AGO protein. The complex of Hfq, sRNA, and mRNA activates 
the nuclease activity of RNase E and guides the degradation of both sRNA and mRNA 
[45]. Many sRNAs in bacteria are encoded on the negative strand of established coding 
sequences and known as antisense RNAs (asRNAs). The perfect base paring of antisense 
RNA to coding sequences negatively regulates the mRNA stability and protein 
translation [47]. A few initial nucleotides exposed in the stem-loop region of asRNAs are 
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involved in base pairing with their targets although additional base pairing interactions 
may form after this initial binding. Many different features of these sRNAs are yet to be 
investigated. For example, the optimal length of the seed sequence and the nucleotide 
composition is not fully defined yet. It has been proposed that the seed length is about six 
to seven nucleotides using example of SgrS and RybB sRNAs but this is not universal for 
all sRNA-mRNA pairs [48, 49]. Moreover, our understanding on the features on target 
mRNA that affect sRNA binding and regulation is very limited. While some studies 
suggested that sRNAs bind at or near to RBS, it is also shown that translation may be 
regulated by sRNA binding at 70 nt upstream or 15 nt downstream of the start codon [50, 
51]. The positive regulators of translation that inhibit the secondary structure formation 
on target mRNA can be even more distantly located [52]. In addition to their role in 
translational regulation, sRNA impacts the stability of mRNA as well. Such sRNA may 
regulate the target mRNA stability at variable locations including in the middle of the 
coding sequences [53]. As the next generation sequencing and whole transcriptome 
sequencing are being cheaper and more efficient each passing day, the field of bacterial 
sRNA is continuously growing, and we can expect the complete picture of bacterial gene 
regulation by sRNAs will be available in near future. 
The regulation of gene expression by RNA in bacteria can also be achieved in a cis-
acting manner. Some mRNA in bacteria contain a structural domain at 5’ UTR which is 
able to fold into a definite structure and bind to a certain metabolite. The binding of the 
target metabolite on the aptamer domain upstream to open reading frame induces the 
structural changes that may either promote or block the translation of the encoded gene. 
These domains are called riboswitches as they are able to switch into different structures 
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by directly sensing the metabolite concentration and are very abundant in bacteria. A 
riboswitch to bind Thiamine pyrophosphate (TPP) is found to exist in archea, bacteria 
and eukaryotes [54]. The action of riboswitches allows the precise regulation of gene 
expression by RNA in accordance with the cellular environment. This ability of RNA to 
sense a small molecule and regulate associated downstream processes might have played 
a significant role during hypothetical RNA world. So far, riboswitches for various 
cofactors including TPP [54], FMN [55], NAD [56], SAM [57], and for other small 
molecules including Lysine, Guanine, Adenine and glycine have been reported [58]. It is 
interesting to note that all metabolic cofactors derived from adenosine, for example NAD, 
FMN, FAD, and SAM have riboswitches, except coenzyme A. As all these adenosine 
derived coenzymes including CoA and CoA thioesters are thought to be existing since or 
even before the RNA world, riboswitches sensing CoA and CoA thioesters might exist 
and are yet to be discovered.  
In addition to the metabolite-sensing RNA motifs, the RNA structures that respond to the 
temperature and pH changes are also found in bacterial mRNA 5’ UTR. Thermosensor 
RNA motifs, also known as RNA thermometers (RNATs) are positioned in 5’ UTR 
regions of some mRNAs. At lower temperature, they form a secondary structure to 
sequester the Shine Dalgarno sequence or AUG start codon and prevents the binding of 
the ribosome [59]. The secondary structure is melted when the temperature is increased 
that alleviates the translational repression. Furthermore, some RNA motifs are found to 
change their secondary structure in response to change in pH of the environment [60]. In 
E. coli, The alx gene locus harbors a pH responsive element upstream of ORF that folds 
into translationally active structure when pH of the growth media is raised to 8.4 from 
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normal growth pH of 6.8 [60]. While the riboswitches to sense and respond to various 
environmental fluctuations including metabolite concentration, temperature and pH are 
abundant in bacteria, their presence is very limited in eukaryotes as only one riboswitch 
for TPP is found to be present in plants and fungi [61]. While more investigation is 
needed to understand the evolution and diversity of riboswitches in various domains of 
life, the ability of RNA to sense and respond to environmental changes greatly supports 
the idea of RNA world hypothesis. 
The roles of RNA in modern biology discussed so far are related to gene expression- 
either as active player of the central dogma like mRNA and tRNA or as a regulator of the 
process like various non-coding RNAs. Catalysis is another aspect of RNA function 
critically important in contemporary biology. RNA can fold into complex structures and 
enhance the rate of various biochemical reactions in a similar way to protein enzymes. 
Self-cleavage is the most common reaction catalyzed by naturally occurring ribozymes. 
These ribozymes cleave their own phosphodiester bond very efficiently and this process 
plays a critical role in organism’s survival. The examples of self-cleaving naturally 
occurring ribozymes include hammerhead ribozyme [62], hairpin ribozyme [63], Varkud 
satellite (VS) ribozyme [64], the hepatitis delta virus (HDV) ribozyme [65], glucosamine-
6-phosphate synthase (glmS) ribozyme, [66] and twister ribozyme [67]. The hairpin 
ribozyme and hammerhead ribozyme catalyze the cis-cleavage of multimeric RNA 
strands generated form the rolling circle replication of viruses. The VS ribozyme was 
isolated from a fugus Neurospora as a part of mitochondrial RNA. The glmS ribozyme is 
located in 5’ UTR of glmS gene and mediates the self-cleavage reaction in presence of 
glucosamine-6-phosphate (GlcN6P), regulating the flux of this metabolite. 
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In addition to the cis-acting ribozymes, trans-acting ribozyme also exists in nature. 
Bacterial Ribonuclease P (RNase P) is a naturally occurring trans-cleaving ribozyme that 
removes the 5’-leader sequences from pre-tRNAs during tRNA maturation [68]. RNase P 
is a large-sized RNA molecule (350-400 nt) that exists as ribonucleoprotein complex 
containing M1 RNA and C5 protein. The protein component is not necessary for its 
catalytic activity. The M1 RNA subunit fold into two unique domains- specificity (S) 
domain that recognizes the TψC loop in pre-tRNA and catalytic (C) domain that mediates 
the hydrolysis of 5’ leader sequence by recognizing 3’ CCA end [69]. This ribozyme is 
universal in all the living cells and central to tRNA maturation process. Ribosome is an 
another example of RNA catalysis in contemporary biology [70]. Although ribosome is 
an RNA-protein complex, the catalytic activity of peptide bond formation resides in its 
rRNA component.        
The repertoire of RNA catalysis is greatly expanded with the development of in vitro 
selection technique that allows to enrich and select a catalytic RNA molecule from a 
random RNA library [10, 11]. Several ribozymes with impressive catalytic activity have 
been selected by using in vitro selection technology. For example, RNA is shown to 
catalyze phosphodiester bond formation [71], phosphodiester bond hydrolysis [72, 73], 
RNA ligation [74], RNA polymerization [75], coenzyme and cofactor synthesis [76], 
RNA capping [77-79], thioester synthesis [12], aminoacylation [80] and peptide bond 
formation [81]. Although these reactions are catalyzed by protein enzymes as of today, 
the diverse catalytic activities associated with RNA support the scenario of RNA world’s 
existence before the evolution of LUCA. 
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The above-mentioned examples on contemporary RNA function establishes RNA as an 
obligate molecule for life. While RNA is indispensable for protein translation, its 
biological significance is not limited to the central dogma and extends far beyond. In 
addition to its role as an information carrier, RNA serves as a regulatory molecule for 
gene expression and catalyst for many biochemical reactions. Although most the catalytic 
activity is associated with in vitro selected RNA, the diverse and impressive activity of 
the selected ribozyme represents a vast potential within RNA. It is logical to argue that 
such activity might have existed a long time ago before the emergence of protein 
enzymes. The advancement in molecular biology tools and RNA sequencing technology 
is broadening the scope of RNA function with discovery of novel types of RNA 
molecules each day. 
1.3 RNA modicications 
Although RNA plays diverse roles in contemporary biology, the chemical 
diversity of RNA itself is limited to four canonical nucleotides A, U, G and C. The 
disparity in between the RNA function and the RNA chemical diversity is somehow 
balanced by employing chemical modifications on the nucleotides. The first sequencing 
of alanine tRNA in 1965 identified more than 10 chemical modifications including 
pseudouridine. Since then, over 100 types of chemical modifications including 7-
methlguanosine cap at the 5’ mRNA end, poly A tail on the 3’ RNA end, methylated 
adenosine (m6A & m1A) and cytosine (m5C and hm5C), metabolic cofactors (NAD, 
Coenzyme A and CoA thioesters), & ribose methylation have been identified in cellular 
RNAs. These modifications play a crucial role in biogenesis, localization, function, 
turnover, and the entire lifecycle of cellular RNA.  
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Eukaryotic messenger RNA (mRNAs) are modified on both the 5’ end and 3’ with 7-
methylguanosine cap, and poly A tail respectively. The presence of m7G cap at 5’ RNA 
end functions to stabilize the transcripts by protecting them from degradation, contributes 
to mRNA export to the cytosol, and the recruitment of initiation factors for the 
translation. The 3’ poly A tail on eukaryotic mRNA recruit poly A binding proteins that 
protects RNA form degradation, facilitates mRNA export, and participates in translation 
initiation. 
In addition to the 5’ cap and 3’ tail, various internal modifications also play a crucial role 
in mRNA metabolism. N6-methyladenosine (m6A) is the most abundant internal 
modification present in mRNAs and non-coding RNAs. Lavi et al used thin layer 
chromatography to estimate the abundance of m6A in nuclear and cytosolic mRNA of 
HeLa cells and estimated it to be about one m6A per 700-800 nucleotides [82]. Although 
m6A is chemically stable, the precise modification sites and the extent of modification 
could not be determined for decades due to the lack of proper method that hindered the 
biological studies of these modifications. However, the identification of m6A readers, 
writers, and eraser enzymes [83, 84] and the advancement in the high throughput 
sequencing technologies revealed the transcriptome-wide m6A modification sites in high 
resolution [85, 86] and fueled the investigations of the biological significance of internal 
m6A modifications. For example, Zhao et al studied the role of m6A modification in 
maternal to zygotic transition during the early life of embryos [87]. Their study revealed 
that maternal RNA is heavily modified with m6A during the early development of 
zebrafish embryo. This modification recruits an m6A binding protein Ythdf2 that decays 
the maternal mRNAs facilitating zygotic genome activation. In another study done by the 
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same group, investigators identified the role of m6A modification in ultraviolet induced 
DNA damage response [88]. The DNA damage by ultraviolet irradiation induces m6A 
transiently that serves as a beacon to facilitate the localization of DNA repair enzyme 
DNA pol-κ to the damage sites. M6A is also shown to affect the translation dynamics by 
inducing steric constraints on the coding regions which destabilizes the codon-anticodon 
pairing [89].  
In addition to N6-methylation on adenosine, N-1 can also be methylated creating m1A 
modification. Such modification was first discovered in tRNAs and rRNAs and later 
found to be present on mRNAs as well [90]. Methylation of N1 creates a positive charge 
on the methylation site which can potentially alter the RNA secondary structures. It was 
recently shown that the positive charge generated by m1A modification induce the local 
duplex melting by disrupting local base-paring of RNA [91]. Although m1A modification 
is shown to induce structural modifications, the key mediators of this modification and its 
biological functions are still unknown. The distribution of m1A is much less than m6A 
modification and is usually m1As are present near to the first splice sites and translation 
sites.  
One of the common epigenetic modification of RNA is the addition of a methyl group in 
C-5 of cytosine to create 5-methyl cytosine (m5C). This cytosine modification is also 
known to exist in RNA but at very low levels [92]. Several m5C sites have been 
characterized in tRNA and rRNA using bisulfite sequencing which was originally 
developed for the detection of same modification in DNA [93, 94]. Various tRNA 
methyltransferases including tRNA methyltransferase 4 (Trm4) [95], tRNA aspartic acid 
methyltransferase 1 (Dnmt2) are reported to be tRNA m5C writer proteins. Although the 
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biological significance of m5C modification is largely unknown, this modification is 
shown to protect tRNAs from stress-induced tRNA degradation. Furthermore, the 
oxidized versions of m5C, 5-hydroxymethylcytosine and 5-formylcytosine, are also 
detected in RNA indicating that m5C is a dynamic RNA modification with potential 
biological roles that remain to be explored [96-99]. 
Pseudouridine (ψ) is the most abundant RNA modification in cellular RNAs which is 
mainly present in tRNAs and rRNAs. This modification arises by the isomerization of 
uridine where the ribose and uracil are attached by carbon-carbon bond instead of C-N 
glyosidic bond. An enrichment protocol of the pseudouridine containing transcripts by 
the chemical biology approach revealed thousands of ψ modified sites in mammalian 
mRNAs [100]. Furthermore, mRNA psedouridylation is shown to be inducible and 
stress-specific indicating the dynamic nature of this modification. The isomerization of 
uridine to pseudouridine is found to alter its base pairing properties. For example, the 
modification of the initial uridine of one of the stop codons (UAA, UGA or UAG) to 
pseudouridine allows the tRNA to read through these stop codons and thus suppresses 
translation both in vitro and in vivo [101]. Pseudouridylation of UAA and UAG codes for 
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serine and threonine respectively and ψGA codes for tyrosine and phenylalanine 
implying a novel way to expand the genetic code. 
Figure 1.1 RNA modifications in contemporary biology. 1) m6A 2) m1A 3) m5C 4) 
5-Hydroxymethyl Cytosine 5) Pseudouridine 6) 2’-O-Methylguanosine 
In addition to the modifications of the nucleobases, 2’ hydroxyl on the ribose moiety can 
also be modified. 2’-O-methylation has been found in all four ribonucleotides and in all 
three major classes (mRNA, tRNA and rRNA) of RNA and is best studied in rRNA. 
Small nucleolar RNAs (snoRNAs) are shown to guide the site-specific methylation of 2’-
OH of rRNA. Aschenbrenner and Marx recently developed a technique to assess the 
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extent of 2’-O-methylation by using a Klenow fragment of DNA polymerase klentaq with 
reverse transcriptase activity [102]. They found that the reverse transcriptase activity of 
klentaq polymerase is stalled by the presence of 2’-O-methylation modification and 
exploited this feature to map the extent of 2’-Ome modification in RNA by simple qRT-
PCR. In spite of the recent progresses in method development to study this modification, 
the biological significance and precise sites of 2’-OMe modifications are still unclear. 
Although RNA functions are very diverse in contemporary biology ranging from 
information storage to information processing, regulation, and catalysis, the chemical 
diversity of RNA is very limited to four canonical nucleotides A, U, G and C. The 
disparity between broad RNA functions and limited chemical diversity is narrowed to 
some extent through above mentioned chemical modifications on the nucleobases and 
ribose sugar. Proteins, on the other hand, have much advantage from the chemistry 
standpoint since they have 20 chemically diverse amino acids as their building blocks. 
One way to further expand the chemical diversity of RNA would be to incorporate 
various functional groups by either modifying bases and sugar or by finding a way to 
install small molecules on RNA containing such functional groups. There are many 
different RNA-derived small molecules in contemporary metabolism bearing diverse 
functional groups. For example, Coenzyme A contains thiol functional group that 
participates in acyl transfer reactions. NAD/ NADH contains nicotinamide group which 
is involved in redox reactions. FAD/FADH2 has isoalloxazine ring that participates in 
electron transfer reactions. S-adenosyl methionine (SAM) has carboxyl, amino and 
methyl groups that is involved in methyl transfer reactions. The association of one of the 
RNA building block (adenosine) with these small metabolites provides a strong 
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supporting evidence on the existence of RNA world where RNA could have been 
decorated with much broader chemical functionality than it has in contemporary biology.  
1.4 Cofactor-linked RNA conjugates 
The idea of incorporating metabolic cofactors into RNA has been around for many years. 
Since NAD and dephosphoCoA contain an adenosine diphosphate (ADP) moiety, they 
can theoretically be used by RNA polymerase to initiate transcription in place of ATP. 
Such an ability of E. coli RNA polymerase was first demonstrated by Malygin and 
Shemyakin in 1979 [103]. They observed the incorporation of two metabolic cofactors 
NAD and FAD at RNA 5’ end by E coli RNA polymerase in a template dependent 
manner. However, such transcription was abortive, and they only found dinucleotide as a 
product of transcription. Twenty years later, three metabolic cofactors- NAD, FAD, and 
dephospho-CoA were incorporated into the RNA in a ribozyme catalyzed reaction [104]. 
Two ribozymes CoES7 (30N) and CoES21 (60N) were found to catalyze the transfer of 
metabolite precursors 4’-phosphopantetheine, NMN and FMN to pppA-RNA labelling 
RNA with CoA, NAD, and FAD respectively [104]. The reaction catalyzed by these 
ribozymes covalently linked NAD, FAD and CoA at the 5’ end of RNA. These findings 
supported the speculated availability of such metabolic precursors in an RNA world. 
While this study is a milestone to claim that RNA was equipped with diverse prosthetic 
groups to perform essential chemistries for life, its application to label RNA with these 
cofactors is limited since the reaction R-p + pppA-RNA → RppA-RNA + ppi is 
catalyzed by the RNA itself. In other words, this method can put NAD, FAD and CoA on 
the 5’ end of CoES7 and CoES21 ribozymes. 
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A key achievement on incorporating NAD, FAD and dephospho-CoA at RNA 5’ end was 
achieved with the finding of T7 φ2.5 promoter in combination with T7 RNA polymerase 
can be used to incorporate any adenosine containing molecule including NAD, FAD, 
dephospho-CoA at RNA 5’ end [105]. This method is not discriminatory against the 
RNA sequences. As adenosine is the only requirement for recognition by T7 RNA 
polymerase, any adenosine containing coenzymes or metabolites can be labelled at RNA 
5’ end by using this approach. In addition to allowing endless adenosine derivatives as 
transcription initiators, this method is advantageous in producing homogenous transcripts 
from an in vitro transcription [106]. Another class of commonly used promoter, T7 φ 6.5 
(class III) initiates transcription with GTP and requires two or more consecutive ‘G’s on 
the RNA [106]. The transcription under class III promoter creates a series of G oligomers 
in substantial concentrations due to repeated abortive transcription. All these G oligomers 
can serve as an initiator for transcription under T7 φ6.5 promoter, resulting in a 
significant heterogeneity at RNA 5’ end. The discovery of T7 φ2.5 promoter solved this 
problem as G oligomers generated by abortive transcription could not serve as an initiator 
when ATP is a first incorporated nucleotide in RNA [106]. This system made it possible 
to incorporate any adenosine analogs at 5’ end of RNA transcripts of any length and any 
defined sequence in high yield. 
The cofactor-linked RNA conjugates have been proven useful for many applications. For 
example, flouorescein labelled RNA was synthesized by using FAM-AMP analogs as a 
transcription initiator [107]. Cyanine based fluorophores Cy3 and Cy5 were incorporated 
into RNA by using Cy3-AMP and Cy5-AMP by one-step transcription under T7 φ2.5 
promoter [108]. Labelling of RNA by these fluorophores is proven useful in studying 
 
23 
ribozyme reaction kinetics, probing RNA structure, and RNA localization. The Cy3/Cy5 
labelling of RNA was shown to serve an alternative for RNA radiolabeling approach to 
study the RNA structure and kinetics [108]. Biotin labelling is another widely used 
technique in molecular biology. It offers a simple and easy way of RNA purification by 
streptavidin/neutravidin beads as the biotin/streptavidin interaction is one of the strongest 
non-covalent interaction found in nature. Biotin-AMP conjugates offered co-
transcriptional biotin labelling of RNA by one-step in vitro transcription [107]. This 
system expanded the application of RNA in imaging, detection, and structure-probing. 
Moreover, AMP-initiated transcripts have found their applications in cancer therapeutics. 
For instance, Folate-AMP was used as transcription initiator to synthesize folate 
conjugated siRNAs that not only helped to target therapeutic siRNAs to cancer cells, but 
also helped to enhance the RNA stability [109, 110]. The presence of such modification 
on RNA 5’ end also prevents the innate immune system activation by transfected RNA 
by replacing a trisphosphate group. 
In addition to RNA labelling with fluorescent-AMP and Biotin-AMP conjugates as 
transcription initiators for their various applications, incorporation of biologically 
relevant adenosine derivatives like NAD, FAD and dephospho CoA into RNA is easily 
achievable by one step-transcription under T7 φ2.5 promoter. The incorporation of such 
cofactors has been proven useful in many applications, specially selection of functional 
RNA molecules like ribozymes. For example, two ribozymes TES1 and TES33 capable 
of catalyzing thioester synthesis were selected by size heterogenous library of CoA-RNA 
[12]. Moreover, CoA-RNAs offer reactive free thiol group on RNA 5’ end that can be 
exploited to perform unique chemistries otherwise unavailable to RNA. For example, 
 
24 
thiol labelling of RNA as in case of CoA-RNA can be used to attach RNAs covalently to 
gold nanoparticles that may have applications in the delivery of therapeutic RNAs like 
siRNAs [111]. The thiol modification can also be applicable to immobilize RNA on solid 
surfaces through the formation of disulfide, thioether and thioester bonds. Such RNA 
immobilization is crucial in the selection of functional RNA molecules by SELEX, where 
few sequences of RNA having unique folding pattern to facilitate either high affinity 
binding for a specific target (aptamers) or ability to perform certain chemistries 
(ribozymes) can be isolated from a pool of random sequenced nucleotides [11]. 
 
Although such in-vitro cofactor-RNA conjugates have broad application in the study of 
RNA localization, delivery, detection and imaging, their biological significance would be 
expanded if such conjugates are found to exist in contemporary biology. The successful 
isolation of ribozymes able to catalyze the synthesis of such cofactors [76], and use 
cofactor linked RNA conjugates as a substrates [12, 13] provided a strong supporting 
evidence on the availability of cofactor-linked RNA conjugates in biology at least in 
ancient RNA world. The impressive discovery of a CoA-linked ribozyme able to self-
acylate as CoA-thioester supports the idea of contemporary Coenzyme A, NAD and FAD 
being originated from functional remnant of ribozyme and demonstrated the biological 
significance of cofactor-linked RNA conjugates. While there is no current example of 
NAD or FAD linked ribozyme, the discovery of such RNA will further broaden the 
significance of these RNA species.  
Interestingly, these cofactor-linked RNA molecules were found to exist in RNA pool of 
contemporary organisms [112, 113]. Two studies from David Liu’s lab at Harvard used 
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size-exclusion chromatography coupled with mass-spectrometry to detect small molecule 
that are covalently conjugated to cellular RNAs [112, 113]. In the first study, cellular 
RNA was treated with a base or a nucleophile to cleave labile small molecules that are 
covalently conjugated to cellular RNAs. Total RNA was isolated from two distant 
bacterial species E. coli and S. venezulae and treated with ammonium bicarbonate or n-
butylamine to release base labile and nucleophile labile small molecules respectively. The 
small molecules liberated after a base treatment or a nucleophile treatment having mass 
of <2,500 Da were subjected to liquid chromatography-high resolution mass 
spectrometry. Three small molecules having mass of 101.0232, 156.1013 and 211.1826 
Da were detected to be abundant in S. venezulae RNA. Interestingly, E. coli RNA 
contained two small molecule conjugates of mass 101.0232 and 211.1826 Da, but not the 
one having mass of 156.1013 [112]. Isotopic labelling and comparison with authentic 
standards later revealed their identity as acetate, methylmalonate, and succinate. The 
macromolecular fraction of total cellular RNA was treated with nuclease P1 so that the 
nucleotides directly conjugated to the nucleophile labile or base labile can be identified. 
The treatment with nuclease P1 yields mononucleotides with 3’-OH and 5’-PO4 and these 
nucleotides along with any chemical modification, if present, can be separated and 
identified by LC-MS/MS. The nuclease P1 digested sample was then treated with base or 
nucleophile to identify where exactly these small molecules are covalently attached. 
Subsequent isotopic labelling experiments and the comparison with authentic standards 
established the identity of these small molecules as dephospho-coenzyme A and its 
acetyl, methylmalonyl and succinyl- thioester derivatives. 
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The method used to identify CoA and CoA-thioester linked RNA molecules is 
limited by the fact that the covalent conjugates must be labile to base or nucleophile. A 
more general method was developed to detect any small molecule-RNA conjugates 
independent of their chemical reactivity [113]. In this method, total cellular RNA was 
subjected to size exclusion chromatography and low-molecular weight contaminants 
(<2,500 Da) were discarded. The macromolecular fraction that contains RNA was 
divided into two halves. Nuclease P1 digestion was performed in first half and other half 
was treated as control group by treating with heat-inactivated Nuclease P1. Both the 
fractions were subjected to size exclusion chromatography and small molecule fraction 
after size exclusion was analyzed by LC-MS. This method detected >20 non-canonical 
species that were enriched in the small molecule fraction. Analysis of MS-MS 
fragmentation pattern led them to hypothesize that one of the highly enriched small 
molecules is NAD and subsequent comparison with authentic NAD-RNA as a positive 







Figure 1.2 Cofactor linked RNA conjugates in bacteria. 1) CoA-RNA 2) acetyl-
CoA-RNA 3) methylmalonyl-CoA-RNA 4) Succinyl-CoA-RNA and 5) NAD-RNA 
 
The sequence identity of CoA-linked, thioester-CoA- linked and NAD-linked RNA is 
important to study their biological significance. However, the sequence information of 
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these cofactor-capped RNA molecules was unfortunately not obtainable from the original 
publications. As the method required treatment of RNA with nuclease P1 before LC-MS 
analysis, any associated sequences would therefore be shredded into nucleotide 
monophosphates. After six year of their known existence, the laboratory of Andres 
Jäschke developed a chemo-enzymatic method for the capture of NAD-RNA without 
degrading their sequences [114]. They found adenosine diphosphate ribocyclase 
(ADPRC) from Aplysia californica can transglycosylate NAD with alkenyl alcohols 
[114]. ADPRC was used to transfer 4-pentyl-1-ol to NAD-RNA and biotin-azide was 
reacted to the transglycosylation product by copper catalyzed azide-alkyne cycloaddition. 
The biotinylated RNA was captured on streptavidin beads, ligated to 3’ adaptor, reverse 
transcribed, ligated second adaptor, amplified by PCR, and sequenced by next-generation 
sequencing (NGS) technology [114]. This method allowed the specific capture and 
amplification of NADlyated RNA that are present in sufficient quantity and show no bias 
toward ADPRC catalyzed transglycosylation reaction. Application of this workflow in 
total RNA of E. coli JM-109 and K12 strain captured many regulatory sRNAs and some 
mRNAs. For example, GadY, McaS, GcvB, ChiX, RNAI, and CopA were enriched 
sRNAs that are reported to act on various regulatory pathways [114]. The latter two 
RNAs- RNAI and CopA, were the most abundant sRNAs which are characterized as 
antisense regulators of plasmid ColE1 and R1 respectively. In addition to sRNAs, several 
mRNA 5’ fragments for example D-tagatose-1,6-bisphosphate aldolase (gatY), 
methylglyoxal synthase (mgsA), glycerol-3-phosphate dehydrogenase (glaA),threonyl-
tRNA synthetase (thrS), pgk, hdeD, ilvL, and hisL were also found to exist as NAD-RNA 
conjugates [114]. The transcripts were only mapped at the 5’ termini, not the full length. 
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Some of the NAD-conjugated transcripts like hisL and ilvL encodes leader peptides that 
attenuate the operons of amino acid synthesis. Several enriched RNAs, for example, 
HdeD and uspE act in stress response to acid and ultraviolet radiation respectively.  
In addition to its regulatory and stress-response related roles, the conjugation of NAD to 
RNA 5’ terminus offers stabilization of these RNAs in the cell. Bacterial RNA 
degradation pathway is largely initiated by interaction of RNaseE with 5’ monophosphate 
[45]. The presence of canonical triphosphate group at the RNA 5’ end therefore prevents 
it from RNase initiated degradation. RNA 5’-phosphohydrolase (RppH) catalyzes the 
removal of 5’ triphosphate and creates 5’ monophosphate, enabling RNase E mediated 
degradation. The presence of NAD as a 5’ cap therefore prevents RNase E to recognize 
and bind to 5’ monophosphate to initiate RNA cleavage. In E. coli, the decapping of 
NAD-capped RNAs is achieved by a nudix hydrolase NudC that generates 5’ 
monophosphate RNA, triggering RNase E mediated decay [114]. The structural basis of 
NudC mediated NAD-RNA decapping was investigated by crystallizing enzyme with 
NAD and extrapolating the structural data for NAD-RNA [115]. These findings solved 
the various aspects of NAD-RNA in bacteria including their sequences, biological role 
and metabolism. 
The biogenesis of cofactor linked RNA conjugates including NAD-RNA and CoA-RNA 
can in principle be achieved by two possible mechanisms. First, considering dephospho-
CoA and NAD contain adenosine diphosphate in their structures, CoA-RNA and NAD-
RNA can be generated by aberrant transcription initiation by dephospho-CoA and NAD 
respectively. This mode of CoA-RNA and NAD-RNA synthesis is experimentally 
established for T7 RNA polymerase under ATP initiated promoter. The original study by 
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David liu’s lab investigated this possibility and tested whether E. coli RNAP can co-
transcriptionally incorporate dephospho-CoA and NAD into RNA [112, 113]. They found 
E. coli RNAP does not incorporate these cofactors on RNA and hypothesized that 
incorporation of CoA and NAD occurs post-transcriptionally. Second, precursors of 
coenzyme A and NAD — 4’-phosphopantetheine and NMN can be transferred to ATP 
initiated RNA post-transcriptionally yielding CoA-RNA and NAD-RNA respectively. 
The artificial ribozymes with such activity were previously discovered by in vitro 
selection [104]. Although these ribozymes are artificial and selected from a random 
library, the possibility of existence of ribozyme or protein enzymes having such activity 
cannot be ruled out. 
In contrast to the results on biogenesis of cofactor-linked RNAs from original study, two 
recent studies demonstrated that NAD, NADH and dephospho-CoA are incorporated into 
RNA co-transcriptionally as non-canonical initiator nucleotides (NCINs) for E coli 
RNAP [116, 117]. Although it was previously shown that E. coli RNAP can initiate 
transcription with NAD, FAD, and CoA in case of abortive transcripts and can make 
cofactor linked RNAs of 2 nucleotides long [103], Bird et al. first demonstrated E. coli 
RNAP can also make full length transcripts (~100 nt long) initiated with NCINs [117]. 
Such an initiation requires +1A promoters, implying that NCIN competes with ATP for 
the transcription initiation. The efficiency of capping was found to be determined by 
promoter DNA sequence at and upstream of the transcription start site (TSS) [117]. In 
addition to +1 position, the position immediately upstream of TSS, -1, affected the yield 
of NCIN-capping indicating the nucleotide at -1 probably mediates additional interactions 
with nicotinamide ring of NAD [117]. However, these results were contradicted by 
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another study performed by Julius and Yuzenkova as they found the yield of NAD 
capping was not dependent on the nucleotide at -1 position of template strand [116]. They 
performed a kinetic study to analyze the efficiency of NAD incorporation under RNAI 
promoter with A, T, G and C at -1 position. While the Km values for NAD and ATP were 
higher for the promoters having A and G at -1 position than for C and T at -1, the 
tendency of ATP incorporation was similar for all four promoters having different base at 
-1 position. If one assumes that the tendency to incorporate ATP RNA 5’ end does not 
necessarily reflect tendency to incorporate NAD, these results are not sufficient to claim 
NCIN capping is independent to the nucleotide at -1 position. 
The idea of transcription initiation by NCINs under definite promoter is supported by 
recent development of CapZyme-seq technique [118]. Using this method, Vvedenskaya 
and colleagues comprehensively analyzed NAD capping under a library of ~16,000 
promoter sequences for E. coli σ70 holoenzyme. This study identified the consensus 
promoter sequence that favors transcription initiation with NAD and defined TSS for 
NAD incorporation into nascent transcripts [118]. The consensus promoter sequence was 
found to be HRRASWW, with underlined A being the TSS (H: A,C or T; R: A or G; S: G 
or C and W: A or T) [118]. Capzyme-seq revealed that nucleotides at -3 to +2 positions 
on the promoter determines the ability of NAD to initiate transcription. Moreover, the 
nucleotide at -1 position was also found to play a role in NCIN capping efficiency as a 
clear favor was seen toward A or G than C and T at -1 probably because of favorable 
stacking interaction of adenosine containing moiety at this position [118, 119]. These 
results collectively established that cofactor linked RNA molecules arose from the ability 
of RNAP to initiate transcription with ADP containing molecules under certain 
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promoters. However, RNAP mediated incorporation may not be the only mechanism for 
the biogenesis of cofactor-linked RNAs. Specially, since ribozyme mediated transfer of 
NMN, FMN and 4’-phosphopantetheine was previously demonstrated [120], a similar 
mechanism may exist for the post-transcriptional labelling of RNA with these cofactors. 
The existence of cofactor linked RNA molecules is not limited to bacterial domain of life. 
NAD-linked RNAs have been found to exist in yeast [121], Plants [122, 123], and in 
humans [124, 125]. In yeast, NAD+ was found to be added to some mRNA encoding 
ribosomal protein and mitochondrial transcripts [121]. The same study suggested that 
NAD was incorporated into RNA co-transcriptionally for two reasons: first the 
enrichment for introns and exons in intron containing NAD-RNA was similar, suggesting 
the NAD+ group was added before the splicing event. Second, there was a strong 
correlation between mitochondrial NAD-RNA transcripts and 5’-end processing of 
mitochondrial RNA [121]. Since most of the mitochondrial RNAs are initiated with ATP 
and only those transcripts that do not undergo 5’ end processing were enriched in the 
study, it was concluded that NAD-RNAs were generated as a result of competition 
between NAD and ATP to initiate transcription under RNA pol II and mitochondrial 
RNA polymerase [121]. In Arabidopsis, thousands of nuclear RNA and mitochondrial 
RNAs were found to contain NAD+ cap [123]. Interestingly, NAD-RNAs in Arabidopsis 
were associated with polysomes and translated [122, 123]. In humans, small non-coding 
RNAs and mRNAs were found to be capped with NAD+ in HEK293T cells [125]. 
Interestingly, NAD-RNA were neither get translated as in case of yeast and Arabidopsis 
NAD-RNA nor this NAD capping helped RNA to make more stable as in case of 
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bacterial NAD-RNA[125]. Instead, tagging cellular RNAs with NAD+ promoted RNA 
decay through DXO mediated deNADding [125]. 
While NAD-RNA were first identified to exist in E. coli and S. venezulae in 2009, a 
method to selectively capture and sequence them was developed seven years later in 
2016. The amount of time it took for NAD-RNA capture method development reflect the 
level of difficulty to selectively capture these species. Once capture method was 
available, appearance of multiple publications in following couple of years hints the 
significance of this area. As of now, many aspects of NAD-RNA in biology including 
their sequences, mechanism of biogenesis, biological functions, and mechanism of 
turnover are investigated. Continued research in this area will further add many other 
dimensions in above-mentioned aspects of NAD linked RNA.  
1.5  CoA-linked RNA 
Although found to exist in both gram positive and gram-negative bacteria at the 
same time as NAD-RNA in 2009, very little is known about CoA-linked RNAs aside 
from their existence. The first and most critical step to study CoA-RNA would be to 
capture them and find out their sequence information. However, a method to specifically 
capture CoA-RNA is not available as of now. Without a specific way to capture them, 
different aspects of CoA-RNA including their sequence, biogenesis, biological function, 
and degradation are still a mystery. As CoA and NAD both are enzyme cofactors in 
contemporary biology, it can be speculated that attachment of CoA on RNA may function 
to protect RNA from RNase E mediated degradation like NAD-RNA, at least in bacteria. 
However, the evolution of two different types of RNA modifications for seemingly same 
function would be questionable. The biological role of CoA-RNA therefore might be 
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speculated beyond RNA protection. As NAD and CoA both are known to interact with 
multitude of protein enzymes, their covalent conjugation with RNA might be involved in 
guiding RNA-protein interactions. As CoA participates as enzyme cofactor in acyl 
transfer reactions, CoA-RNA might serve in such a capacity. Indeed the original study 
carried out by David Liu’s lab found that CoA-RNA in bacteria is thioesterified with 
three different acyl groups: acetate, methylmalonate, and succinate; and exists as 
acetylCoA-RNA, methylmalonylCoA-RNA and succinylCoA-RNA [112]. As these 
CoA-thioesters represent different energy state of the cell whose concentration vary 
according to the metabolic needs, thioester-CoA-RNA and CoA-RNA transcripts may 
sense the cellular energy state and may act as a trigger for specific metabolic changes. 
Synthetic CoA-RNA transcripts were first generated by the action of ribozyme that can 
catalyze the reaction pant-p + pppA-RNA → CoA-RNA+ Ppi. Successful isolation of 
RNA enzyme with CoA synthesizing activity strongly supported the idea that CoA and 
CoA-thioesters might have been present since RNA world. Although these ribozymes 
were isolated from non-natural randomized RNA library, the possibility of existence of 
such ribozymes in contemporary biology with such activity cannot be debunked. In this 
sense, CoA-RNAs and thioester-CoA-RNAs found in bacteria may still be acting as 
ribozymes or the molecular fossils of ribozymes form hypothetical RNA world. The 
sequence information of CoA-RNA is the fundamental requirement to explore such 
functional capabilities of CoA-RNA in current biology. 
The biogenesis of CoA-RNA can be speculated to occur by two mechanisms: 1) RNAP 
mediated transcription initiation by dephospho-CoA and 2) post-transcriptional transfer 
of 4’-phosphopantetheine to ATP initiated RNA. Co-transcriptional incorporation of 
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dephospho-CoA is not straightforward as that of NAD. The cellular concentrations of 
NAD can reach low millimolar range (up to ~3 mM at high glucose containing media), 
that makes it able to compete with cellular ATP for transcription initiation [126]. 
However, the concentration of dephospho-CoA does not reach at such high 
concentration. CoA itself cannot act as a transcription initiator because of the 3’ 
phosphate group. The cellular concentration of dephospho CoA is about 40 µM while 
ATP is in 1-5 mM concentration [127]. This ~100-fold difference in concentration makes 
dephospho-CoA a very weak competitor of ATP to initiate transcription. Furthermore, all 
the ATP initiating promoters cannot incorporate NCIN at +1 position [118, 124]. The 
promoter’s ability to incorporate NCINs like dephospho-CoA puts another layer of 
regulation for CoA-RNA biogenesis. Therefore, it can be speculated that the combination 
of two constraints- low cellular concentration of dephospho-CoA initiator and the 
promoter’s ability to incorporate NCIN at +1 position makes it difficult to incorporate 
dephospho-CoA into RNA co-transcriptionally. 
The post-transcriptional mode of CoA-RNA biogenesis can be thought similar to 
eukaryotic mRNA capping. In eukaryotes, a cap of 7-methylguanosine (m7G) is added 
post-transcriptionally by the combined action of three different enzymes: RNA 
triphosphatase that trims off the  pyrophosphate from pppRNA to make pRNA; mRNA 
guanylyltransferase that transfers GTP to pRNA and finally RNA-(guanine-N7-)-
methyltransferase that transfers methyl group to N7 of guanosine [119, 128]. A similar 
mechanism may exist to transfer pant-p to ATP-RNA post-transcriptionally. Such 
mechanism will not have concentration constraints and promoter bias problem but the 
RNA structure at the 5’ end may be a restriction to enzyme’s access and may serve as a 
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basis of selectivity. Moreover, NAD-RNA can also be generated by a similar mechanism 
where the coenzyme precursor NMN are transferred to ATP initiated RNA by PPAT 
(coaD) like enzymatic activity of NadD. PPAT (coaD) is an enzyme of CoA-biosynthetic 
pathway that catalyzes the transfer of pant-p to ATP to make dephospo CoA. Since ATP-
RNA can be considered as an analog of ATP, PPAT itself may be able to catalyze such 
transfer. Alternatively, there could be another enzymatic machinery that accepts pppRNA 
or pRNA generated after RppH hydrolysis and transfers the pant-p to yield CoA-RNA. 
Without capturing and uncovering their sequence, we can only speculate the function and 
biogenesis of CoA-linked RNA. 
In addition to unknown biogenesis and significance of CoA-RNA in current biology, 
their existence in different domains of life is not clear. If RNAP mediated transcriptional 
initiation by dephospho-CoA is the only mode of CoA-RNA biogenesis, it can be 
speculated that CoA-RNA conjugates are limited to bacterial domain of life only. While 
CoA synthesis is bacterial and eukaryotes follows the same reactions orders, the 
mechanism is slightly different. In eukaryotes, the last two enzymes of the CoA 
biosynthesis pathway, coaD and coaE, exist as a single multifunctional complex known 
as CoA synthase. Therefore, dephosphoCoA is not released during the synthesis in 
eukaryotes while in bacteria coaD and coaE exist as two separate enzymes allowing 
release of free dephospho-CoA in cytosol. The unviability of dephospho-CoA initiator 
molecule in higher eukaryotes can therefore be speculated as a limitation for the 
existence of CoA-RNA and thioester-CoA-RNA beyond bacterial domain of life.  
The successful capture and sequencing of CoA-RNA will be a significant 
achievement to expand the horizon of CoA function and RNA-function in contemporary 
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biology. The development of CoA-RNA capture method will be a milestone to 
investigate their diversity in other domains of life other than bacteria. The capture method 
will require a CoA-specific protocol like that of NAD-RNA capture protocol. Since CoA 
and CoA-thioesters are believed to have ancient origin, study of CoA-RNA conjugates 
may reveal the hidden molecular secrets of evolution. The study of CoA-RNA will 
therefore help to better understand the fundamentals current biology and origin of life. 
We are inspired to find answers to many questions arose by the finding of CoA-RNA 
existence. For example, beside myriad of functions of CoA in contemporary biology, are 
there any more responsibilities that CoA is undertaking? How these CoA-RNA 
transcripts are being made in the cell? Do these CoA-RNA conjugates are functional or 
exists as molecular fossils from RNA world? What functional and evolutionary 
advantage did RNA get by having a CoA and thioester CoA-tag? This work will give us 
new perspective to expand our knowledge in these areas. Answer to these questions will 
expand our knowledge about ourselves, our origin, our evolution into current shape, and 
our environment. Therefore, uncovering the sequences and biogenesis of CoA-RNA will 










CHAPTER II – OBJECTIVES OF RESEARCH 
The existence of CoA-RNA and CoA-thioester-RNA in E. coli and S. venezulae 
opened a new research questions on contemporary RNA functions and expanded the 
conventional role of not only CoA and CoA thioesters as enzyme-cofactors in acyl 
transfer reactions but also RNA. Since CoA and CoA-thioesters are believed to have an 
ancient origin, the existence of CoA linked RNA in modern organism may represent a 
snapshot of evolutionary transition at the molecular level from ancient RNA world to 
contemporary RNP world. These molecules may represent the true molecular fossils 
existing since RNA world and their identification and characterization may be beneficial 
in expanding our understanding on how the evolution took a current shape. Moreover, 
these CoA linked RNA molecules may not be just a reminiscent of evolution rather 
possibly functioning as a metabolite sensor, RNA enzymes, or directing RNA for 
different purposes. The identification of sequences of CoA linked RNA is the first step to 
comprehensively understand their biological significances. The development of CoA-
RNA capture protocol keeping the integrity of CoA linked RNA is therefore crucial. Our 
lab’s long history in studying CoA & RNA and our expertise in chemistry and biology of 
both CoA and RNA has set us in a unique position to develop such method for CoA-RNA 
capture and study their function, biogenesis, and metabolism.  
The goal of this research is to illuminate the sequences, and mechanism of biogenesis of 
CoA linked RNA in bacteria. We hypothesize that the enzyme of CoA biosynthesis 
pathway can be used to synthesize dephospho CoA and other dephospho-CoA analogs so 
that synthetic CoA-RNA is easily accessible. We further hypothesize that CoA-RNA can 
be captured if we could find an enzyme that specifically forms a thioester between 
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biotinylated fatty acid and CoA-RNA. Moreover, we speculate that the CoA labelling on 
RNA occurs post-transcriptionally by the activity of phosphopantetheine 
adenylyltransferse (PPAT).  The specific objectives of this research are: 
1. Development of an easy and simple method for the synthesis of dephospho-
CoA.  
The successful development of CoA-RNA capture protocol requires an easy 
access to synthetic CoA-RNA. While T7 RNA polymerase in combination with 
T7 φ2.5 promoter can initiate transcription with dephospho-CoA yielding CoA-
RNA, the availability of initiator dephospho-CoA molecule is limited. The first 
objective of this research is to develop an easy method for the synthesis of 
dephospho-CoA so that synthetic CoA-RNA is easily accessible to scientific 
community. The two enzymes of CoA salvage pathway, PanK and PPAT, will be 
purified recombinantly and their ability to synthesize dephospho CoA and its 
analogs will be investigated.  
2. Search of an acyl CoA ligase enzyme able to ligate biotinylated fatty acid to 
CoA linked RNA. 
 The capture of CoA-RNA from E. coli RNA will require a specific method to 
ligate them to a purification handle like Biotin. We hypothesize that the enzymes 
of acyl CoA ligase family may able to catalyze the ligation of biotinylated fatty 
acid and CoA-RNA allowing their capture in intact form. The candidate enzymes 
will be cloned, expressed and purified recombinantly and their ability to accept 
modification on canonical substrates will be characterized. Biotinylated fatty acid 
will be chemically synthesized, and dephospho-CoA will be used a transcription 
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initiator to make CoA-RNA by in vitro transcription. If an enzyme that can ligate 
CoA-RNA to biotinylated fatty acid is found to exist, it will be used to capture 
CoA-RNA from total RNA pool which will be sequenced and characterized later.  
3. Synthesis of pantetheine analogs for the labelling of CoA-RNA in vivo 
The capture of CoA-RNA can alternatively be achieved by labelling them in vivo 
with a pantetheine containing a purification handle like biotin. Various 
pantetheine analogs will be synthesized and their ability to enter the cell and label 
RNA will be characterized. We hypothesize that the incorporation of positive 
charges on the analogs will be advantageous for their entry into the cell. A 
fluorescent or radioactive reporter tag will be integrated to the pantetheine 
analogs to track their cellular entry and localization.   
4. Determination of CoA-RNA biogenesis in E. coli 
There are two possible scenarios for CoA-RNA biogenesis- (1) by co-
transcriptional mode where dephospho CoA acts as a transcription initiator and 
(2) by post-transcriptional mode where pant-p is transferred to ATP initiated RNA 
by some unknown enzymatic machinery. We are hypothesizing that CoA-RNA is 
being synthesized post-transcriptionally in E. coli. We further speculate that 
phosphopantetheine adenylyltransfersase (PPAT (coaD)) can accommodate ATP 
initiated RNA in its active site yielding CoA-RNA in a similar way it forms 
dephospho-CoA. The enzyme will be expressed and purified recombinantly and 





CHAPTER III – MATERIALS AND METHODS 
3.1 INSTRUMENTATION AND EQUIPMENTS 
 
Name – Model (Company) 
Accumet Basic pH meter – XL25 (Fisher Scientific) 
Analytical Balance – HR 60 (A&D Co)  
Autoclaves – LG 250 and 3031-S (Amsco Eagle)  
Balance – Pioneer (Ohaus)  
Centrifuge – Avanti J-26 XP (Beckman Coulter)  
Centrifuge Rotors – JA-14, JA-16.250, JA-20, and JA 25.50 (Beckman) 
Chemical fume hood (Labconco) 
Electrophoresis Power Supply – EC 154 (E-C Apparatus Corporation) 
 Electrophoresis Power Supply – EC4000P (E-C Apparatus Corporation) 
 Electrophoresis Power Supply – PowerPac Basic (BioRad) 
 Freezer -20 °C (Frigidaire)  
Freezer -80 °C (Forma Scientific)  
Gel Documentation System – ChemiDoc MP (Bio-Rad) 
Gel Dryer – Model 853 Gel Dryer (Bio-Rad)  
Heating Blocks – 12359030 (VWR) 
HPLC Control - SCL-10A VP (Shimadzu)  
HPLC Diode Array Detector – SPD-10A VP (Shimadzu)  
High Pressure Liquid Chromatograph – LC-10AT VP (Shimadzu) 
 HPLC Degasser – DGU 14A (Shimadzu) 
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HPLC Organizer (Hitachi) 
HPLC- UV Detector L2400 (Hitachi) 
HPLC- pump L2180 (Hitachi) 
Horizontal Electrophoresis System – FB-SB-710 (Fisher)  
Horizontal Electrophoresis System – Mini-sub Cell GT (BioRad) 
 Incubator 37 °C – 120 (Labline Instruments Inc.)  
Liquid Scintillation Counter – 425 034 (Hidex) 
Lyophilizer (Labconco) 
Mass spectrometer 
Microcentrifuge – 5415 C (Eppendorf)  
Microplate Reader – SpectraMax M3 (Molecular Devices)  
NMR (Burker) 
Micron Centrifugal Filter Devices – M3, M10, M30, & M50 (Millipore)  
Phosphorimager/Molecular Imager FX – 729 (BioRad)  
phosphor screen (Kodak) 
Pipettes – P-1000, P-200 (VWR)  
Pipettes – P-200, P-10, P-2 (Fisherbrand)  
Pipettes – P-1000, P-200, P-20 (Thermo)  
Refrigerator -20 °C & +4 °C (Kenmore) 
Reverse phase HPLC columns (Agilent and Econosphere) 
Rotary evaporator (IKA) 
Sonicator – XL-2000 (Misonix)  
Spectrophotometer – 8453 (Agilent)  
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Stirrers (Nuova)  
Thermocycler – Mastercycler (Eppendorf)   
Thermocycler (Bio-rad) 
UV Lamp – Blak-Ray B100A (UVP)  
Vacuum pump (Fisher Scientific/ Welch) 
Vertical Gel Apparatus – V16 (GibcoBRL)  
Vertical Gel Apparatus – Mini Protean 3 (BioRad)  
Vortexer – G560 (VWR)  
 
3.2 Chemicals, Reagents, and Kits 
Name – (Company) 
Acetic acid (Fisher) 
Acetonitrile (Fisher) 
Acrylamide (40%, 19:1) – (Bio-Rad) 
Acrylamide (30%, 37.5:1) – (Bio-Rad) 
Adenosine triphosphate (Sigma) 
Agar (DIFCO) 
Agarose (Fisher) 
Ammonium Persulfate (Sigma) 
Ampicillin sodium salt (Sigma) 
Ampliscribe T7 Flash Transcription Kit (Epicentre) 
Βeta-Mercaptoethanol (Sigma) 
Boric Acid (Sigma) 
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Bromophenol Blue (Sigma) 
Chloroform (Fisher) 
Coenzyme A Trilithium salt (Sigma) 
Dextrose (Fisher) 
DCM (Sigma) 




EDTA Disodium Salt (Fisher) 
Ethanol (Decon) 
Ethidium Bromide (Sigma) 
Ethyl acetate (VWR) 
Formic acid (Fisher) 
GelCode Blue Safe Protein Stain (Thermo) 
Glacial Acetic Acid (Sigma) 
Glycerin (Fisher) 
Glycine (Research Products International Corp.) 
Glycolate methyl ester (Alfa Aesar) 
HCTU (Chem impex international) 
Hydrochloric Acid (Fisher) 
Imidazole (Sigma) 
Isopropyl β-D-1-Thiogalactopyranoside (IPTG) (Fisher) 
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Kanamycin Sulfate (Fisher) 
Kodak Storage Phosphor Screen SO230 (Bio-Rad) 
Lactate methyl ester (Alfa Aesar) 
Lauryl Sulfate (Research Products International Corp.) 
Magnesium Chloride (Fisher) 
Methanol (Fisher) 
Microcon M30 and M50 Centrifugal Filter Devices (Millipore) 
MMLV Reverse Transcriptase (Promega) 
N-methyl morpholine (Chem Impex International) 
NiNTA HisPur Resin (Thermo) 
Pantethine (Chem impex international) 
Piperidine (Sigma) 
Phosphoric Acid (Sigma) 
Poly-Prep Chromatography Columns (Bio-Rad) 
Potassium Chloride (Fisher) 
Potassium Phosphate Monobasic (Sigma) 
Potassium Phosphate Dibasic (Sigma) 
Q5 Hot-Start DNA Polymerase (New England Biolabs) 
RNasin (New England Biolabs) 
Sodium Acetate (Sigma) 
Sodium Chloride (Fisher) 
Sodium Hydroxide (Fisher) 
T7 RNA Polymerase (Epicentre) 
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Taq DNA Polymerase (Promega) 
TBDMS Chloride (Chem Impex International) 
TCEP (Oakwood Chemical) 





Xylene Cyanol (Sigma) 
Yeast Extract (Fisher) 
3.3 Buffers and commonly used reagents 
Table 3.1 5X CoaDA buffer (pH 7.0, 10 mL) 
Components 5x Concentration 1x Concentration 
Tris 250 mM 50 mM 
KCl 100 mM 20 mM 
MgCl2 5 mM 1 mM 
 
Table 3.2 5X ACS Buffer pH 8.4 
Components Concentration 
Tris 100 mM 
MgCl2 10 mM 





Table 3.3 5X SucCD buffer pH 7.4 
Components Concentration 
Hepes 0.1 M 
MgCl2 10 mM 
KCl 50 mM 
 
Table 3.4 5X MatB buffer pH 7.2 
Components Concentration 
Tris 100 mM 
MgCl2 5 mM 
KCl 50 mM 
 
Table 3.5 5X FadK buffer (pH 7.5, 10 mL) 
Components 5x Concentration 1x Concentration 
Tris 200 mM 40 mM 
MgCl2 25 mM 5 mM 
 
Table 3.6 Denaturing gel loading dye (10 mL) 
Components Concentration 
4.2 g Urea 20% 
1 mL 10x TBE buffer 7 M 
Bromophenol blue 1X 
Xylene cyanol  
4 mL water  
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Table 3.7 20% Denaturing Gel mix 
Components Concentration 
200 ml 40% acrylamide (19:1) 20% 
210 g Urea 7 M 
50 mL 10X TBE 1X 
Water  
 
Table 3.8 12% Denaturing Gel mix 
Components Concentration 
150 ml 40% acrylamide (19:1) 8% 
210 g Urea 7 M 
50 mL 10X TBE 1X 
Water  
Table 3.9 10% Denaturing Gel mix (500 mL) 
Components Concentration 
125 ml 40% acrylamide (19:1) 8% 
210 g Urea 7 M 










Table 3.10 8% Denaturing gel mix (500 mL) 
Components Concentration 
100 ml 40% acrylamide (19:1) 8% 
210 g Urea 0.1% 
50 mL 10X TBE 1X 
Water  
 
Table 3.11 LB growth medium (1 L) 
Components Concentration 
10 g Tryptone 10% 
5 g yeast extract 5% 
10 g NaCl 10% 
Water to 1 L and autoclave  
 
Table 3.12 M9 growth medium (1 L) 
Components Concentration 
5X M9 salts  1X 
4 g Glucose 0.4% 
12 mg MgSO4 0.1 mM 
10 µL 1 M CaCl2 5 µM 






Table 3.13 PCR (100 µL) 
Components Concentration 
10 µL 10x thermophilic taq buffer 1X 
10 µL 25 mM MgCl2 2.5 mM 
1 µL 25 mM dNTPs mix 250 µM 
5 µL 20 mM primer pair 1 µM 
1 µL 5 U/ µL Taq DNA polymerase  0.05 U/ µL 
Template DNA  
Water to 100 µL  
 
Table 3.14 T7 RNA transcription (20 µL) 
Components Concentration 
2 µL 10x transcription buffer 1X 
2 µL 100 mM DTT 10 mM 
6 µL 25 mM NTPs mix 7.5 mM 
2 µL 10 µM (10X) Template DNA  1 µM/ 1X 
0.5 µL 40 U/ µL RNase inhibitor  1 U/µL 
2 µL T7 RNA polymerase 10% v/v 








Table 3.15 Reverse transcription (20 µL) 
Components Concentration 
4 µL 5X RT Buffer 1X 
0.8 µL 25 mM dNTPs 1 mM 
1 µL 20 µM Primers 1 µM 
RNA ~50 nM 
1 µL of 10u/µL MLV reverse 
transcriptase 
0.5 u/ µL 
Water to 20 µL  
 
Table 3.16 12% SDS-PAGE Gel solution (15 mL) 
Components Concentration 
3.75 mL Tris 1.5 M, pH 8.8 375 mM 
0.75 ml 2% SDS 0.1% 
6 ml 30% acrylamide (37.5:1) 12% 
20 μl TEMED 0.13% v/v 
90 ul 10% ammonium persulfate 0.06% 










Table 3.17 4% SDS-PAGE Gel solution (6 mL) 
Components Concentration 
1.5 mL Tris 1.5 M, pH 6.8 125 mM 
0.3 ml 2% SDS 0.1% 
0.8 ml 30% acrylamide (37.5:1) 4% 
7 μl TEMED 0.11% 
37 ul 10% ammonium persulfate 0.06% 
Water to 6 mL  
 
Table 3.18 10X TBE Buffer (1 L) 
Components Concentration 
121.1 g Tris 1 M 
61.8 g Boric Acid 1 M 
7.4 g EDTA disodium salt 20 mM 
Water to 1 L  
 
Table 3.19 10X Tris-glycine running buffer 
Components Concentration 
30 g Tris 250 mM 
144 g Glycine 2 M 
10 g SDS 1% 





Table 3.20 Tris buffered saline (TBS) 5X 
Components Concentration 
30 g Tris 250 mM 
146.1 g NaCl 2.5 M 
Adjust pH to 8.0, 




3.4 General Experimental Procedures 
3.4.1 Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) was carried out in 10 μL- 100 μL volumes 
according to the need with 1X thermophilic buffer or Q5 buffer, 0.25 mM dNTPs, 1 μM 
forward and reverse primer, and 0.02-0.05 U/μL of Q5 DNA Polymerase or Taq DNA 
polymerase following the manufacturer’s protocol. The dsDNA template was denatured 
at 95°C-98 °C for 2’ and cycled for 10 seconds of denaturation, 10 seconds of annealing 
at the temperature predicted by IDT, and extension at 72 °C 1 min/kb. The PCR products 
were separated by agarose gel electrophoresis, stained with ethidium bromide and 
visualized using Molecular Imager FX. 
3.4.2 In vivo cloning 
The DNA fragments for the assembly was prepared by PCR. An overlap of 20 bp 
was created at both ends of the fragments by using overhang on the PCR primer. DNA 
fragments were cleaned up either by gel purification or by using Zymo PCR clean and 
concentrator kit following manufacturer’s protocol. The fragments were mixed in vitro in 
~1:1 concentration and transformed into competent E. coli cells. The cells were grown 
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overnight at 37 °C, colonies were picked up next morning, and grown for ~12 h at 37 °C. 
The plasmid isolation was carried out by standard protocol. 
3.4.3 Preparation of Plasmid DNA 
Preparation of plasmid DNA was carried out by following standard protocol from 
Epoch life sciences with few modifications. Cells were grown in 5 mL antibiotic 
containing media overnight at 37 °C with constant shaking. They were harvested by 
centrifugation (10,000 RPM, 2 minutes) and the cell pellet was resuspended in 200 µL 
Mx1 buffer. Lysis buffer (MX2), 250 μL was added and incubated at room temperature 
for 1 minute. 350 μL MX3 buffer was added to neutralize the lysate and cleared by 
centrifugation (10,000 RPM, 2 minutes). The supernatant was transferred into genecatch 
spin column and centrifuged for 30 seconds at 5,000 RPM. Washing was performed with 
500 μL of WN and 700 μL of WS buffer at 9,000 RPM. Residual ethanol was removed 
by centrifugation at 13,000 RPM for 2 min. Then plasmid DNA was eluted from the 
column with 50 μL EB by centrifuging at 13,000 RPM for 30 seconds. 
3.4.4 Agarose gel electrophoresis 
Agarose gel was prepared by dissolving the required amount of agarose (0.3 g for 1% and 
0.6 g for 2%) in 30 mL 1X TBE buffer at 100 °C. It was allowed to cool down to ~ 70 °C 
and 5 μL EtBr was added as a staining dye. The gel was poured into the casting tray, 
wells were created by putting a comb, and left at room temperature for ~20 minutes to 
set. The samples were prepared by mixing with equal volume of 2X gel loading buffer. 
Gel was run for 30 min- 1 h at 4 100 V/ 4 W. The gel was visualized by molecular imager 




3.4.5 Small Scale protein expression and solubility testing 
The plasmid harboring the gene of interest was transformed int expression cell lines 
(High-Control Bl21 DE3, Rosetta 2 DE3, Rosetta2 DE3 plysis) following manufacturer’s 
protocol. The transformants were grown in a LB-Agar plate containing appropriate 
antibiotics. A colony was picked up next morning, grown in 5 mL of the media until 
OD600 reached 0.6. Cells from 0.5 mL of the culture was harvested, resuspended in 50 
μL 4X Lamelli buffer, and used a uninduced lysate. Rest of the culture was induced by 
adding IPTG in 0.2 mM – 0.5 mM concentration for 3 hours at 37 °C. The cells were 
harvested same way as for uninduced lysate. Both induced lysate and uninduced lysate 
were heated at 95 °C for 5 minutes and then spun at 5,000 X g for 5 minutes. The 
remaining culture was pelleted, resuspended in 1 mL 1X TBS buffer, and lysed by 
sonicating on ice for 3 cycles of 10 seconds on and 50 seconds rest using a sonicator with 
the XL-2000 Misonix Ultra Liquid Processor probe. The resulting cell lysate was pelleted 
by spinning 16,000 X g for 5 minutes. 4X Lamelli buffer was added to both pellet 
(insoluble fraction) and supernatant (soluble fraction). All the samples- uninduced cell 
lysate, induced cell lysate, soluble lysate and insoluble lysate was loaded onto the SDS-
PAGE gel and run for 1 h at 160 V. The gel was visualized by Bio-rad imager after 
staining with Gelcode blue proteins stain for 1 h and destaining overnight with water.  
3.4.6 Large scale protein expression and the preparation of cell lysate 
After establishing the conditions for soluble expression of a protein, glycerol stocks were 
used to inoculate 5 mL antibiotic containing media (LB-Kan for all the proteins used in 
this work) and grown overnight at 37 °C. The overnight culture was used as a starter 
culture and transferred into 0.5- 1 L of the same media. The cells were grown until 
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OD600 reached 0.6 and induced by adding 0.5-1 mM IPTG. The protein expression was 
performed for 3 h (at 37 °C) or overnight (at 16°C). The cells expressing recombinant 
protein were then harvested by centrifugation (10,000 X G) for 10 minutes, resuspended 
in 10 mL lysis buffer and lysed by sonication using XL-2000 sonicator for 5 cycles of 20 
seconds on and 40 seconds rest on ice. The lysate was cleared by centrifugation at 40,000 
X g for 30 minutes at 4 °C. The protein was purified from the supernatant of the lysate. 
 
3.4.7 Protein purification by Ni-NTA chromatography 
Proteins were purified by immobilized metal affinity chromatography using Ni-NTA 
resin for His-tagged proteins. The column was prepared by settling 1 mL slurry of Ni-
NTA resin in poly-prep chromatograph column. The resin was washed with water and the 
equilibrated with 1X TBS. The soluble lysate was loaded into the column three times 
back while collecting flow-through. The column was washed with 1X TBS containing 20 
mM imidazole. wash was monitored by UV continued until absorbance at 280 reaches 
zero. The bound protein was eluted by 200 mM imidazole in 1x TBS. The protein was 
quantitated by UV using extinction coefficient predicted by expasy protparam tool. M10-
M100 membrane filters (amicon) were used to remove the imidazole and concentrate 
protein depending on the protein size. Buffer exchange was carried out with 1x TBS and 
the all the proteins were finally stored at -20 °C after supplementing with 40% glycerol. 
 
3.4.8 General silylation procedure 
Alcohol to be silylated (1 equivalent) and imidazole 2 equivalents were dissolved in dry 
DMF. 1.5-2 equivalents of TBDMSCl was added under nitrogen. The reaction was stirred 
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overnight (16 h) at room temperature and quenched by adding water. oil-free rotary 
evaporator was used to remove the volatiles at 60° C for 20 minutes. The corresponding 
TBDMS ether was extracted with ethyl acetate. Organic phase was combined, washed 
with 4x20 ml water and dried with Na2SO4. The corresponding mono- and di-TBDMS 
ether was obtained in nearly quantitative yield after removing the solvent by rotary-
evaporation at 60° C for 1 h. 
3.4.9 General desilylation procedure 
Desilylation was carried out by using three different acids: formic acid, acetic acid, and 
TFA. Three different concentration- 5%, 10% and 20% of these acids were prepared by 
mixing respective acid in MeCN containing 15% water. The reaction was initiated by 
mixing corresponding TBDMS ether with acid/aceteronitrile/water solutions in 1:10 ratio 
by volume. For model compounds TBDMS lactate methyl ester and TBDMS glycolate 
methyl ester, a small amount was taken out at different time points, quenched by adding 
NaHCO3 and injected in HPLC for kinetic analysis. UV detector of HPLC was set at 210 
nm for the carbonyl group detection. Area under the curve at different time points of 
reaction was calculated by integration feature of Ezchrom Elite software to calculate the 
rate of the primary TBDMS desilylation at different conditions.  
3.4.10 General procedure for transcription 
In vitro transcription was carried out by using Ampliscribe T7 Flash kit from Epicentre 
following the manufacturer’s protocol. Briefly, a reaction was set by mixing 1X Reaction 
buffer, 7.5 mM NTPs, 10 mM DTT, 1 U RNase inhibitor, 1μM dsDNA template 
containing φ2.5 promoter, and 10% v/v T7 RNA polymerase. The reaction volume was 
adjusted to 20 μL by adding water. Transcription was carried out at 37 °C for 1 to 3 
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hours. The synthesized RNA was cleaned-up either by using zymo RNA clean and 
concentrator kit or by NaoAc/EtOH precipitation. 
 
3.4.11 RNA clean-up 
Zymo RNA clean and concentrator kit was used to clean up RNA after transcription 
following manufacturer’s protocol. Briefly, 30 μL nuclease free water was added to 20 
μL transcription reaction to maintain the starting volume of 50 μL. Two volumes (100 
μL) of RNA binding buffer and one volume (150 μL) of 200 proof EtOH was added and 
transferred into the provided Zymo-spin IC column. It was spun for 30 seconds, flow-
through was discarded and 400 μL RNA prep buffer was added. The column was spun 
again at 16,000 x g for 30 seconds. Flow-through was discarded and 700 μL RNA wash 
buffer was added, spun and washed one more time with 400 μL RNA wash buffer. The 
column was spun at 16,000 x g for 2 minutes to remove all the wash buffer. RNA was 
eluted from the column by adding 15 μL nuclease free water.  
3.4.12 DNA/RNA precipitation 
The precipitation of DNA/RNA was carried out by sodium acetate and Ethanol. In a 
representative 100 μL DNA/RNA solution, 11 μL 3 M NaOAc and 333 μL 200 proof 
Ethanol was added. 1-5 μg of tRNA or glycogen was added as a carrier for precipitation 
whenever needed. It was mixed by vortexing and incubated at -20 °C for 1 h. The 
precipitated nucleic acid was collected by centrifugation at 16,000 x g for 10 minutes. 
The pellet was washed with 70% ethanol and spun down at 16,000 x g for 5 minutes. It 
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3.6  Cell lines and genotype 
1. Bl21 (DE3) Competent E. coli Cells (New England Biolabs) - fhuA2 
[lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
2. High-Control Bl21 (DE3) Competent E. coli Cells (Lucigen) – F - ompT 
hsdSB (rB- mB-) gal dcm (DE3)/Mini-F lacIq1 (GentR) 
3. Rosetta 2 (DE3) Competent E. coli Cells (Novagen) - F- ompT hsdSB 
(rBmB) gal dcm (DE3) pRARE2 (CamR) 
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4. One Shot TOP10 Chemically Competent  E. coli (Thermo Fisher)  
F- mcrA Δ( mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 




CHAPTER IV – CHEMOENZYMATIC SYNTHESIS OF 
DEPHOSPHO-COA AND ITS ANALOGS 
4.1 Introduction 
Coenzyme a and its thioesters are known to play a vital metabolic role in all 
domains of life. They participate in acyl transfer reactions as enzyme cofactors in almost 
~10% of the total enzymes in any organism that makes up more than 500 metabolic 
reactions at least [129]. In addition to a central role in metabolism, CoA is involved in 
regulation of cellular energy metabolism through multiple mechanisms including 
regulation of enzymes by substrate/product inhibition and regulation of gene expression 
by histone acetylation/deacetylation. For example, the abundance of acetyl CoA signals a 
cell for growth and proliferation by inducing Gcn5p/SAGA-catalyzed acetylation of 
histone [130]. This event triggers the rapid expression of growth-related genes, linking 
the cell growth and proliferation to nutrient availability through acetyl CoA 
concentration. Furthermore, the imbalance on intracellular CoA concentration may cause 
the onset of various neurodegenerative diseases including pantothenate kinase associated 
neurodegeneration (PKAN) [131]. Lowering of the CoA concertation in a cell model of 
PKAN was shown to have decreased acetylation of histone and tubulin that results in 
impaired DNA damage response, decreased locomotor function, and shorter life span 
[131]. The intracellular concentration of CoA is therefore tightly regulated, mainly by the 
feedback inhibition of pantothenate kinase (PanK) through free CoA and CoA-thioesters 
[127, 132-134]. In E. coli, PanK exists as a homodimer of 36 kD subunits and has a 
consensus ATP binding sequence of GXXXXGKS [132]. The structural data of the E. 
coli enzyme showed that CoA is a competitive inhibitor of ATP in PanK reaction as the 
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phosphate binding sites of ATP analog AMPPNP and CoA were shown to overlap. 
Furthermore, CoA thiol was shown to interact with the aromatic residues of the PanK 
making the enzyme able to discriminate in between CoA and CoA-thioesters [132]. PanK 
is the main point of regulation in mammalian CoA biosynthesis as well. Two isoforms of 
PanK (PanK1α and PanK1β) exists in murine model that arises from the alternative 
splicing of the same gene [133]. Both isoforms were shown to be regulated by feedback 
inhibition of CoA and CoA-thieosters. 
The universality of CoA and CoA-thioesters in biology may be attributed to two 
different reasons. First, a thioester bond that forms between CoA thiol and carboxylic 
acid has both ‘high energy’ and ‘stability’. Because of their optimal balance between a 
high energy and stability, CoA-thioesters were hypothesized to play a vital role during 
the evolution of biology from chemistry [135]. From an evolutionary standpoint, it is 
considered that contemporary metabolic systems could have been evolved from an 
ancient CoA centered metabolism in RNA world. Origin of life research has collected 
extensive biological evidence to suggest CoA’s ancient origin back at least to the last 
universal common ancestor (LUCA). The peculiar structure of CoA having thiol 
functional group anchored in Adenosine (RNA) further supports the idea that CoA is a 
molecular vestige from RNA world [136, 137]. In vitro evolution of a ribozyme able to 
synthesize CoA from its precursor molecule phosphopantetheine (Pant-p) strongly 
supported an availability of CoA and CoA thioesters in RNA world [76]. Ribozymes 
were further shown to catalyze CoA-thioester synthesis [12, 138] and acyl transfer 
reactions form CoA thioesters providing a strong experimental evidence on the existence 
of CoA-centered metabolic pathways during RNA world [13]. In addition, the thioesters 
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of CoA serve as activated intermediates in variety of transacylation reactions including 
TCA cycle, fatty acid biosynthesis and degradation, amino acid biosynthesis and 
degradation and polyketide synthesis in current biology. 
 
The importance of CoA in biology has promoted numerous investigations on the 
synthesis of CoA and its analogs by chemical, enzymatic, and chemo-enzymatic methods. 
The initial chemical CoA synthesis was achieved by Khorona in 1959 [139]. The 
development of chemical route to make CoA drew a significant scientific attention that 
led to the subsequent synthetic improvement by Michelson [140] and the synthesis of 
number of CoA analogs [141-143]. On the other hand, the biochemical pathway for CoA 
synthesis were elucidated, revealing the involvement of five separate enzymes- from 
CoaA/PanK to CoaE/DPCK- are required to transform vitamin B5 (pantothenate) into 
CoA in vivo [144-146]. Progress in recombinant protein expression and purification made 
these enzymes available to the scientific community that provided different enzymatic 
and chemoenzymatic routes to synthesize CoA and its analogs. Two pathways exist for 




Scheme 4.1 Synthesis of coenzyme a via de novo pathway and salvage pathway. De novo 
pathway starts with pantothenate and completes in five enzymatic transformations. 
Salvage pathway recycles the cellular CoA pool by transforming pantetheine into CoA 
through the action of three different enzymes. 
 
The de-novo pathway starts with pantothenate and yields CoA as a result of five 
enzymatic reactions. The salvage pathway recycles the existing CoA using pantetheine as 
a starting metabolite and leads to CoA in three enzymatic steps. PanK, the first enzyme of 
the pathway, can transfer phosphate from ATP to pantothenate, pantetheine, and 
pantethine (oxidized form of pantetheine). While the enzymes of CoA salvage pathway 
(PanK, PPAT and DPCK) are promiscuous, the second and third enzymes of de novo 
pathway (CoaB and CoaC) are very selective/ specific to their natural substrate. The first 
example of substrate flexibility of CoA biosynthetic enzymes was shown by an 
incorporation of desulfopantetheine into CoA by beef liver enzyme [147]. Various 
modification on the thiol of pantetheine are allowed as a result of the broad substrate 
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promiscuity of CoaADE enzymes. For instance, fluorescently labelled CoA analogs 
including BODIPY-CoA, coumarin CoA and dansyl-CoA were synthesized exploiting 
the activities of three enzymes of CoA salvage pathway. Such fluorescently labelled CoA 
analogs can have various applications to study CoA-related cellular processes. While 
designing and synthesizing such analogs, the molecular distance between the amide 
carbonyl and pantetheine thiol is crucial. For example, when the cysteine moiety of 
pantetheine is replaced by homocysteine, increasing few angstroms, the resulting analog 
did not act as an enzyme substrate [148]. A plethora of CoA analogs, for instance, acetyl 
3’-O-benzyl CoA [149], ethyldethia-Coenzyme A [142], didemethyl CoA [150], 
pyrophospho CoA [151], hemithioacetal CoA [152] and CoA thioesters including 
methylmalonyl CoA [153], succinyl CoA [153], propionyl CoA [154], benzyl CoA [155] 
and long chain CoA thioesters [156] were synthesized and available in the literature now. 
Synthesis of propionyl CoA analog was achieved by chemically replacing pantetheine 
sulfur by methylene, ethylene and thiomethylene and by using enzyme to incorporate 
pantetheine analogs into coenzyme A. Nazi and colleagues performed chemoenzymatic 
synthesis of CoA analogs using PanK, PPAT and DPCK enzymes [157]. In their 
synthetic procedure, pantetheine was chemically modified into various thioesters and 
oxygen esters first which were then converted into corresponding CoA analogs by the 
action of three CoA salvage enzymes. The CoA biosynthetic pathway was reconstituted 
by Strauss and Begley by overexpressing the five enzymes of de novo pathway 
coaABCDE [158]. They also analyzed the selectivity of CoA biosynthetic enzymes 
among various substrates and found CoaBC was largely responsible for the substrate 
selectivity as demonstrated by the acceptance of cysteine over serine.  
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Surprisingly, CoA and its thioesters are recently found to be present in RNA 5’ end in 
both gram positive and gram-negative bacteria [112]. As previously discussed in chapter 
I of this dissertation, the sequence and metabolism of these RNA species is still unknown. 
The existence of CoA on RNA 5’ end nonetheless brings up interesting questions beyond 
the aforementioned roles of CoA in biology. To unfold the biological significance of 
CoA-RNA species, their sequences need to be identified first that requires a protocol for 
CoA-RNA capture. An easy access to synthetic CoA RNA is imperative for the 
development of such capture protocol. Furthermore, functionalization of RNA CoA and 
its derivatives can be important in investigating plausible RNA centered metabolic 
pathways in an RNA world. Additionally, incorporation of thiol and amino functional 
group and Biotin handle in RNA can be useful to purify RNA by affinity chromatography 
[159, 160], RNA immobilization [109, 161] and RNA conjugation with various 
nanoparticle and macromolecules [109, 162].  
As previously discussed, our lab has developed a simple method to prepare CoA-RNA by 
in vitro transcription by using dephospho CoA (dephospho-CoA) as transcription initiator 
under T7 φ2.5 promoter. However, the initiator dephospho-CoA is very expensive to buy 
from commercial sources ($146.50 for 5 mg at Sigma-Aldrich). DephosphoCoA can be 
synthesized form CoA by using acid phosphatase as demonstrated previously [76]. 
However, CoA itself is not an ideal starting molecule because of its high cost ($51.10 per 
10 mg at Sigma-Aldrich). To overcome the limitations of dephospho-CoA availability, 
we developed a simple and efficient enzymatic method for the synthesis of dephospho 
CoA in a single step one-pot reaction followed by simple purification by reverse phase 
column chromatography. Although literature reported procedure can be followed to 
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synthesize pantetheine substrate form its simple precursors: D-pentolactone, β-alanine, 
and cysteamine, we decided to use commercially available pantethine- an oxidized 
version of pantetheine- and ATP. Both of these starting molecules are relatively 
inexpensive costing $65.00/ 100 g for ATP and $80.00 for 25 g for pantethine at Chem 
Impex International. 
4.2 Results and Discussions 
4.2.1 Expression of PanK and PPAT as a single polypeptide 
As shown in scheme 4.1, the sequential activity of PanK and PPAT leads to the 
formation of dephospho-coenzyme A from a pantetheine with the expense of two ATP 
molecules. We decided to use these two enzymes of CoA salvage pathway to develop a 
simple and economical method to synthesize dephospho-CoA from inexpensive starting 
molecules pantethine and ATP. In order to make the enzyme purification simpler, we 
attempted to fuse the two enzymes as a single polypeptide having both activities. We 
designed a linker sequence EAAAKEAAAKEAAAKEAAAKEAAAK to connect PPAT 
and PanK in the expression plasmid. The plasmid was constructed by our in vivo cloning 





Figure 4.1 In vivo cloning method. The parent plasmid was digested extensively 
with restriction endonucleases and PCR amplified. The insert was also PCR 
amplified by using a primer pair having ~20 nt overhang that matches exactly 
with the two ends of linearized backbone. An overlap of 20 bp on both ends was 
generated by PCR. Upon transformation of plasmid and insert in 1:1 ratio in 
competent E. coli cell, a plasmid was constructed in vivo. 
 
We used the plasmids encoding PanK/ CoaA and PPAT (coaD) to construct another 
plasmid for the expression of fused PanK and PPAT. A plasmid encoding CoaA 
(pET28a-Ec.coaA) was a gift from Erick Strauss, Addgene #50386 and the plasmid 
encoding PPAT(pET28a-Ec.coaD) was a gift from Tadhg Begley & Erick Strauss, 
Addgene # 50388. We used pET28a-Ec.coaD plasmid as a parent plasmid, digested it and 
inserted a polynucleotide linker of sequence 
GAGGCCGCTGCAAAGGAAGCTGCCGCTAAAGAGGCTGCCGCCAAGGAGGCA
GCCGCTAAGGAGGCTGCAGCCAAA by our in vivo cloning method. We amplified 
the PanK coding sequence by PCR using pET28a-Ec.coaA plasmid as a PCR template. A 
20 base pair overlap at both flanking ends of the insert was created by PCR. The insert 
and backbone were mixed in approximately 1:1 molar ratio and transformed into E. coli 
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DH5α cells by standard heat shock. The transformants were plated on antibiotic 
containing agar plate and a colony was picked up next morning for plasmid purification. 
After the verification of the plasmid by restriction digestion and agarose gel 
electrophoresis, BL21(DE3) cells were transformed with the correct plasmid for the 
expression of PPAT-Linker-PanK as a single polypeptide. The transformants were grown 
in Kanamycin containing LB agar overnight and 2 colonies were picked up next morning 
for the protein expression analysis. The cells were grown in LB-Kan broth until the 
OD600 reaches 0.6. IPTG was added in 1 mM final concentration for the induction of 
protein expression. Upon incubation at 37 °C for 3h for the expression, the cells were 
harvested by centrifugation, lysed by sonication, and analyzed by 12% SDS-PAGE as 





Figure 4.2 Cloning and Expression of PanK/CoaA and PPAT/ CoaD as a single 
polypeptide. A) a 25 amino acid linker was used to fuse PanK and PPAT as a 
single polypeptide. The expression of the recombinant PPAT-Linker-PanK 
yielded insoluble protein. B) The insertion of SUMO tag to assist in solubility did 
not help to make the fused enzyme soluble. 
The fused PanK-PPAT protein showed a good expression upon induction by 
IPTG as evidenced by a strong band at ~60 kDa on the induced lane (Lane 3, Figure 
4.2A). After confirming the expression, the solubility analysis was carried out by 
denaturing SDS-PAGE. The cells expressing the fused PPAT-PanK polypeptide were 
lysed by sonication and the lysate was cleared by centrifugation. The supernatant was 
separated from the pellet, mixed with lamelli buffer and loaded on the gel. Similarly, 
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small amount of precipitate was directly dissolved in lamelli buffer and loaded on the 
polyacrylamide gel.  However, the solubility analysis showed that the protein was 
expressed in an insoluble form as can be seen on the figure 4.2A, lane 4. Since the 
bacterial growth is slower at lower temperature, the recombinant protein expression at 
lower temperature is also slow. Although it takes longer time (~16 h at 16 °C vs 3h at 37 
°C) to produce enough recombinant protein at lower temperature, the probability of 
protein folding in a correct way and hence the chance of soluble expression is higher. 
With that in consideration, we tried to express the PanK/PPAT fused polypeptide at 16 
°C overnight. The SDS-PAGE analysis showed good protein expression but in insoluble 
form. 
The insoluble expression of PanK-PPAT fusion protein at physiological 
temperature and at a lower temperature led us to consider the use of SUMO fusion tag to 
enhance the solubility. We replaced the linker peptide with a SUMO fusion tag using our 
in vivo recombination cloning method. The DNA fragments to be assembled together 
were generated by PCR and transformed into competent E. coli as before. The individual 
colonies were grown in the antibiotic containing media, plasmids were isolated and 
verified by restriction enzyme digestion followed by agarose gel electrophoresis. The 
correct plasmid was then transformed into expression cells, grown, and protein 
expression analysis was carried out as before. Unfortunately, the PPAT-SUMO-PanK 
fusion protein also remained insoluble as shown in figure 4.2B. The dark band at ~60 kD 
on lane 4 of fig 4.2B represents the insoluble PPAT-SUMO-PanK polypeptide. These 
results indicated that the PanK-PPAT fusion protein suffers from intrinsic solubility 
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problem which could not be overcome either by altering the experimental conditions like 
incubation temperature or by fusing with a protein folding assistor like SUMO tag. 
4.2.2 Co-expression and Co-purification of PanK and PPAT 
We next tried to clone PPAT and PanK encoding genes coaD and coaA 
respectively in a single plasmid but as two independent translation units. Using our same 
in vivo recombinational cloning method, we created two different versions of the 
plasmids: pCoaDAa and pCoaDAb. The first construct pCoaDAa had a ribosomal 
binding site (RBS) inserted between the coaD stop codon and His6-coaA start codon. In 
the second construct pCoaDAb, we inserted both a T7 promoter sequence and a 
ribosomal binding site in between two genes. Both the plasmids were verified by 
restriction enzyme digestion and an agarose gel electrophoresis as before. The correct 
plasmids were then transformed into expression cells BL21(DE3) to analyze the protein 
expression and solubility. The colonies were picked up from the transformants, grown in 
5 mL LB-Kan media until OD600 reached 0.6 and the protein expression was induced by 
adding IPTG in 1 mM concentration. Expression was carried out at 37 °C for 3 h. The 
cells were harvested by centrifugation, resuspended in 1 mL 1x TBS buffer and lysed by 
sonication. The cell lysate was cleared by centrifugation. It was then mixed with lamelli 
buffer and loaded into 12% SDS-PAGE gel. As shown in figure 4.3, both plasmid 
constructs pCoaDAa and pCoaDAb expressed PPAT and PanK enzymes in a good 
quantity. The successful expression of PanK and PPAT as soluble enzymes led us to 




The BL21(DE3) cells harboring the pCoaDAa plasmid were selected for the 
large-scale co-expression and co-purification of PanK and PPAT. The cells expressing 
PanK and PPAT were inoculated in 5 mL LB with 50 µg/mL Kanamycin and the culture 
was grown overnight at 37 °C with shaking at 200 rpm which was diluted into the 500 
mL of the same media and the culture was further grown at 37 °C until the optical density 
reached 0.6 at 600 nm. Isopropyl β-D-thiogalactopyranoside (IPTG) was added to a final 
concentration of 0.5 mM to induce protein expression. 
 
Figure 4.3 Co-expression and co-purification of PanK and PPAT in a single 
step. CoaA/CoaD expression and solubility analysis by using A) pCoaDAa and 
B) pCoaDAb plasmids. Both the constructs showed good protein expression. C) 
Co-purification of expressed PPAT and PanK enzymes in a single 
chromatographic step.   
 
The culture was incubated for additional 3 hours at 37 °C with shaking at 200 rpm and 
later cells were collected by centrifugation (13,000 x g for 10 min, 4 °C). The cells were 
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by sonication for 6 cycles at 35% amplitude, with 10 sec on, 50 sec off at 0 °C. The crude 
cell lysate was centrifuged at 20,000 x g for 15 min at 4 °C and the supernatant was 
passed through the Ni-NTA column pre-equilibrated with binding buffer (50 mM Tris, 
500 mM NaCl, 20 mM imidazole, pH 8.0). The column was washed with binding buffer 
until the absorbance at 280 nm reached the baseline. PanK and PPAT proteins were 
eluted from the column by 5 mL elution buffer (50 mM Tris, 500 mM NaCl, 200 mM 
imidazole pH 8.0). A total of 14 mg protein was obtained after concentrating the elution 
fractions by 10K membrane filtration. 
The purity of the purified proteins was analyzed by 12% SDS-PAGE gel. As can be seen 
in figure 4.3 C, we got the mixture of two enzymes in near homogeneity.  A few small 
bands were also visible on the gel, but the quantitation of the bands by an imagelab 
software showed that all the impurities combined are <2% of the total band intensity. As 
most of the bands corresponding to impurities are present above PanK and PPAT bands, 
the relative molar concentrations of those impurities would be even lesser than that of the 
imagelab estimation. Furthermore, we quantitated the relative amount of PanK and PPAT 
(upper band and lower band respectively) by using the same program. Since the band 
intensity of PanK and PPAT is 66% and 33% respectively, we concluded that two 
proteins were present in ~1:1 molar ratio in the purified enzyme cocktail. The 
discrepancy in band intensity (66% for PanK vs 33% for PPAT) is due to their size 
difference: 36.3 kD for PanK vs 17.83 kD for PPAT. The purified enzyme cocktail was 





4.2.3 One pot enzymatic synthesis and purification of dephospho Coenzyme A 
We used the purified enzymes to carry out the one-pot enzymatic synthesis of 
dephospho coenzyme a starting from the commercially available and inexpensive 
pantetheine ($85 for 25 g, Chem Impex international). The enzymatic synthetic strategy 
for the synthesis of dephosphocoA is presented in scheme 4.2. The commercially 
available pantethine (ox-pan, 1) was easily reduced to a CoA precursor Pantetheine 2 
using a common reducing agent such as dithiothreitol (DTT) or tris(2-carboxyethyl) 
phosphine (TCEP). Subsequently, the addition of the purified enzymes and ATP in a 
Mg2+ containing buffer successfully yielded dephosphoCoA 4 through a 
phosphopantetheine intermediate 3. 
 
 
Scheme 4.2 Strategy for the one-pot enzymatic synthesis of dephospho-CoA from 
commercially available and inexpensive pantethine by using a mixture of PanK and 
PPAT. 
 
The developed enzymatic synthetic protocol was used to synthesize dephosphoCoA in 
large scale. We dissolved 58 mg, 0.110 mmol of oxidized pantetheine,1, Ox-Pan in 1 mL 
10 mM Tris buffer pH 7.0. The ox-pan was reduced to Pan, 2 by 34 mg, 0.118 mmol 
TCEP. The reaction was analyzed by HPLC and was complete in 1 h at room temperature 
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as can be seen in figure 4.4. After the completion of the reduction, 4 ml reaction buffer 
containing 80 mM MgCl2, 25 mM KCl, 140 mM ATP, 75 mM Tris pH 8.0 was added. 
The reaction was initiated at 37 °C by adding 0.2 mg of PanK & PPAT mixture. At 2 h 
incubation time, the majority of reactant 2 was converted to the intermediate 
phosphopantethine (Pan-p, 3) and the product dephospho-CoA 4.  
Figure 4.4 HPLC analysis of the enzymatic synthesis of dephosphoCoA from 
Pantethine and ATP. The starting material Ox-Pan was treated with reducing 
agent TCEP to afford the enzyme substrate Pantetheine. Addition of ATP and 
PanK/PPAT cocktail transformed Pantetheine into dephospho CoA after 
overnight incubation. The product was purified by reverse phase column 
chromatography and characterized by 1H-NMR. HPLC conditions were: 
Econosphere C18 4.6x50 mm column with 1 mL/min flow rate. The column was 
equilibrated with 40 mM KH2PO4 before sample injection. The separation was 
carried out in 0-30% acetonitrile gradient over 5 min. The peaks were detected 
at 210 nm. 
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The addition of ATP and PanK/PPAT enzymes should produce two new peaks 
corresponding to phosphopantetheine intermediate 3 and dephospho CoA product 4. 
However, we only observed an appearance of a single peak having an adenosine UV 
signature. As can be seen in figure 4, there is only one additional peak although the 
reaction is not complete.  We hypothesized that the compounds 3 and 4 have the same 
retention time under our HPLC conditions. To test this hypothesis, we expressed and 
purified PanK and PPAT enzymes separately so that the HPLC profiles of their 
corresponding products can be established. The plasmids pET28a-Ec.coaA and pET28a-
Ec.coaD were separately transformed into BL21(DE3) cells. Single colony was picked 
from each of the plate, grown in LB-Kan media till OD600 reached 0.6. Both the proteins 
were expressed and purified by IMAC which yielded 18 mg of PanK and 14 mg of PPAT 






Figure 4.5 Expression and Purification of PanK and PPAT separately. A) The 
dark band in between 35 kD and 45 kD corresponds to recombinantly expressed 
PanK. A dark single band in lane 3 shows the good purity of the PanK after 
IMAC purification. B) The PPAT enzyme was also purified same way as PanK. A 
dark band below 18 kD marker corresponds to PPAT. The enzyme was eluted 
from the Ni-NTA resin using 200 mM imidazole as shown in lanes E1, E2 and 
E3. A membrane filter of 10 kD cut-off was used to remove imidazole and 
concentrate the protein. Both proteins were stored at -20 C in 1x storage buffer 
containing 50% glycerol. 
 
The PanK and PPAT activity was tested separately and checked by HPLC. Pantetheine 2 
(2.8 mg/10 micromole) was dissolved in 0.5 mL 2X PanK reaction buffer and added 100 
ul 200 mM ATP & 0.2 mg PanK. The reaction was incubated at 37 °C for 30 minutes. 
The progress of the reaction was monitored by HPLC. As shown in figure 4.6, the 
enzyme transformed ~60% of pantetheine 2 into phosphopantetheine 3 within 30 
minutes. PPAT was then added to the reaction and further incubated for 2 hours under the 
same conditions. HPLC analysis showed the increase in peak size but did not show 
another peak with different retention time. Furthermore, the peaklabelled as 3&4 in figure 
6 showed the UV signature of adenosine having λmax of 260 nm. The appearance of 






formation of the dephospho-CoA product. The increase in peak size on the same location 
confirmed that Phosphopantetheine intermediate 3 and dephosphoCoA 4 had the same 
retention time under our HPLC conditions. 
 
Figure 4.6 HPLC profiles of PanK and PanK+PPAT reaction products during 
enzymatic synthesis of dephospho coenzyme A. The pank reaction product 3 and 
PPAT reaction product 4 elute off together at 3.6 minutes in our HPLC 
conditions. 
 
After resolving the HPLC profiles of the intermediates, a large-scale synthesis of the 
dephospho CoA was carried out as a one-pot reaction. The reaction was started by adding 
PanK/PPAT enzyme cocktail in the solution of pantetheine and ATP. It was then 
incubated at 37 °C overnight. As can be seen from figure 4, there is no detectable amount 
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of reaction intermediate 2. The peak 4 in figure 4 corresponds to both 
phosphopantetheine 3 and dephospho-CoA product 4. Considering PPAT reaction is 
faster than PanK reaction, we assumed that peak 4 only in figure 4 only corresponds to 
dephospho CoA product. Furthermore, the size of the peak did not change upon addition 
of PPAT and ATP but increased upon addition of phoshpopantetheine. These results 
suggested that the reaction is complete after overnight incubation at 37 °C.  
The formation of the dephospho-CoA product was further indicated by the appearance of 
large amount of white precipitate of magnesium pyrophosphate (Mg2P2O7) generated by 
PPAT reaction. The precipitate was removed by centrifugation. Phenol/chloroform 
extraction was used to remove PanK and PPAT enzymes from the reaction. The product 
was purified by reverse phase column chromatography. A C18 reverse phase column (32 
x 160 mm) was prepared by packing 50 g C18 functionalized Silica. The column was 
equilibrated with 200 mL 100 mM phosphate buffer pH 4.7. The crude product was 
loaded into the column, washed with 200 mL water and the pure dephospho-CoA 4 was 
eluted from the column by 150 mL 30% acetonitrile. The solvent was removed under 
reduced pressure at 50 °C until there was no change in mass. The product (115 mg) was 
obtained as a white powder in 81% yield. The identity and the purity were confirmed by 
proton and phosphorous NMR. 
1H NMR (400 MHz, Deuterium Oxide) δ 8.35 (s, 1H), 8.05 (s, 1H), 5.98 (d, J = 5.4 Hz, 
1H), 4.62 (t, J = 5.3 Hz, 3H), 4.41 (t, J = 4.6 Hz, 1H), 4.28 (t, J = 3.1 Hz, 1H), 4.18 – 4.08 
(m, 2H), 3.89 (s, 1H), 3.73 (dd, J = 9.7, 4.7 Hz, 1H), 3.47 (dd, J = 10.0, 4.7 Hz, 1H), 3.35 
(t, J = 6.6 Hz, 2H), 3.19 (t, J = 6.6 Hz, 2H), 3.02 (p, J = 8.0, 7.3 Hz, 1H), 2.48 (t, J = 6.6 
Hz, 2H), 2.35 (t, J = 6.5 Hz, 2H), 0.78 (s, 3H), 0.66 (s, 3H). 
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31P NMR (400 MHz, Deuterium Oxide) δ -10.92 (d, J = -20.1 Hz), -11.52 (d, J = -19.9 Hz) 
 
4.2.4 Broad substrate tolerance of PanK and PPAT 
The CoA biosynthetic enzymes PanK and PPAT are known to be promiscuous 
toward various pantothenate analogs[163]. The broad substrate tolerance of these 
enzymes has been used to obtain various CoA analogs by simple enzymatic 
biotransformation. Such CoA analogs can be synthesized by chemically modifying the 
thiol of pantetheine followed by enzymatic reaction. For example, various fluorescently 
labelled CoA analogs including BODIPY-CoA, Coumarin CoA and dansyl CoA were 
synthesized by the activity of PanK, PPAT and DPCK on thiol modified substrates. We 
exploited the relaxed substrate specificity of PanK and PPAT to generate various 
dephosphoCoA analogs. We excluded the final enzyme of CoA biosynthetic pathway i.e. 
DPCK so that the synthesized analogs have free 3’-OH instead of 3’ phosphate as in case 
of CoA analogs. Such feature makes it possible to initiate the in vitro transcription by 
these analogs and labelling RNA with them at the 5’ terminus. Specifically, we extended 
the enzymatic dephospho-CoA synthetic strategy and achieved the synthesis of oxizized 
dephospho CoA (ox-dephospho-CoA), Amino dephospho CoA, and Biotin dephospho 
CoA. Ox-dephospho-CoA is more stable than dephospho-CoA and hence ideal for the 
long-term storage. Amino-dephospho CoA has a reactive amine group that can be used to 
label dephospho-CoA analogs and RNA with various fluorophores and reporter tags. 
Biotin-dephospho-CoA can be used to label RNA with biotin at the 5’ end that can have 
various applications including RNA affinity purification by streptavidin column and 
selection of functional RNA molecules like aptamers and ribozymes.  
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4.2.4.1 Synthesis of Ox-dephospho-CoA 
Oxidized form of dephosphoCoA (Ox-dephospho-CoA, 9) was synthesized by using 
oxidized pantetheine as a starting molecule. The elimination of TCEP reduction step in 
scheme 1 yielded Ox-dephospho-CoA product through 4 intermediates as shown in 
scheme 4.3. The synthesis of Ox-dephospho-CoA was carried out as one-pot enzymatic 
reaction catalyzed by PanK/PPAT cocktail. The reaction was set up by dissolving 117 mg 
(0.21 mmol) Ox-Pan (1) in 6 mL reaction buffer containing 80 mM MgCl2, 25 mM KCl, 
175 mM ATP, 75 mM Tris pH 8.0. The reaction was started by adding 0.4 mg of the 
purified enzyme cocktail of PanK and PPAT and incubated at 37 °C. The reaction 
progress over time was monitored by HPLC using a reverse phase column. As shown in 
scheme 4.3, the reaction generated four intermediates in one-pot reaction procedure. 
PanK phosphorylated ox-Pant 1 to generate monophosphorylated pantetheine Ox-Pan-p 
which may either undergo another phosphorylation to produce bisphosphorylated 
pantethine 6 Ox-Pan-2p, or adenylated by PPAT to yield monoadenylated pantethine 7, 
Pan-dephospho-CoA. Phosphorylation of the intermediate 7 or the adenylation of 
intermediate 6 generatesmonophosphorylated and monoadenylated pantethine 8 p-Pan-
dephospho-CoA. Adenylation of the common intermediate 8 by PPAT enzyme yielded 










Scheme 4.3 one-pot enzymatic synthesis strategy for ox-dephospho-CoA. The mixture of 







Figure 4.7 Analysis of the Ox-dephospho-CoA synthesis reaction progress with 
time. Mixture of PanK and PPAT was used to make Ox-dephospho-CoA from 
pantethine and ATP. The reaction yielded ox-dephospho-CoA product in one-pot 
procedure through multiple intermediates. A single peak before and after the 
reaction shows the purity of the reactant 1 and the product 9.  HPLC conditions 
were kept same as those in figure 4-4. 
The progress of the reaction over time was analyzed by reverse phase HPLC as 
can be seen in figure 4.7. The mixture of PanK and PPAT quickly converted Ox-pant 1 
into multiple intermediates upon 30 minutes and 2 hours incubation as expected. While 
there should be 6 peaks in HPLC chromatogram corresponding to one reactant (ox-pant), 
four reaction intermediates (5-8), and one product (ox-dephospho-CoA), we observed 
only four peaks. We hypothesized that some intermediates did not get separated under 
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our HPLC condition as in case of dephospho-CoA synthesis and eluted together from the 
column. A separate HPLC analysis was performed to establish the elution profile of the 
intermediates. We set up a PanK reaction by incubating pantethine and ATP with the 
purified enzyme in 1x reaction buffer at 37 °C for 30 minutes. As can be seen from figure 
4.8, two new peaks appeared in HPLC chromatogram that were designated as ox-pant-p 
and ox-pant-2p. when PPAT enzyme is added to the PanK reaction, one new peak 
appeared that was designated as dephospho-CoA product. Furthermore, peak 5 and 6 
showed a characteristic of adenosine UV signature upon addition of PPAT enzyme. This 
clearly indicated that the intermediates 5&7 and 6&8 were not resolved under our HPLC 
conditions. The conclusion was further supported by the appearance of an adenosine UV 
signature in peak 5 and 6 upon addition of PPAT enzyme. 
All the intermediates were converted to a single peak (Ox-dephospho-CoA 
product, 9) upon overnight incubation at 37 °C. The while precipitate of Mg2P2O7 was 
cleared by centrifugation. Phenol chloroform extraction was used to remove PanK and 
PPAT from the reaction. The crude product was purified by simple reverse phase column 
chromatography. The crude reaction after phenol chloroform reaction was loaded into a 
C18 column (32x160 mm) preequilibrated with 0.1 M KH2PO4. It was washed with 
2x200 mL water and the pure Ox-dephospho-CoA product was eluted by 150 mL 40% 
acetonitrile. The solvent was removed by rotary evaporator under reduced pressure at 50 








Figure 4.8 Analysis of reaction intermediates during Ox-dephospho-CoA 
synthesis form ox-Pan and ATP.  When only PanK was used in the reaction, two 
peaks corresponding to ox-pan-p and ox-pan-2p were produced. When PPAT 
was added, one new peak corresponding to ox-dephospho-CoA product was 
appeared. This comparison established that ox-pan-p and ox-pan-dephospho-
CoA co-eluted in our HPLC conditions. Furthermore, ox-pan-2p and p-pan-
dephospho-CoA also eluted together. HPLC conditions were same as those in 




The identity and purity of the product was confirmed by NMR and mass spectroscopy. 1H 
NMR (400 MHz Deuterium Oxide) δ= 8.40 (s, 2H), 8.11 (s, 2H), 6.02 (d, J=5.7 Hz, 2H), 
4.72 (ddd, J=4.1,2.7,1.9 Hz, 4H), 4.70-4.69 (m, 2H), 4.66 (t, J=5.4 Hz, 2H), 4.15 (dd, J=4.9, 
2.7 Hz, 4H), 3.64 (s, 6H), 3.34 (dt, j=14.7, 6.4 Hz, 8H), 2.75-2.61 (m, 4H), 2.36 (t, J=6.6 
Hz, 4H), 0.82 (s, 6H), 0.69 (s, 6H).  
31P NMR (400 MHz, D2O) δ=-10.8 (d, J=21 Hz), -11.3 (d, J=21 Hz).  
MS (ESI) calculated for C42H67N14O26P4S2 [M-H]
-: 1371.27, found: 1371.08 
Dephospho CoA (4) can easily be afforded by reducing Ox-dephospho-CoA (9) with 
reducing agents like TCEP or DTT as shown in figure 9 A. Because Oxygen in the air 
easily oxidizes dephospho-CoA into its dimer, Ox-dephospho-CoA is a better molecule 
for long term storage. It can be directly used to prepare CoA-RNA by in vitro 
transcription under T7 φ2.5 promoter. Since DTT is present in a T7 transcription buffer 
as a reducing agent for T7 RNA polymerase, dephospho-CoA is generated in situ from 
ox-dephospho-CoA by the action of DTT. We incubated ox-dephospho-CoA (9) with 1 
equivalent of TCEP for 1 hour at pH 7.0 and room temperature. As can be seen from 
figure 9B, this treatment completely reduced ox-dephospho-CoA into dephospho-CoA as 



















Figure 4.9 Synthesis of dephospho-CoA from Ox-dephospho-CoA. A) dephospho-
CoA can be synthesized by one step reduction by TECP or DTT. B) HPLC 
analysis of dephospho-CoA synthesis from Ox-dephospho-CoA. When incubated 
with 1 equivalent of TCEP, ox-dephospho-CoA was completely reduced to 





The synthesis of Ox-dephospho-CoA in one-pot reaction illustrated the substrate 
promiscuity of PanK and PPAT enzymes. The activity of both the enzymes toward ox-
pant was comparable to that of pantetheine. Our finding on the relaxed substrate 
specificity is further supported by the crystal structure of these two enzymes. The 
pantetheine binding pocket of both the enzymes is wide and open allowing broad range of 
modifications on the thiol. The modifications on the pantothenate part of pantetheine may 
be restricted. It can be clearly seen from the crystal structure that the cysteamine part of 
pantetheine is not interacting with the enzymes. This feature of CoA biosynthetic 
enzymes was previously used by other researchers to make various CoA analogs. We 
exploited this feature of the enzyme to expand the scope of dephospo CoA analogs and 
synthesized aminodephospho CoA and Biotin dephospospho CoA by one-pot enzymatic 
synthetic strategy. 
4.2.4.2 Synthesis of Amino dephospho-CoA 
The synthesis of amino dephospho CoA was carried out as presented in scheme 
4.4. The reaction was started by reducing pantethine (Ox-pan) with TCEP. The free thiol 
generated by TCEP reduction was reacted with Bromoaminoethane to afford amino 
group on the pantetheine. The addition of PanK and PPAT enzymes at 1x reaction buffer 
containing ATP into the reaction afforded aminodephospho CoA 12 through a 








Scheme 4.4 one-pot synthesis of aminodephospho CoA. i) TCEP, 1 h, RT, pH 7.0 (ii) 2-
Bromoaminoethane, pH 10 (iii) PanK, ATP and (iv) PPAT, ATP 
The reaction progress over time was analyzed by reverse phase HPLC. As can be 
seen from figure 4.10, incubation of 27 mg (0.1 mmol) pantethine with 30 mg (0.12 
mmol) TCEP at room temperature easily afforded pantetheine in 1 hour. The reaction pH 
was adjusted to 10.0 by adding NaOH and five equivalents of bromoaminoethane was 
added. The reaction was completed in one hour at room temperature as no peak 
corresponding to pantetheine was detected in HPLC and a new peak having slightly 
higher retention time was appeared. The reaction pH was adjusted to 7.0 by adding HCl 
and added reaction buffer to 1x final concentration, 2.5 equivalents of ATP (125 mg) and 
0.1 mg PanK/PPAT enzyme mixture. The reaction was incubated at 37 °C. HPLC 
analysis showed ~70% reaction completion within 1 hour of incubation. Overnight 
incubation at 37 °C transformed all the starting material into the aminodephospho CoA 
product as can be seen from figure 10. 
The reaction generated a white precipitate of Magnesium pyrophosphate that was cleared 
by centrifugation. The enzymes were extracted by phenol/chloroform as before and 
purified by reverse phase column chromatography. The crude product was loaded into a 
reverse phase column (32x160 mm) pre-equilibrated with 200 mL 100 mM KH2PO4. The 
column was washed with 200 mL water and the product 12 was eluted by 20% MeCN. 
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The solvent was removed under reduced pressure at 50 °C to obtain white powder of 
aminodephosphoCoA in 82% overall yield. 
 
Figure 4.10 HPLC profiles of reactant, intermediates and product during 
aminodephospho-CoA synthesis. Aminopantetheine was synthesized by a 
reaction between pantetheine and bromoaminoethanne.  
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4.2.4.3 Synthesis of Biotin-dephospho-CoA 
Biotinylation of RNA has many useful applications in the study of RNA function. 
A tight interaction of biotin and streptavidin (Kd=10-14 M) allows the selection, 
enrichment, and pull-downs of biotin-tagged RNA molecules. Our lab had previously 
shown a one-step procedure for labeling RNA with biotin at the 5’ terminus. The 
procedure involved the use of Biotin-AMP as a transcription initiator under T7 φ2.5 
promoter. Biotinylated RNA can also be generated by initiating transcription with Biotin-
dephospho CoA. This molecule allows the installation of both coenzyme a and a biotin at 
RNA 5’ end. A simple thioester hydrolysis of biotin-dephosphoCoA initiated transcripts 
would yield CoA-RNA. The synthesis of biotin-dephosphoCoA was carried out in 
accordance with the scheme 4.5. 
 
Scheme 4.5 Synthesis of Biotin-dephospho CoA by combined action of PanK and PPAT.  
Reagents and conditions: (i) TCEP, RT, pH 7.0 (ii) CDI, DMF (iii) PanK, ATP, 37 °C, 2 
h (iv) PPAT, ATP, 37 °C, 2 h   
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The synthesis of Biotin-dephosphoCoA was started by activating biotin with 
carbonyldiimidazole (CDI). Biotin (366 mg, 1.5 mmol) and 295 mg CDI was dissolved in 
5 ml dry DMF in a reaction vessel filled with N2. The reaction was stirred at 80 °C for 15 
min, brought to rt and stirred for 2 h. Pantetheine, 630 mg, (Ox-Pan 1) was reduced by 
adding 420 mg TCEP.HCl. in 1 mL DMF and 0.2 mL TEA as a solvent a base 
respectively. The reduced pantetheine was added to Biotin-CDI reaction and stirred 
overnight. HPLC analysis showed a thioester peak at 4.5 minutes when eluted in isocratic 
mode with 30% acetonitrile. The reaction was quenched by adding 20 mL phosphate 
buffer pH 4.7. the crude product was loaded into a reverse phase C18 column (32 x160 
mm) preequilibrated with 0.1 M KH2PO4. The column was washed with 3x100 mL water 
followed by 2 x100 mL 10% Methanol. The product was eluted with 200 mL 50% 
Methanol. The solvent was removed under reduced pressure at 40 °C to yield 600 mg of 
Biotin-pant in 79% overall yield.  
Although biotin-dephospho-CoA can be synthesized by one-pot procedure using the 
combined activity of PanK and PPAT, we pursued the separate reactions of PanK and 
PPAT. The purification of biotin-pantetheine-phosphate had been proven useful in 
selecting functional RNA sequences from a random library as discussed in chapter VI. 
Biotin-pant, 0.1 mmol/ 50.4 mg was dissolved in 5 mL 2x reaction buffer. ATP 67 mg 
(1.2 equivalent) was dissolved in water, pH was adjusted to 6.5 and added into the biotin-
pantetheine solution. The reaction was initiated by adding 0.2 mg PanK enzyme at 37 °C. 
The progress of a reaction over time was analyzed by HPLC. The reaction was found to 
be completed at 1.5 hour of incubation. The product was purified by reverse phase 
column chromatography using the same purification protocol as that of biotin-pantetheine 
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discussed above. The removal of solvent under reduced pressure at 40 °C yielded 52 mg 
of the product in 80% yield.  
The biotinylated dephospho-CoA was synthesized by adenylation of biotin-
pantetheine phosphate by PPAT in presence of ATP. Biotin-pantetheine phosphate, 6 
mg/10 µmol, was dissolved in 1 mL CoaD reaction buffer containing 20 mM ATP. The 
reaction was initiated by adding 0.2 mg/ ~100 nmol PPAT enzyme. The reaction was 
incubated at 37 °C and its progress over time was analyzed by reverse phase HPLC. As 
can be seen in figure 11, the formation of a biotinylated dephospho-CoA product resulted 
a new peak in HPLC having a characteristic UV spectrum of thioester at λmax of 230 nm 
and adenosine at λmax of 260 nm. The reaction was complete after 2 hours incubation at 
37 °C. The crude product was purified by reverse phase column chromatography 
following the exact same protocol as used in biotin-pant-p purification discussed above. 
The removal of the solvent at reduced pressure yielded 7.1 mg (77%) of biotin-
dephospho-CoA as a white powder. 
4.2.5 Construction of CoA Salvage pathway in a single plasmid 
Coenzyme A (CoA) is ubiquitous in all three domains of life. This cofactor is vital to the 
activity of ~10% of the total enzymes. A simple and easy method for CoA synthesis is 
therefore a valuable tool study CoA-related processes. We extended the enzymatic 
synthesis of dephospho-CoA and its analogs into the synthesis CoA from its 
commercially available precursors pantethine and ATP (fig 4.11 a). The required 
phosphorylation of 3’ hydroxyl of dephospho-CoA was carried out by the third enzyme 
of CoA salvage pathway, dephosphoCoA kinase.  
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The enzymes required for the one-pot synthesis of CoA were co-expressed and co-
purified in a single enzyme preparation. coaE, a gene that encodes DPCK enzyme, was 
amplified by PCR using E. coli genomic DNA as a template and a pair of coaE specific 
primers. An overlapping region of 20 base pairs at the flaking ends of the DPCK gene 
was created by PCR so that it can be inserted in the plasmid encoding PanK and PPAT 
using our in vivo recombination cloning procedure. An internal ribosomal binding site 
was inserted in between the coaA stop codon and coaE initiation codon. The PCR 
amplified DNA fragments- CoaDA plasmid as the backbone and coaE having 20 bp 
overlap as an insert- was mixed and transformed into competent E. coli DH10β cells. The 
plasmid was isolated, verified by restriction enzyme digestion & agarose gel 
electrophoresis and transformed into competent E. coli BL21(DE3) cells for the 
expression. The protein was expressed and purified by following the exact same protocol 
as used for PanK/PPAT purification. A total of 12 mg protein mixture was obtained form 
500 mL bacterial culture. The identity and purity of the enzyme mixture was analyzed by 
12% SDS-PAGE (figure 4.11 b). The band below 45 kD marker on the induced and 
purified lane corresponds to PanK; the dark band in between 18 kD and 25 kD marker 
corresponds to DPCK and the band below 18 kD on induced and purified lanes 
corresponds to PPAT enzyme. Densitometric analysis showed that three enzymes are in 








Figure 4.11 Expression, purification and activity of DPCK from E. coli. A 
plasmid harboring coaE gene under lac operator and T7 promoter was 
transformed into BL21(DE3) cells. The expression was induced by the addition 
of IPTG and the protein was purified from cell lysate using Ni-NTA 
chromatography. A) SDS-PAGE analysis of purified protein showed that DPCK 
was purified to near homogeneity. B) HPLC analysis of the enzyme activity using 
dephospho-CoA as a substrate. 
 
The activity of the purified enzyme was assayed by its ability to synthesize coenzyme a 
from dephospho Coenzyme a. The reaction was set at 37 °C by incubating 1 mM 
dephospho-CoA and 2 mM ATP with ~1 µM DCPK enzyme. As can be seen from figure 
13B, the activity of the DPCK is confirmed by the appearance of a new peak that 
corresponds to CoA. However, the reaction did not reach completion as ~20% 









The incomplete conversion of dephospho-CoA into CoA by DPCK indicated that 
our above stated explanation of partial reaction is not correct. If PanK’s feedback 
inhibition by CoA was the reason for the incomplete reaction as in case of CoA synthesis 
by a cocktail of 3 enzymes, the later reaction i.e. dephospho-CoA + ATP → CoA, 
catalyzed by DPCK enzyme should reach completion. This could be because the reaction 
conditions may not be optimum and may need to be explored further. As DephospoCoA 
and CoA are nicely separated in reverse phase HPLC (Fig 13 B), CoA can be easily 
purified form the crude reaction even if the reaction is incomplete. 
4.3 Conclusions 
A simple, easy, and efficient method for the enzymatic synthesis of dephospho 
CoA, oxidized dephospho CoA, amino dephospho CoA, and Bition was developed in this 
study. The synthesis was started with commercially available and inexpensive 
pantetethine which is an oxidized version of dephospho-CoA precursor pantetheine. In 
our reaction, ATP was another enzyme substrate that served as a source of phosphate 
group in first phosphorylation reaction and as a source of AMP in the second 
adenylylation reaction. The enzymes required for the synthesis were cloned into a single 
plasmid by our PCR based in vivo cloning method [164]. The cloning method only 
requires overlapping region of ~20 nucleotides on both fragments to be assembled, that 
can be easily created by PCR. Upon transformation into competent E. coli cells, a circular 
plasmid is assembled in vivo that can be isolated and manipulated. As only those 
fragments that overlap with each other can undergo the recombination process during 
plasmid assembly, our method creates significantly low background compared with other 
cloning methods in current practice. Two versions of plasmids were created and the 
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expression of PanK and PPAT was achieved from both versions of the plasmid. Two 
proteins were expressed and purified together in one-shot that significantly saved the time 
and resources.  
The co-purified enzyme cocktail was used to synthesize dephosphocoA and its oxidized 
dimer in one-pot reaction via two different synthetic routes. In the first route, ox-pant was 
reduced by TCEP and used as a substrate for PanK/PPAT cocktail. In this route, the 
dephospho CoA product was obtained via only one synthetic intermediate 
phosphopantetheine. In the second route, ox-pant was used as substrate directly without 
reduction. This route yielded dephospho CoA product via four synthetic intermediates. 
All the intermediates were characterized by HPLC. The final dephsphoCoA product was 
obtained by reducing the final intermediate of the route ox-dephosphosphoCoA by TCEP. 
The product was obtained in a pure form after a simple purification step by reverse phase 
chromatography. This method can be used to prepare hundreds of milligrams of 
dephospho-CoA and ox-dephospho-CoA within 2 days. The procedure can be scaled up 
for the preparation of grams of dephospho-CoA and ox-dephospho-CoA as well. 
The successful preparation of ox-dephospho-CoA by using pantethine as the 
substrate for PanK and PPAT exemplified the broad substrate tolerance of these two 
enzymes. Such broad tolerance of enzymes is special as it can be harnessed to synthesize 
wide variety of dephospho-CoA analogs. We exploited this feature of PanK and PPAT to 
synthesize two dephospho CoA analogs: aminodephospho-CoA and Biotin-dephospho-
CoA. These analogs may be valuable tools to study CoA-related processes. Furthermore, 
as dephospho-CoA can be incorporated into RNA 5’ end co-transcriptionally by in vitro 
transcription under T7 φ2.5 promoter, these analogs can also be used as a transcription 
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initiator for T7 RNA polymerase, that will expand the chemical diversity of RNA. As 
biotin has very strong affinity for streptavidin, biotin labelled RNAs prepared by using 
biotin-dephospho-CoA as transcription initiator may find their applications in RNA 
purification and in vitro selection of functional RNA molecules. 
Our method for the chemo-enzymatic synthesis dephospho CoA and its various analogs 
will make these molecules easily accessible to broad scientific community. As bacterial 
RNA was recently found to contain CoA and CoA-thioesters at the 5’ end, the method 
developed here will be applicable to capture and characterize such RNA. Furthermore, it 
was recently shown that intracellular CoA levels in eukaryotes may be adjusted by 
exogenous CoA [165], our method may find its application to investigate dephospho-




CHAPTER V - CHEMOENZYMATIC APPROACHES OF COA-
RNA CAPTURE  
5.1 Introduction  
The discovery of CoA-RNA, thioester CoA-RNA and NAD-RNA in 2009 raised 
many questions about bacterial transcription, coenzyme functions, and RNA functions 
[112, 113]. These findings challenged the previously accepted nature of the bacterial 
transcripts that they do not contain cap or cap like structure at their 5’ end. However, only 
small fractions of total RNA (~2000 copies per cell for NAD RNA and ~100 copies per 
cell for CoA-RNA) contain these cofactor caps [112, 113]. The original studies that 
identified the existence of cofactor capped RNA species could not establish their 
sequences as their method of finding small molecule-RNA conjugates required chopping 
off RNA by nuclease treatment followed by high resolution mass spectroscopy. The 
sequence identification of these cofactor linked RNA molecules would be vital to 
understand their metabolism and biological significance. A specific method to capture 
them without degrading their sequences is therefore the first step for the characterization 
of CoA-RNA, thioester CoA-RNA and NAD-RNA. 
A capture method for NAD-RNA was developed six years after their initial 
discovery of existence [114]. The laboratory of Andres Jäschke developed a chemo-
enzymatic strategy to specifically capture NAD- linked RNA species [114]. They found 
that ADP-ribosylcyclase (ADPRC) enzyme from Aplysia californica can replace 
nicotinamide with 4-pentyl-1-ol, transferring a NAD-RNA into clickable 
transglycosylation product that was biotinylated by azide-alkyne cycloaddition. The 
biotinylated RNA was then pulled down by streptavidin beads. The development of 
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capture method sparked the attention of many scientists in the field. Application of NAD-
RNA capture protocol identified this modification in prokaryotes including E. coli, S. 
Venezueleae, B. subtilis and in eukaryotes including Yeast, Arabidopsis, and Human 
[122, 123, 125, 166-170]. NAD cap in RNA was found to be involved in various cellular 
processes including modulating the RNA stability by protecting RNA from RNAse E 
mediated degradation in bacteria and targeting RNA for DXO mediated deNADing and 
degradation in humans [114, 168]. Furthermore, NAD-linked RNAs were found to be 
translated and many of them were present in actively translating polysomes. The primary 
mode of RNA NADlyation has also been investigated. NAD-RNAs are synthesized co-
transcriptionally by RNA polymerase where NAD acts as a non-canonical initiating 
nucleotide for transcription initiation. However, since small RNAs that are generated 
post-transcriptionally after processing of the primary transcripts were found to contain 
NAD-cap at their 5’ end, an alternative mode of NAD-RNA biogenesis is also speculated 
[166].  
The association of CoA and CoA-thioesters with RNA was identified before the finding 
of NAD-RNA. However, the sequences, metabolism, and biological roles of CoA linked 
RNA are still a mystery. They could be functioning in a same way as NAD-RNA species 
but the evolution of two different modifications for seemingly same purpose can be 
questioned. As NAD-incorporation in RNA is not random and is determined by the 
promoter sequences at -4 to +3 region, CoA-RNAs also cannot simply be considered as a 
result of non-specific transcription initiation by RNA polymerase [118]. The diverse 
functional roles of NAD-RNA support this line of thought as it can be speculated that if 
they arise from the non-specific activity of RNAP, they would not have any biological 
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significance. Furthermore, as CoA-RNA was found to exist in three different forms in E. 
coli (free CoA-RNA, acetyl CoA-RNA and succinyl CoA-RNA) and in four different 
forms in S. venezueleae (free CoA-RNA, acetyl CoA-RNA, methylmalonyl CoA-RNA 
and succinyl CoA-RNA), it can be speculated that CoA-RNA is not just the 
transcriptional noise, but has functional significances in contemporary biology. Since 
CoA and CoA-thioesters are vital to cellular energy metabolism, the RNA species 
containing CoA and thioester CoA at their 5’ end might be sensing the energy state of 
cellular metabolism. Furthermore, many enzymes need CoA for their catalysis, CoA-
RNAs may be participating in acyl transfer reactions as enzyme cofactors similar to free 
CoA. Moreover, CoA attachment to RNA might guide the localization of these transcripts 
at certain cellular locations and help them to bind or interact with cellular proteins with 
better affinity. Without having a CoA-RNA specific capture protocol, the biological role 
of CoA-RNA and thioester CoA-RNA can only be speculated.  
The development of CoA-RNA capture protocol will illuminate these questions by 
allowing their sequence identification and characterization. The goal of this research is to 
develop a capture protocol specific to CoA-RNA. Our lab has unique opportunity and 
advantage in this regard because of our expertise in RNA chemistry, CoA, and cloning 
method. our previous attempts to capture CoA-RNAs were not successful. We previously 
strived to capture CoA based on the reactivity of thiol. Once captured, various release 
strategies including photocleavage and enzymatic cleavage by Nudix hydrolases were 
attempted. However, our efforts based on thiol chemistry were not successful mainly for 
two reasons- 1) low abundance of CoA-RNAs (they are 10-fold less abundant than phe-
tRNAs) and 2) high abundance of thiol- modified nucleotides in rRNA and tRNA. 
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The success of NAD-RNA capture protocol is because of ADPRC’s specificity toward 
NAD conjugated transcripts. Only RNA species containing the NAD modification are 
biotinylated as a result of enzymatic activity and click chemistry. If an enzyme having 
such activity for CoA-RNA could be identified, CoA-RNA capture can be successfully 
achieved. In the first part of this study, the ability of various acyl CoA-synthetases to 
accept CoA-RNA in place of CoA and biotinylated fatty acid in place of free fatty acid is 
assessed. The successful ligation of CoA-RNA to biotinylated fatty acid via thioester 
linkage would allow their specific capture on streptavidin beads. In the second part of this 
study, various pantetheine analogs containing biotin as a purification handle and a 
reporter tag (fluorophore or radiolabel) will be synthesized and their ability to label CoA-
RNA in vivo will be analyzed. The internal labelling of CoA-RNA with these analogs 
will not only facilitate their capture on the streptavidin beads but also will help to track 
their cellular localization and identify their interaction partners. 
5.2 Results and Discussion  
5.2.1 Acid CoA ligases for CoA-RNA capture  
Acyl CoA ligases catalyze the formation of thioester bond between carboxylic 
acid and coenzyme A with the hydrolysis of ATP. These enzymes can be used for CoA-
RNA capture if they have relaxed substrate specificity and accept biotin conjugated fatty 
acid and CoA-linked RNA as their substrates. The overall strategy of CoA-RNA capture 




Figure 5.1 Overall strategy for the capture of CoA-RNA from total bacterial RNA 
using biotinylated fatty acids as a substrate and acid CoA ligases as a catalyst to 
attach biotin handle on them. After biotinylation, CoA-RNAs can be separated by 
rest of the cellular RNA by using streptavidin beads.   
 
Six different acyl CoA synthetases from three different organisms were expressed 
and purified recombinantly in E. coli BL21(DE3) cells with a goal of generating a stock 
of high efficiency enzyme having broad substrate tolerance that can take biotinylated 
fatty acid and CoA linked RNA as two substrates. The purified enzymes were acetyl CoA 
synthetase (ACS), Succinyl CoA synthetase, medium chain fatty acyl CoA synthetase 
(FadK) and long chain fatty acyl CoA synthetase (FadD) from E. coli and Malonyl CoA 
synthetase (MatB) from Streptomyces coelicolor. As the genome sequence is available 
for both organisms, the best route to obtain these enzymes is to clone the gene encoding 
the respective proteins into an expression vector by using in vivo recombinational cloning 
as shown in figure 4-1 above. 
5.2.1.2 E. coli Acetyl CoA synthetase 
Acetyl CoA synthetase or acid CoA ligase catalyzes the formation of thioester 
bond between acetate and coenzyme a forming acetyl CoA with the hydrolysis of ATP as 
shown in figure 5.2A. The acetyl CoA formed can be used in the TCA cycle or can be 
used in fatty acid biosynthesis. The reaction is catalyzed in two steps: first ATP is 
hydrolyzed to AMP and pyrophosphate. The bound AMP causes the conformational 
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change in the enzyme’s active site referred to as A cluster. The conformational changes 
induced by AMP binding causes the rotation of the active site and brings acetate and CoA 
together. Once the CoA and acetate are brought together by rotation, a thioester bond is 
formed between acetate and CoA. 
The cloning of Acetyl CoA synthetase (ACS) from E. coli was carried out to analyze the 
broadness in substrate tolerance of the enzyme. Since genome sequence is available for 
E. coli, the gene encoding ACS was isolated by PCR using E coli genomic DNA as a 
template. PCR generated 2016 kb fragment containing 19 bp overlap region with the 
pET-nHis-Kan vector. A plasmid for recombinant expression of ACS was constructed in 
vivo by a homologous recombination event in E coli DH5α cells which was facilitated by 
the 19 bp overlap regions present in the vector and the insert. The transformed cells were 
plated in agar plate containing LB/Kan. Overnight incubation at 37° C yielded ~30 
colonies. Two colonies were picked and grown overnight in the LB/Kan broth for 
plasmid isolation. The isolated plasmids were analyzed by restriction digestion using 
NdeI and HindIII that confirmed that the isolated plasmids are correct. The high 
efficiency and very low background of in vivo recombinational cloning technique 
eliminated the requirement of sequencing of the isolated plasmids that saves both time 
and money. 
One of the plasmids (ACS1) was taken for the transformation into BL21(DE3) cells. The 
ACS gene in the plasmid is under T7 promoter and thus requires T7 RNA polymerase for 
its transcription. BL21(DE3) strain of E. coli contains a chromosomal copy of T7 RNA 
polymerase under LacUV5 promoter, which is inducible by lactose and lactose analog 
like IPTG. The addition of IPTG in the growth media induces the transcription of both 
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ACS and T7 RNA polymerase, diverting most of the available cellular resources to the 
production of ACS. Upon transformation, two colonies were chosen for the expression 
analysis. Cells were grown at 37° C in 5 mL LB-Kan media until OD600 reached 0.6 and 
the expression was induced by adding IPTG in 1 mM final concentration. The cells were 
harvested by centrifugation, resuspended in 200 ul native lysis buffer and lysed by 
heating at 95 °C for 10 minutes. The lysate was cleared by centrifugation and the pellet 
fraction was resuspended in 20 ul 4X Lamelli buffer. The supernatant and pellet fractions 
were run in 12% SDS-PAGE to analyze the expression and solubility. The protein was 
found to be soluble as indicated by dark band near 70 kD in the supernatant fraction 
(figure 5.2B). The cells expressing ACS was inoculated in 1 L of the same media, grown 
until OD600 reaches 0.6 induced by adding 1 mM IPTG for the large-scale expression. 
They were then harvested by centrifugation (10 K RPM in JA-14 rotor), resuspended in 
15 ml 1X TBS and lysed by sonication on ice (5 cycles, 25% amplitude, 20 sec on and 40 
sec rest). The lysate was cleared by centrifugation (JA-20 rotor, 15 min, 18,000 RPM). 
The supernatant was loaded into the Ni-NTA column which is preequilibrated with 1x 
TBS. As the protein tagged with His6 at N-terminal, IMAC resin was used to purify ACS 
to near homogeneity. Millipore spin columns of 50,000 Da molecular cut-off was to used 
remove the imidazole. The protein concentration was determined by Beer’s law using 
absorbance at 280 nm and the molar extinction coefficient of 138,770 M-1cm-1 
ascalculated by using Expasy Protparam tool. A total of 18 mg protein was purified from 
1 L expression. The protein is stored in 2 x 1 mL aliquots in -20 °C in 1x TBS with  




Figure 5.2 Expression and purification of Acetyl CoA synthetase. A) ACS 
catalyzes the transfer of acetate to CoA forming acetyl CoA. B) ACS was cloned, 
expressed and purified as a recombinant protein. 
 
The activity of purified ACS was tested by using 1 mM coenzyme a and 10 mM 
sodium acetate as a substrate in 1x ACS buffer for 1 h at 37 °C. The reaction was 
analyzed by HPLC using a C-18 reverse phase column with an 0-20% acetonitrile 
gradient elution to separate the products and reactants based on their hydrophobicity. The 
UV absorbance was monitored at 260 nm for adenosine and at 230 nm for thioester 
product. The formation of acetyl CoA was observed as a new peak having distinct UV 









Scheme 5.1 Solid phase synthesis of TOTDDA-Acetate for the substrate scope analysis of 
ACS. 
To test of enzyme function with modified substrates, two non-cannonical 
substrates were used: dephospho-CoA instead of CoA and TOTDDA conjugated Acetate 
instead of free acetate. The synthesis of TOTDDA conjugated acetate was achieved by 
solid phase synthetic strategy as shown in scheme 5.1. The ability of ACS to accept 
various modifications in both of its substrate is mandatory for Its successful applications 
in CoA-RNA capture. When dephospho CoA and sodium acetate were used as substrates 
in a typical ACS reaction, acetyl dephospho CoA was readily formed indicating the 
enzyme is accepts modifications on CoA. However, when the reaction was set up against 
TOTDDA-acetate as a substrate, no additional peak was appeared in HPLC showing that 
modifications on the fatty acid side is not allowed. The non-functionality of the enzyme 
against chemically modified acetate analogs made it unsuitable for its use in CoA-RNA 
capture. 
5.2.1.3 E. coli Succinyl CoA synthetase 
The limitations on the ACS substrate scope led us to consider Succinyl CoA 
synthetase (SCS) for its use in CoA-RNA capture protocol. SCS catalyzes the ligation of 
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succinate to Coenzyme a, forming succinyl CoA and the hydrolysis of succinyl CoA to 
succinate and free CoA (Fig 5.3 A). The enzyme contains two subunits: α-subunit is 
encoded by SucC gene and β- subunit is encoded by SucD gene. The SucCD fragment 
was amplified by PCR using E. coli genomic DNA as a template. An overlap of 19 bp 
was created on both 5’ and 3’ end of the insert by incorporating the overlapping regions 
in the PCR primer. The PCR amplified insert was mixed with the pET- nHis Kan vector 
and transformed into competent E. coli DH5a cells. The plasmid was constructed by in 
vivo recombination which was isolated and analyzed by restriction digestion.  
Figure 5.3 Expression and purification of E. coli Succinyl CoA synthetase 
(SucCD). A) SucCD catalyzes the transfer of succinate to CoA-SH forming 
succinyl CoA. B) SucCD was solubly expressed in E. coli BL21 (DE3) cells 






After the verification of the plasmid, it was transformed into E. coli BL21(DE3) cells for 
its expression. Assuming that most of the colonies obtained from transformation of 
SucCD plasmid into BL21(DE3) cells were correct based on their successful growth in 
antibiotic containing media, two colonies were picked up and grown further for the 
protein expression analysis. However, both colonies gave a negative result. Six more 
colonies were picked up and grown in the same condition as mentioned above. 
Expression analysis showed only one positive colony and the cells expressing SucCD 
were further grown in 5 ml LB/Kan to assess the protein solubility. The protein 
expression is induced when OD600 reached 0.7 by adding IPTG in 1 mM concentration. 
After 3 hours of expression at 37 °C, the cells were harvested by centrifugation, 
resuspended in 250 ul 1X TBS and lysed by heating at 95 °C for 10 minutes. The lysate 
was centrifuged at 10,000 rpm for 4 minutes to separate the soluble supernatant and 
insoluble pellet fractions. Both the fractions were mixed with 4X lamelli buffer and 
analyzed by 12% SDS-PAGE.  
The appearance of two bands at about 40 kDa and 30 kDa confirmed the presence of 
SucC (41 kDa) and SucD (30 kDa) in the supernatant fraction as shown in fig. 5.3B. 
Large scale expression was carried out by inoculating the SucCD expressing cells in 1 L 
LB/Kan. Cell growth and induction conditions were kept same as mentioned above. The 
purification of protein by IMAC resin yielded 32 mg protein in 1:1stoichiometric ratio of 
SucC and SucD as shown in Fig 5.3C.  Millipore spin column of 10,000 Da cut-off was 
used to remove imidazole. The protein was stored at -20 °C after adding 50% glycerol 
and in the final concentration of 220 µM. 
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The activity of purified enzyme was tested against succinate and coenzyme A for its 
ability to form succinyl CoA from its natural substrates. When sodium succinate and CoA 
were incubated with SCS and ATP in 1X SCS buffer at 37 °C for 1 h, HPLC analysis 
showed an additional peak having UV spectrum of both adenosine and thioester 
confirming that the enzyme is in active form. The substrate scope of the enzyme is 
analyzed by replacing coenzyme a with dephospho CoA and sodium succinate to 
TOTDDA-Succinate. The later substrate, TOTDDA succinate was present in the lab as 
previously synthesized stock. HPLC analysis showed the formation of succinyl 
dephosopho CoA, showing a degree of substrate flexibility in its CoA arm. However, the 
enzyme activity against TOTDDA-Succinate as a substrate is null as HPLC did not show 
the formation of a new peak. Inactivity of the enzyme toward chemically modified 
succinate limited its application in CoA-RNA capture protocol. 
5.2.1.4 E. coli FadK 
The limitation in broad substrate tolerance of central metabolic enzymes ACS and 
SCS led us to consider medium chain fatty acyl CoA ligase (FadK) for its application in 
CoA-RNA thioesterification with biotin-conjugated fatty acids. FadK catalyzes the 
esterification of exogenous fatty acids into fatty acyl CoA for their degradation and 
incorporation into phospholipids (fig 5.4A). The enzyme is active on broad range of 
substrates from C6:0 to C18:0 with maximal activity on fatty acids having C6-C12 chain 
length. As biotin has C-5 arm, conjugation of C6-C8 fatty acid with biotin will yield a 




FadK gene (1758 bp) was amplified from E. coli genomic DNA using PCR. The PCR 
product was verified by agarose gel electrophoresis, mixed with the pETlite-nHis-Kan 
backbone, and transformed into E. coli DH5a cells. The plasmid was formed in vivo by 
recombination which was isolated and verified by restriction enzyme digestion using 
NdeI and HindIII. The plasmid was transformed into E. coli BL21(DE3) cells for the 
protein expression. With an assumption of all the colonies on the plate are correct based 
on their growth in antibiotic containing media, two colonies were picked up for the 
protein expression analysis. Both colonies expressed protein solubly as evidenced by a 
strong band slightly higher than 60 kDa on the SDS-PAGE gel (Figure 5.4B). The large-
scale expression was carried out by inoculating FadK expressing cells in 1L of the 
LB/Kan media, grown till OD600 reached 0.7 and induced by adding IPTG in 1 mM final 
concentration. The expression was carried out at 16 °C overnight. cells were harvested by 
centrifugation and the protein is purified by IMAC resin using 200 mM imidazole as an 
eluent. The imidazole was later removed by filtering through M-50 membrane filters. 
Protein was quantitated by measuring UV absorbance at 280 nm and by using extinction 
coefficient of 68,715 M-1cm-1. A total of 18 mg pure protein (Fig 5.4C) was yielded from 
1 L expression. Glycerol was added to 50% final concentration (v/v) and the protein was 





Figure 5.4 Expression and Purification of E. coli FadK. A) FadK catalyzes the 
thioesterification of medium chain fatty acid to CoA B) FadK was expressed in 
E. coli recombinantly and purified to near-homogeneity by Ni-NTA 
chromatography. 
The ability of FadK to make fatty acyl CoA thioesters was analyzed by HPLC using C8:0 
fatty acid as a substrate. The enzyme was incubated with 1 mM CoA and 10 mM 
octanoic acid in 1x FadK buffer. No product peak was observed in HPLC analysis 
implying the inactivity of the enzyme. 
5.2.1.5 S. coelicolor Malonyl CoA synthetase 
The approach of using E. coli enzymes for CoA-RNA capture was unsuccessful 
as the enzymes studied were either specific to one substrate (ACS and SCS) or inactive in 
vitro (FadK and FadD). This problem led us to think about an alternative enzyme source. 
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Streptomyces coelicolor A3(2) is a gram-positive soil bacterium that is able to synthesize 
polyketides as its secondary metabolites. These polyketides are synthesized by complex 
enzymatic machinery that uses Malonyl CoA as an extender unit. Malonyl CoA 
synthetase (MatB) is an enzyme of acid CoA ligase class catalyzing the synthesis of 
malonyl CoA/ methylmalonyl CoA extender units with the hydrolysis of ATP (Fig 5.5A). 
The natural substrates of MatB are malonyl CoA, methylmalonyl CoA and coenzyme A. 
Interestingly, Amanda Hughes and colleagues showed the broad substrate promiscuity of 
MatB and successfully synthesized ethylmalonyl CoA, methoxymalonyl CoA and 
hydroxymalonyl CoA. Moreover, the same study revealed that the substrate tolerance on 
the thiol acceptor side is also broad that makes the enzyme able to synthesize pantetheine 
and SNAC linked extender units [171]. The crystal structure further explained the 
enzyme’s broad substrate tolerance behavior showing a big room to bind methylmalonate 
derivative having R- stereochemistry at the α-carbon malonate. In addition, the crystal 
structure also revealed pantetheine is the only requirement at the thiol acceptor side.   
The broad substrate tolerance of MatB on both acid donor side and thiol acceptor side led 
us to hypothesize that a biotin conjugated malonate and CoA-RNA may be accepted by 
the enzyme as an acid donor and a thiol acceptor respectively. MatB gene was isolated 
amplified by PCR using S. coelicolor genomic DNA as a template and matB specific 
primers (Fig 5.5B). The organism S. coelicolor was a generous gift from Dr. Jurgen 
Rohr’s lab at University of Kentucky. PCR produced two bands- a major band with the 
expected size and a minor band corresponding to non-specific amplification. The correct 
band was excised form the gel, purified, mixed with pETlite-6His-Kan vector, and 
transformed into competent E. coli DH5α cells. Two colonies were isolated and grown 
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for plasmid preparation. The isolated plasmids were analyzed by restriction digestion and 
agarose gel electrophoresis. The electrophoretic mobility of the RE digested fragments 
showed two bands of 4060 bp and 2716 bp that matched well with the expected pattern 
and confirmed the isolated plasmids were correct (Fig 5.5C). 
The plasmids were then transformed into BL21(DE3) cells for their expression. The 
transformants were grown overnight in antibiotic containing agar plate. Two colonies 
were picked up for the analysis of protein expression and solubility. Cells were grown in 
5 mL LB/Kan at 37 °C until OD600 reached 0.6. MatB expression was induced by adding 
1 mM IPTG in the growth media and the protein was expressed for 3 h at 37 °C. The 
cells were harvested by centrifugation, resuspended in 250 uL 1X TBS and lysed by 
heating at 95 °C for 5 minutes. The lysate was cleared by centrifugation, mixed with 
lamelli buffer and both the supernatant and pellet fractions were loaded on 12% SDS gel. 
The strong band slightly above the 50 kDa marker corresponds to MatB as shown in 
figure 5.5D. As the protein is found to be solubly expressed, large scale expression is 
carried out in 1 L of the same media. After purification to near homogeneity by IMAC 
resin, yield wascalculated by Beer’s law using absorbance reading at 280 nm and molar 
extinction coefficient of 33,920 M-1cm-1. A total of 18 mg protein was purified from 1 L 





Figure 5.5 Cloning, expression and purification of S. coelicolor MatB. A) 
Malonyl CoA catalyzes the synthesis of Malonyl/methylmalonyl CoA from CoA 
and malonate. B) PCR amplification of MatB gene from S. coelicolor genomic 
DNA C) matB Plasmid analysis after restriction digestion and D) Expression 
and purification of MatB in E. coli as recombinant protein.   
The activity of purified enzyme against malonate and dephospho Coenzyme A 
was analyzed by HPLC. A reaction was set up in 1X MatB buffer containing 5 mM 
Malonate and 1 mM dephospho-CoA. Upon addition of the enzyme in 5 µM 
concentration, a new peak corresponding to malonyl CoA was appeared in the 
chromatogram. The new peak in the chromatogram has both thioester and adenosine UV 
signature as expected. 
An ability of MatB enzyme to accept biotinylated malonate substrate is crucial for its 
application in CoA-RNA capture. The biotinylated malonate was synthesized from 
diethylamino malonate as shown in scheme 2. The carboxyl group of a biotin was 
activated with carbonyl diimidazole (CDI) in DMF and coupled with diethylamino 
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malonate to form an amide linkage between 2-amino group of diethylamino malonate and 
carboxyl group of a biotin. The ethyl ester group was hydrolyzed with potassium 
hydroxide to yield biotinylated malonate. 
Scheme 5.2 Synthesis of a biotinylated malonate as a substrate for MatB reaction. 
The activity of MatB was tested against biotinylated malonate using dephospho 
CoA as another substrate. HPLC analysis showed no enzymatic activity against 
biotinylated malonate. Although the enzyme has broad substrate tolerance against various 
modifications on α-carbon of malonate, biotin modification was not allowed may be due 
to the large size of the biotin. 
The search of an enzyme able to transfer biotinylated fatty acid into CoA-RNA was 
unsuccessful. All the enzymes used in the study were found to be either very specific to 
their particular natural substrates or with the limited substrate promiscuity. An enzyme 
with ability to accept biotin and CoA linked RNA as its two substrates would be ideal for 
this purpose. However, the enzyme with such activity could not been found in our study. 
A biotin-CoA ligase would be another good candidate enzyme. Although biotin CoA 
ligase was shown to exist in at least one organism [172], unavailability of genome 
sequence information of such organism is a barrier in obtaining Biotin-CoA ligase by 
recombinant protein expression. As an enzyme with the activity against biotin/ biotin 
fatty acids and CoA-RNA could not be found in this study, alternative approaches were 
used to achieve the goal of capturing CoA-linked RNA as described later in this chapter. 
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5.2.2 In vivo labeling of CoA-RNA with Pantetheine analogs 
The ability of phosphopantetheinyl adenylyltransferase (PPAT (coaD)) to accept a broad 
range of modifications on the thiol of pantetheine was demonstrated by the successful 
conversion of biotin-pantetheine thioester into biotin-dephospho CoA. The broad 
substrate tolerance of CoaD can be exploited to generate biotinylated CoA analogs in 
vivo by providing the bacteria with biotinylated pantetheine analogs in a growth medium. 
We hypothesized that such analogs would be able to label CoA-RNA with a biotin 
handle, which can used be used to selectively isolate them by using a streptavidin resin. 
A schematic representation of labelling CoA-RNA with biotin using biotinylated 
pantetheine analogs is depicted in figure 5.6. 
 
Figure 5.6 strategy for labelling CoA-RNA with biotinylated pantetheine analogs 
in vivo 
The pantetheine analog should have two essential features: 1) the presence of a 
reporter molecule i.e. a fluorophore or a radiolabel so that the transport of these 
molecules across the cell membrane, their localization, and their incorporation into in E. 
coli RNA can be visualized; and 2) the presence of a biotin to provide a handle for the 
selective isolation of labelled RNA species. With the consideration of these two 
properties of the analog, a synthetic scheme is designed to synthesize a pantetheine 
analog labelled with biotin as a purification handle and Cy3 as a flouorescent reporter 
tag. The synthetic strategy of a designed analog is depicted in scheme 5.3.  
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The synthesis begins with the selective protection of secondary hydroxyl of 
commercially available pantethine molecule by tertbutyldimethylsilyl (TBS) protecting 
group. The selective protection of the secondary alcohol of pantethine is mandatory for 
its loading to the trityl bromide beads through the primary hydroxyl group. The reduction 
of the pantethine on the beads by DTT would yield a free thiol which reacts with 
Bromoaminoethane to yield an amine functional group. The terminal amino group can be 
used to install a biotin handle and a Cy3 tag as shown in scheme. 
 
 
Scheme 5.3 Synthesis of pantetheine analogs having a biotin as a purification handle and 
a Cy3 as a reporter fluorophore. 
The solid phase synthesis is advantageous over normal liquid phase synthesis 
because it has a high efficiency, simplicity, and speed as the arduous task of purification 
after each step of the synthesis is not required. Because of this reason, solid phase 
synthesis was deemed as an appropriate strategy for the synthesis of biotin and Cy3 
labelled pantetheine analogs. The primary hydroxyl group of pantethine can be exploited 
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for its initial loading on the bromotrityl resin. However, the presence of a secondary 
hydroxyl makes the loading non-selective to primary alcohol as both the primary 
hydroxyl group and the secondary hydroxyl group are able to react with a bromotrityl 
resin. Therefore, the selective protection of a secondary hydroxyl group of pantethine is 
mandatory to achieve its selective loading via primary hydroxyl group. 
There are various alcohol protecting strategies available which are reviewed elsewhere in 
the literature. Among them, Tert-butyldimethylsilyl (TBDMS) is one of the most reliable 
and commonly used protecting group for alcohols. Both primary and secondary hydroxyl 
groups can be protected as TBDMS ethers without difficulty. This feature allows an easy 
protection strategy but comes with the limitation that selective protection of one over 
another is not hard to achieve. Since primary TBDMS ethers are more reactive toward 
deprotection conditions than their secondary counterparts, a better way of achieving 
selective protection of secondary hydroxyl would be by selective deprotection of primary 
TBDMS ethers after both types of hydroxyls are TBDMS protected. However, a simple, 
high yielding, and environmentally friendly procedure for the selective desilylation of 
primary TBDMS ether while keeping their secondary counterpart protected is not 
available. As complex synthetic schemes in contemporary organic chemistry and 
medicinal chemistry require a good way to selectively protect and deprotect TBDMS 
ethers, development of a mild and selective method for primary TBDMS deprotection 






5.2.3 Selective deprotection of primary TBDMS ether by formic acid 
A mild, efficient and environmentally friendly method for the selective 
deprotection of primary TBDMS ether was developed in order to achieve selective 
protection of secondary hydroxyl group. In this method, both the primary and secondary 
hydroxyls were first protected as TBDMS ethers and selective deprotection of primary 
TBDMS group was carried out by formic acid in acetonitrile which is shown in scheme 
5.4. The rate and selectivity of the desilylation reaction was established in different 
concentrations of formic acid and compared to that of acetic acid and TFA.  
 
Scheme 5.4 Strategy for the selective protection of secondary alcohols as TBDMS ethers 
in presence of their primary counterparts. 
Complex synthetic targets in modern organic chemistry require a manipulation of 
various functional groups. The ability to selectively mask and unmask these precious 
functional groups is crucially important in many areas of organic synthesis. Tert-
butyldimethylsilyl (TBDMS) group is one of the most reliable and popular method for 
hydroxyl group protection because of its easy installation and removal [173]. Both the 
primary and the secondary hydroxyl groups can be protected as TBDMS ethers without 
any preference. During the synthesis of complex natural products and biomolecules, there 
are many instances where selective protection of secondary hydroxyl is required without 
affecting the primary hydroxyl functionality[174-181]. This cannot be directly achieved 
as primary hydroxyl group will also be reacting in all the conditions that secondary 
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hydroxyl reacts.  The common practice for the selective protection of secondary hydroxyl 
group in presence of its primary counterpart involves protection of both the hydroxyls 
followed by selective deprotection of primary hydroxyl group [182-185]. 
The selective deprotection of TBDMS ether have been the subject of numerous 
investigations. Fluoride ion based reagents such as HF [186] and TBAF [175, 176]  are 
widely used for the desilylation; however, they lack the preference among primary and 
secondary alcohol because of the strong affinity of fluoride for silicon. The strong 
basicity of the fluoride ion might cause unwanted side reactions while using fluoride-
based desilylation reagents. Inorganic acids like HCl and H2SO4 are also known to 
deprotect TBDMS ether but without any selectivity [187]. Lewis acids like BF3
-, ZnBr, 
and LiBr require longer time and higher temperature [188]. Organic acids including 
Acetic acid, p-Toulenesulfonic acid (TsOH), Camphorsulfonic acid (CSA), and 
Trifluoroacetic acid (TFA) are also used for the desilylation. Ogilvie and co-workers used 
80% aqueous acetic acid to  desilylate the 5’-hydroxyl of nucleosides [189]. This method 
suffers from poor selectivity, low yield, and requirement of high acid concentration. 
TsOH and CSA also lack the selectivity among primary and secondary alcohols. TFA is 
another acid widely used for desilylation [187, 188, 190]. Because of its strong acidic 
strength, the deprotection reaction by TFA is hard to control; therefore, selectivity cannot 
be achieved when both primary and secondary TBDMS ethers are present. Many other 
reagents including Pd(II) based reagents [191-194], LiAlH4 [195], Neutral alumina [195], 
AlCl3.6H2O [196], Zn(II)trifluoromethanesulfonate [197], Sodium tetrachloroaurate 
dihydrate [198], Sulfated cellulose,[199] Hafnium triflate [200], Sodium sulphide [201], 
Quinolinium fluorochromate [178], Oxone [184], SbCl5 [202], 1,1,3,3-
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tetramethyguanidine (TMG) [203], and Tetrabutylammonium tribromide (TBABr)[204] 
are also available now for the selective desilylation of primary TBDMS ether. These 
reagents are not environmentally friendly, require special handling procedures, show poor 
selectivity and low yielding. In all these examples, while primary TBDMS ethers are 
preferentially deprotected, secondary TBDMS ethers are also cleaved to various degrees, 
resulting in undesired byproducts and low yields. Whereas optimal deprotection 
conditions for achieving high selectivity and yield may exist for specific target 
molecules, it is by no means a simple task – involving searching for different acids, 
concentrations, temperature, and reaction time. 
Despite being a subject of numerous investigations, a simple, easy and environmentally 
friendly procedure for selective desilylation of primary TBDMS ether is not available. 
So, development of a selective desilylation procedure for the primary TBDMS ether in 
presence of their secondary counterparts will be of great utility for synthetic organic 
chemists. When examining various procedures for selective deprotection of TBDMS 
ethers in the literature, it came to our attention that the medium strength formic acid is 
rarely used, while both stronger (TsOH, CSA, HCl, TFA) and weaker (acetic acid) acids 
are often utilized. There are two reports of TBDMS deprotection by formic acid. 
Kawahara and co-workers investigated the 2’-O desilylation of nucleotides and found 
that 20%-40% formic acid can effectively deprotect 2’-O TBDMS from protected 
oligoribonucleotides.[205] In another report, Kende and colleagues used 30% formic acid 
to deprotect secondary TBDMS ethers during the synthesis of lankacidin C macrolide 
[206]. While formic acid can globally deprotects TBDMS ethers at high concentrations 
(>30%), its utility at lower concentrations for selective deprotection of primary TBDMS 
 
125 
ethers had not been explored. We developed a selective desilylation of primary TBDMS 
group by different concentrations of formic acid. We used TBDMS-Glycolate and 
TBDMS-lactate as model compounds to represent primary TBDMS ether and secondary 
TBDMS ether respectively as shown in scheme 5.5. 
 
 
Scheme 5.5 Model sytem for the study of rate and selectivity of desilylation reaction by 
5%, 10% and 20% formic acid. 
 
5.2.3.2 Synthesis of TBDMS glycolate methyl ester 
The model compound for the primary TBDMS ether, TBDMS glycolate methyl 
ester, was synthesized by dissolving methyl glycolate 0.9 g (10 mmol, Alfa Aesar 98%) 
in 5 ml dry DMF, followed by adding 1.36 g (20 mmol, imidazole (Alfa Aesar 99%). 
TBDMSCl (Chem impex international 99%, 2.4 g, 16 mmol) was added under Nitrogen 
and stirred overnight at room temperature. The reaction was quenched by adding 2 ml 
water. It was then extracted with 2x10 ml ethyl acetate. Organic phase was collected, 
washed with 4x20 ml water, dried by 5g Na2SO4. Solvent was removed under reduced 
pressure at 60° C. It yielded 1.93 g (95%) clear oil. The compound was confirmed by 1H 
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NMR (Chloroform-d) δ 4.14 (s, 2H), 3.63 (s, 3H), 0.81 (s, 9H), 0.02 (s, 6H) which is 
shown in fig A1.  
5.2.3.3 Synthesis of TBDMS lactate methyl ester 
The model compound for the secondary TBDMS ether, TBDMS lactate methyl 
ester was synthesized by dissolving 1.05 g (10 mmol, Alfa Aesar 97%) methyl (s)-(-) 
lactate in 2.5 ml dry DMF and 1.36 g (20 mmol) imidazole was added under nitrogen. 
The reaction mixture was stirred overnight at room temperature. 2 ml water was added 
into it to quench and then extracted with 2x10 ml ethyl acetate. The organic phase was 
collected, washed with 4x20 ml water, dried over 5 g Na2SO4. Removal of solvent under 
reduced pressure at 60 ° C yielded 2.04 g (94%) crude product as a clear oil. The product 
was characterized by 1H NMR (Chloroform-d) δ 4.14 (s, 2H), 3.63 (s, 3H), 0.81 (s, 9H), 
0.02 (s, 6H). 
After the successful synthesis and characterization of the model compounds to represent a 
primary TBDMS ether and a secondary TBDMS ether, different concentrations of formic 
acid in acetonitrile/ water were used to the rate and selective of desilylation by formic 
acid. We started the reaction by incubating TBDMS glycolate methyl ester and TBDMS 
lactate methyl ester with the desilylation reagent in 1:10 ratio by volume. A typical 
desilylation reagent contains formic acid, 15% water and acetonitrile. For example, 5% 
desiylation reagent was prepared by mixing 0.5 ml formic acid, 1.5 ml water and 8 ml 
acetonitrile. Similarly, 10% formic acid and 20% formic acid desilylation reagents were 
prepared by mixing acetonitrile: water: formic acid in the ratio of 75:15:10 and 65:15:20 
respectively. The reaction was quenched by neutralizing with 1 M NaHCO3 at different 
time points and the quenched reaction mixtures were immediately stored at -20 °C until 
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the HPLC analysis is performed. The rate of the desilylation reaction was determined by 
HPLC using Gemini C18 4.6 x 50 mm column. A flowrate of 1 ml/min was used in 
isocratic elution mode at 40% acetronitrile and 10% 40 mM KH2PO4 for 1 h to elute the 
silylated starting materials. Under these conditions TBDMS-glycolate methyl ester and 
TBMDMS lactate methyl ester have retention time of 3.2 min and 3.5 min respectively. 
The desilylated reaction products glycolate methyl ester and lactate methyl ester do not 
retain in the column and elutes at void volume with formic acid. The detector was set at 
210 nm to detect the carbonyl group. Same amount of the both TBDMS lactate methyl 
ester and TBDMS glycolate methyl ester at time 0 was injected in HPLC and used as a 
control for the reaction rate analysis. The reaction kinetics was analyzed by measuring 
the area under the curve using EZChrom Elite software. 
The desilylation of TBDMS glycolate methyl ester required 16 hours of reaction at room 
temperature in order to reach completion as shown in fig 5.7A. The same deslilyation 
condition does not deprotect TBDMS protecting group form TBDMS lacate methyl ester 
(figure 5.7B) showing a good selectivity for the primary alcohol. As acetic acid and TFA 
were previously used to achieve a selective desilylation of primary alcohols, we 
compared the rate and selectivity of these two existing methods with our newly 
developed formic acid-based method. As acetic acid is about 10 times weaker than formic 
acid based on their pKa, we expected much slower reaction, if acetic acid in 5% 
concentration was able to desilylate TBDMS lactate. As shown in fig. 5.7C, 5% acetic 
acid did not desilylate any TBDMS lactate within 16 h that was detectable in our 
conditions. On the other hand, TFA is ~10 times stronger than formic acid and predicted 
to have higher desilylation rate and lower selectivity. As expected, TBDMS glycolate 
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methyl ester was completely desilylated by 5% TFA within 2 h reaction time (Fig 5.7 D). 
When TBDMS lactate methyl ester, a model compound for secondary alcohol was 
subjected to desilylation by 5% TFA, ~50% was desilylated into its corresponding 
alcohol within 2 hours. 
The desilylation reaction by 5% formic acid is selective but very slow, requiring ~12 h 
for completion. We investigated effect of formic acid concentration in terms of reaction 
rate and selectivity. We used 10% formic and 20% formic acid for the TBDMS 
deprotection keeping other conditions identical to 5% and studied the reaction rate and 
selectivity toward primary TBDMS ether. It was expected that any increase in acid 
concentration would enhance the reaction rate but limit the selectivity. When the formic 
acid concentration is increased to 10%, the reaction completion time is shortened my ~3 
fold to 4 hours (Fig 5.8 A). Interestingly, 10% formic acid did not desilylate TBDMS 
lactate methyl ester in a detectable rate within 4 hours (Fig 5.8B). Unlike 5% acetic acid, 
10% acetic acid was able to deprotect primary TBDMS ether but required a very long 
time for the completion (Fig 5.8C). 10% TFA was faster than both 10% formic acidand 
10% acetic acid, requiring only ~1 h to completely deprotect the primary TBDMS ether 










Figure 5.7 HPLC analysis of desilylation of TBDMS glycolate methyl ester and 
TBDMS lactate methyl ester by 5% formic acid, 5% Acetic acid and 5% TFA. 
Desilylation kinetcs of A) TBDMS-Glycolate methyl ester by 5% formic acid, B) 
TBDMS lactate methyl ester by 5% formic acid, C) TBDMS Glycolate methyl 






Figure 5.8 HPLC analysis of desilylation of TBDMS glycolate methyl ester and 
TBDMS lactate methyl ester by 10% formic acid, 10% Acetic acid and 10% TFA. 
Desilylation kinetcs of A) TBDMS-Glycolate methyl ester by 10% formic acid, B) 
TBDMS lactate methyl ester by 10% formic acid, C) TBDMS Glycolate methyl 
ester by 10% acetic acid and D) TBDMS Glycolate methyl ester by 10% TFA. 
The rate and selectivity of desilylation by low concentration of formic acid was 
further investigated by using 20% formic acid as a desilylating agent. The establishment 
of a desilylation kinetics and selectivity at different formic acid concentrations provides 
an opportunity to select the desilylation reagent according to the experimental conditions. 
For instance, if one needs quicker reaction but not the high degree of selectivity, higher 
formic acid concentration would be preferred. On the other hand, if higher degree of 
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selectivity is required in the deprotection reaction, 5% formic acid would be a suitable 
choice. We found the desilylation by 20% formic acid is about three times faster than 
10% formic acid and about nine times faster than the 5% formic acid. As shown in figure 
5.9A, the desilyation reaction of TBDMS glycolate methyl ester was more than 95% 
completed in ~1.2 hours when 20% formic acid was used as a desilylating reagent. Under 
the same conditions, the deprotection of TBDMS lactate was <5% (Fig. 5.9B). Acetic 
acid in 20% concentration is also able to promote desilylation but at significantly slower 
rate (Fig 5.9C). TFA, in 20% concentration, is 4 times faster than the 20% formic acid 
requiring only 15 minutes to desilylate ~95% TBDMS lactate methyl ester as shown in 
figure 5.9D. 
The desilylation kinetic curves were calculated by determining the amount of 
starting material i.e. TBDMS glycolate methyl ester or TBDMS lactate methyl ester at 
different reaction time by integrating the peaks. The half-lives of both primary and 
secondary TBDMS ethers under different deprotection conditions were calculated from 
the kinetic curves which are presented in table 5.1. Although both primary and secondary 
TBDMS ethers can be deprotected by 5-20% formic acid, our data showed a strong 
preference of 40-60 times for the primary TBDMS ether over secondary TBDMS ether. 
Such preference toward the primary TBDMS ether was also shown by acetic acid but the 
deprotection time is ~20 times longer at the similar concentration. TFA, on the other 
hand, can desilylate both primary and secondary TBDMS ethers much faster. However, 
the preference for primary TBDMS ethers over secondary TBDMS ethers decreases 





Figure 5.9 HPLC analysis of desilylation of TBDMS glycolate methyl ester and 
TBDMS lactate methyl ester by 20% formic acid, 20% Acetic acid and 20% TFA. 
Desilylation kinetics of A) TBDMS-Glycolate methyl ester by 10% formic acid, 
B) TBDMS lactate methyl ester by 20% formic acid, C) TBDMS Glycolate 
methyl ester by 20% acetic acid and D) TBDMS Glycolate methyl ester by 20% 
TFA. 
 
The selective desilylation of the primary TBDMS ethers over the secondary TBDMS 
ethers can be achieved by exploiting the significant difference in their half-lives under 
different formic acid concentrations. We determined the deprotection regioselectivity of 
TBDMS ethers by using the relative amount of primary and secondary alcohols under a 
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defined condition of desilylation reagent concentration and the reaction time.  As shown 
in table 5.2, 95% deprotection selectivity for primary TBDMS ethers was achieved by 
using 5-20% formic acid while keeping the desilylation of secondary TBDMS ethers 
under 5%. Since acetic acid was not able to desilylate secondary TBDMS ethers 
effectively, the selectivity of formic acid and acetic acid could not be compared. TFA, a 
commonly used desilylation reagent can reach only about the regioselectivity ratio of 
95:40, i.e. 40% of secondary TBDMS ether would also be deprotected when primary 
TBDMS ether is 95% desilylated. 
 
















Table 5.2 Desilylation selectivity of 5%-20% formic acid and 5-10% TFA 
 
Our data suggested that both the acid strength and acid concentration play an important 
role in determining the desilylation rate and selectivity between primary and secondary 
TBDMS ethers. When the acid strength is high as in case of TFA, the deslilylation rate is 
faster but has a poor selectivity. on the other hand, 5-20% acetic acid offers a high 
desilylation selectivity between primary and secondary TBDMS ethers as the secondary 
TBDMS ethers are practically stable in these conditions, this method suffers from the 
slow deprotection rate. Since formic acid lies between TFA and acetic acid in terms of 
acid strength, it came as no surprise that we found formic acid as an ideal desilylation 
reagent for optimal desilylation rate and selectivity. 
Many organic reactions require anhydrous condition for their success. In such context, we 
tested the requirement of water in our desilylation protocol. When we treated TBDMS 
glycolate methyl ester, our model compound for primary TBDMS ether, in 5-10% 
anhydrous acetonitrile overnight, no desilylation occurred in a detectable amount. This 
experiment suggested that a small proportion of water is required for the desilylation 









Formic Acid 5 12 95 <5 
10 4 95 <5 
20 0.5 95 <5 
TFA 5 2.5 95 40 




speculated that water is required for the dissociation of formic acid into HCOO- and H+, 
without which the reaction cannot proceed. 
The broad utility of formic acid as a simple and efficient primary TBDMS desilylation 
reagent was demonstrated by investigating the desilylation of six different diols 
containing both primary and secondary hydroxyl groups. The diols were fully protected 
first as TBDMS ethers using TBDMSCl and imidazole in dry DMF. The installation of 
two TBDMS groups them made them hydrophobic making their purification possible by 
simple extraction. The fully protected diols were extracted with ethyl acetate, dried and 
characterized by 1H NMR. 
1,3-Bis(tert-butyldimethylsiloxy) butane 
Butane-1,3-diol 0.45 g (5 mmol, Aldrich 98%) was dissolved in 5 ml dry DMF. The 
reaction was started by adding 1.36 g (20 mmol) imidazole and 2.51 g (17 mmol) 
TBDMSCl under Nitrogen. The reaction mixture was stirred overnight at room temperature 
and quenched by adding 2 ml water. It was then extracted with 2x 10 ml ethyl acetate. 
Organic phase was collected, washed with 4x20 ml water, dried by 5 g Na2SO4. The 
removal of the solvent under reduced pressure at 60° C yielded 1.52 g (96%) crude product 
as colorless oil. 1H NMR (Chloroform-d) δ 3.94 – 3.89 (m, 1H), 3.68 – 3.56 (m, 2H), 1.69 
– 1.46 (m, 3H), 1.10 (d, J = 6.2 Hz, 4H), 0.85 (s, 18H), 0.08 (s,12H). 
3-diethylamino-1,2-bis(tert-butyldimethylsiloxy) propane  
To 1.21 g (8 mmol) 3-diethylamino-1,2 propane (Alfa Aesar 97%), 4 ml dry DMF, 2.82 g 
(40 mmol) imidazole, and TBDMSCl 4.15 g (27 mmol) were added under Nitrogen. The 
reaction mixture was stirred overnight at room temperature and quenched by adding 4 ml 
water next morning. It was then extracted with 2x 20 ml ethyl acetate. Organic phase was 
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collected, washed with 4x25 ml water, dried by 5 g Na2SO4. Removal of the solvent 
under reduced pressure at 60° C yielded 2.73 g (91%) crude product as light yellowish 
oily liquid. 1H NMR (Chloroform-d) δ 3.69 – 3.60 (m, 1H), 3.58 (dd, J = 10.1, 4.7 Hz, 
1H), 3.45 (dd, J = 10.1, 5.7 Hz, 1H), 2.53 – 2.41 (m, 4H), 2.26 (dd, J = 13.6, 5.3 Hz, 1H), 
0.94 (t, J = 7.1 Hz, 6H), 0.90 – 0.78 (s, 18H), 0.05 (s, 12H). 
3-phenoxy-1,2-bis(tert-butyldimethylsiloxy) propane 
To 0.34g (2 mmol) 3-phenoxy 1,2 propanediol (TCI America), 2 ml dry DMF, 0.68 g (10 
mmol) imidazole and TBDMSCl 1.2 g (8 mmol) were added under Nitrogen and stirred 
overnight at room temperature. The reaction was quenched by adding 2 ml water and 
extracted with 2x10 ml ethyl acetate. Organic phase was collected, washed with 4x20 ml 
water, dried by 5 g Na2SO4. Solvent was removed under reduced pressure at 60° C to 
yield 0.76 g (96%) crude product as clear oily liquid. 1H NMR (Chloroform-d) δ 7.22 – 
7.12 (m, 2H), 6.87 – 6.76 (m, 3H), 4.02 – 3.92 (m, 2H), 3.80 – 3.71 (m, 1H), 3.57 – 3.50 
(m, 2H), 0.97 – 0.62 (m, 30H). 
3-(2-Methoxyphenoxy)-1,2-bis(tert-butyldimethylsiloxy) propane 
To 0.40 g (2 mmol) 3-(2-methoxyphenoxy)-1,2 propanediol (Alfa Aesar 97%), 2 ml dry 
DMF, 0.68 g (10 mmol) imidazole and TBDMSCl 1.22 g (8 mmol) were added under 
Nitrogen and stirred overnight at room temperature. 2 ml water was added to quench the 
reaction extracted with 2x10 ml ethyl acetate. Organic phase was collected, washed with 
4x20 ml water, dried by 5 g Na2SO4. Solvent was removed under reduced pressure at 60° 
C that yielded 0.79 g (94%) crude product as colorless oil. 1H NMR (Chloroform-d) δ 





To 0.41 g (2 mmol) 3-(4-chlorophenoxy)-1,2 propanediol (Alfa Aesar 99%), 3 ml dry 
DMF, 0.68g (10 mmol) imidazole, and 1.2 g (8 mmol) TBDMSCl were added under 
Nitrogen and stirred overnight at room temperature. The reaction was quenched by adding 
2 ml water. It was then extracted with 2x10 ml ethyl acetate. Organic phase was collected, 
washed with 4x20 ml water, dried by 5 g Na2SO4. Solvent was removed under reduced 
pressure at 60° C. Yield – 0.80 g clear oily liquid (93%).  1H NMR (Chloroform-d) δ 7.19 
– 7.12 (m, 2H), 6.79 – 6.73 (m, 2H), 4.04 – 3.93 (m, 2H), 3.80 – 3.75 (m, 1H), 3.62 – 3.50 
(m, 2H), 0.83 (s, 18H), 0.08 (s,12H). 
2-Ethyl-1,3-bis(tert-butyldimethylsiloxy) hexane 
To 0.73 g (5 mmol) 2-Ethyl-1,3-hexane (TCI America), 3 ml dry DMF, 1.71 g (25 mmol) 
imidazole. TBDMSCl 3.05 g (20 mmol) was added under Nitrogen and stirred overnight 
at room temperature. The reaction was quenched by adding 2 ml water. It was then 
extracted with 2x10 ml ethyl acetate. Organic phase was collected, washed with 4x20 ml 
water, dried by 5 g Na2SO4. Solvent was removed under reduced pressure at 60° C. Yield 
– 1.77 g clear liquid (95%). 1H NMR (Chloroform-d) δ 3.79 (ddq, J = 6.7, 5.6, 3.6 Hz, 
1H), 3.59 – 3.40 (m, 2H), 1.67 – 1.07 (m, 8H), 0.90 – 0.85 (s, 18H), 0.84 (m, 6H), 0.08 
(s,12H) 
The protected diols were treated with 10% formic acid in acetonitrile/water at room 
temperature for 4 hours. The products were isolated by simple extraction with ethyl 
acetate and the products were analyzed by 1H-NMR. As presented in table 5.3, the 
treatment of disilylated alcohols with 10% formic acid yielded corresponding 
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monosilylated primary alcohols in excellent yields. The identity and purity of the isolated 
products was established by 1H-NMR. 
Table 5.3 Selective deprotection of different disilylated alcohols by 10% formic acid in 





After developing a good method for the selective protection of secondary alcohols in 
presence of their primary counterparts, we applied this method to selectively protect 
secondary hydroxyl of pantethine so that it can be loaded to the bromotrityl resin through 
the primary hydroxyl group according to figure 5.10 A. As shown in figure 5.10B, 
desilylation of globally protected pantethine by 10% formic acid successfully yielded the 
di-TBDMS pantethine in 90% crude yield. 
Figure 5.10 Selective protection of secondary hydroxyl of pantethine by using 
10% formic acid for the selective desilylation. A) strategy for the global 
protection and selective primary TBDMS ether deprotection and B) HPLC 
profile of the di-silylated pantetheine after selective deprotection. The fully 
protected pantethine does not elute from the column. No fully deprotected 
pantethine, that elutes at 4.7 minutes in these conditions, was detected. 
5.2.4 Synthesis of Biotin-Cy3 Labelled Pantetheine 
The synthesis of biotin-cy3 labelled pantetheine was carried out by a solid phase 
synthetic strategy. The reaction was started by loading TBS-pantetethine onto the 
bromotrityl resin, which were prepared from commercially available trityl alcohol beads 
by reacting with excess of acetyl bromide in DCM under the Nitrogen environment. TBS-
pantethine was synthesized by desilylating fully protected pantethine with 10% formic 
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acid and reacted to the bromo-functionalized beads in DCM. The reaction yield was 50% 
which was determined by calculating an increase in dry mass of the beads. 
The pantethine was reduced to pantetheine on the beads by adding 1 equivalent of TCEP 
in DCM/TEA. It was then reacted with excess of 2-bromoethylamine in DCM/TEA to 
generate reactive amimo functional group. The carboxyl group of fmocLys(TFA)-OH 
was activated by HCTU in 1:0.9 molar ratio and reacted to the amino functionalized 
beads. The loading of orthogonally protected lysine residue on the beads made it possible 
to conjugate biotin and Cy3 on α-amino and £-amino group respectively as shown in 
scheme 5.3. The Fmoc deprotection in α-amino was carried out by treating beads with 
20% piperidine in DMF for 5 minutes. Under such conditions, the TFA protecting group 
on the £-amino group of lys remained intact. Biotin was activated with HCTU and 
reacted to the deprotected α-amino group. 
A cyanine dye Cy3 was synthesized by following a literature procedure which is shown 
in scheme 5.6 [108, 207, 208]. Briefly, 1 mmol of 4-aminobenzyl acetic acid was 
dissolved in 1 ml 1M NaOH. The solution was acidified by adding 1.2 ml 12 M HCl at 0 
°C and added 1equivalent of 2 M NaNO2. The reaction was stirred for 30 minutes. It was 
then reduced by adding 5 equivalents of SnCl2 in HCl. The reaction produced white 
precipitate upon addition of SnCl2. The precipitate was filtered, washed with ether, 
neutralized by NaHCO3 and dried under vacuum. The crude product was directly used in 




Scheme 5.6 Synthesis of Cy3 dye for the fluorescent labelling of biotin pantetheine 
conjugates. 
One equivalent of compound 2 was added and 2 equivalents of potassium acetate and 5 
equivalents of methyl isopropyl ketone and dissolved in glacial acetic acid. The reaction 
mixture was stirred for 1 h at room temperature until 232 nm peak in UV disappeared and 
a new peak of λmax= 273 nm appeared. The reaction was then refluxed for 2 h, cooled 
down to RT and concentrated by vacuum. The crude product 4 was purified by flash 
column chromatography using DCM/MeOH/TEA= 98/0/2→ 88/8/2 as solvent. N-
methylation of compound 4 was carried out by adding excess of iodoethane in DMSO at 
80 °C. After 1 h of reaction, the solvent was evaporated under reduced pressure and the 
crude residue was dissolved in dry pyridine. Ten equivalents of triethyl orthoformate was 
added slowly and the reaction was set for reflux for 3 hours. The solvent was removed 
under reduced pressure, crude residue was purified by following literature procedure 
[108] to yield Cy3 dye 6 in 55% yield.  
Cyanine dyes including Cy3 was previously used to label RNA by using cyanine-
AMP conjugates (Cy3-AMP) as transcription initiator under T7 φ2.5 promoter [108]. 
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However, our attempts to conjugate Cy3 dye on the amino-functionalized beads were 
unsuccessful which is probably the presence of two equally reactive carboxyl groups. We 
then decided to use C-14 acetate as a reporter tag instead of Cy3 fluorophore in 
pantetheine analogs which is described later in this dissertation chapter 
5.2.5  Synthesis of Biotin-C14 Labelled Pantetheine 
Various pantetheine analogs were designed to achieve the in vivo labelling of 
CoA-RNA. All the analogs contain biotin as a purification handle, C-14 as a reporter tag, 
pantetheine as an enzyme substrate, and varying number of positive charges that might be 
helpful for their uptake. Because of the simplicity in purification and faster reactions, 
solid phase synthetic strategy was used to synthesize these analogs. The synthesis started 
with commercially available trityl chloride resin. It was reacted with excess of 
diethylamine to change chloro functional group to amino functional group. Fmoc-
protected biotin-lysine was activated and reacted to the amino beads by standard peptide 
coupling reaction. The beads were divided into four equal parts so that pantetheine 
analogs with charges +1, +2, +3, and +4 can be synthesized. Each group of beads were 
coupled to 0-3 protected lysine to achieve the desired positive charge. After Lys, 
Cysteine was added to create a thiol functional group that was reacted to diiodopropane. 
Finally, Pantetheine was installed through thiol-iodo reaction and the analog was globally 







5.2.5.1 Synthesis of Biotin-1lys-cys-pant (B1KP) 
The synthesis of Biotin-1lys-Cys-pant (B1KP) was synthesized by solid phase 
synthetic strategy as shown in scheme 5.7. The synthesis was started by swelling 350 
mg/0.45 mmol trityl chloride beads (chem impex international catalog no 03902) in 5 mL 
dry DMF. The solvent was drained, and excess of ethylene diamine was added to 
transform chloride beads into amino beads. The reaction was agitated at room 
temperature by gentle rotation for an hour. The solvent was drained, and the beads were 
washed with 3x4 mL DMF. Fmoc-Gly-oh, 267 mg/ 0.9 mmol (Chem Impex international 
catalog #: 02416) was activated by adding 322 mg/ 0.95 equivalents HCTU in 3 mL 20% 
NMM/DMF for 5 minutes and added into the beads to form standard amide bond. Fmoc 
was deprotected by 2 mL 20% piperidine/DMF and coupling yield was determined to be 
~90% by UV. The unreacted amino beads were capped by reacting with excess of acetic 
anhydride before fmoc deprotection. 
Scheme 5.7 Solid phase synthesis of B1kP Reagents and conditions: (i) ethylene diamine, 
DMF, 10 min, RT (ii) Nα-Fmoc-Nε-biotinyl-L-lysine, HCTU (iii) and (v)  20% piperidine 
in DMF, RT, 5 min (iv) fmoc-cys(stbu)-OH, HCTU (vi) [1-14C] NaoAc, HCTU (vii) 1 M 
DTT, 60 ° C, 3 h (viii) 1,3-diiodopropane, DMF, RT, 30 min (ix) pantetheine, DMF, RT, 
30 min (x) 5% TFA/DCM, RT, 10 min. 
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The beads were split into four equal parts at this point. The first fraction was 
directly used for coupling with Fmoc-(stbu)-Cys. The beads were swelled in dry DMF. 
Fmoc-L-Cys(stbu)-OH, 172 mg, 400 micromoles (Chem Impex International, catalog 
number 02403) was activated by adding 157 mg/ 380 micromoles HCTU in 1 mL 20% 
NMM/DMF at room temperature for 5 minutes. It was added to the beads and gently 
agitated for 30 minutes at room temperature. The solvent was drained and 3x2 mL DMF 
was used to wash the resin. Fmoc deprotection was carried out as before by 20% 
piperidine in DMF. Quantitation by UV spectrophotometry showed near quantitative 
yield. The amino group generated by fmoc deprotection was used to form an amide bond 
with acetate. Acetic Acid, Sodium Salt, [1-14C], 62 micromoles/ 100 µCi radioactivity and 25 
mg, 60 micromoles HCTU were dissolved in 0.5 mL 20% NMM/DMF for the activation. The 
activated acetate was added to the beads and reacted with gentle stirring for 1 hour. The 
unreacted amino functional group were capped with excess of acetic anhydride. The solvent 
was drained, and the resin was washed with 3x2 mL DMF. 
The deprotection of stbu protecting group on cysteine thiol was effected by 1 M DTT at 
60 °C for 3 hours. The thiol group on the resin was then coupled with excess of 1,3 
diiodopropane (Oakwood chemical, catalog # 003098) in DMF for 30 minutes at room 
temperature. The solvent was drained and washed with DMF. Pantethine 150 mg, 270 
micromoles were reduced to pantetheine by adding 2 equivalents of DTT in DMF, 
precipitated by diethyl ether and reacted to the iodo functional group on the beads for 30 
minutes at room temperature. Finally, B1KP was deprotected from the beads by 
TFA/DCM/TIPS in 1:18:1 ratio at room temperature for 10 minutes. The product was 
directly drained into ether for precipitation which was collected by centrifugation and 
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dried to yield 71 mg (84%) of B1KPP. The yield was further verified by liquid 
scintillation counting of the product. 
5.2.5.2 Synthesis of Biotin-2lys-cys-pant (B2KP) 
The synthesis of B2KP was carried out as shown in scheme 5.8. The second group 
of beads were coupled with Fmoc-Lys (Boc)-OH to get a charge of +2 in final 
pantetheine analog. The beads were swelled in dry DMF. Fmoc-L-Cys(stbu)-OH, 172 
mg, 400 micromoles were activated by adding 157 mg/ 380 micromoles HCTU in 1 mL 
20% NMM/DMF at room temperature for 5 minutes. It was added to the beads and gently 
agitated for 30 minutes at room temperature. The solvent was drained and 3x2 mL DMF 
was used to wash the resin. Fmoc deprotection was carried out as before. All other steps 
including Cysteine coupling, fmoc deprotection, acetate coupling, stbu deprotection, 1,3-
diiodopropane reaction and final pantetheine coupling were identical as described above. 
Finally, the global deprotection of the product (deprotection from the trityl resin and Boc 
deprotection) was carried out by TFA/DCM/TIPS in 50/45/5 ratio at room temperature 









Scheme 5.8 Solid phase synthesis of B2KP. Reagents and conditions: i) Nα-Fmoc-Nε-Boc 
-L-lysine, HCTU, NMM/DMF, 20% piperidine DMF  ii) fmoc-cys(stbu)-OH, HCTU 
iii) 20% piperidine DMF, RT, 5 min  iv)  [1-14C] NaoAc, HCTU v) M DTT, 60 ° C, 3 h  vi) 
1,3-diiodopropane, DMF, RT, 30 min vii) pantetheine, DMF, RT, 30 min viii) 5% 
TFA/DCM, RT, 10 min. 
5.2.5.3 Synthesis of Biotin-3lys-cys-pant (B3KP) 
The synthesis of B3KP was started by coupling of 12 with Fmoc-Lys (Boc)-OH 
as shown in scheme 5.9. All other steps including cysteine coupling, fmoc deprotection, 
acetate coupling, stbu deprotection, 1,3-diiodopropane reaction and final pantetheine 
coupling were identical as described above. At the end, deprotection from the trityl resin 
and deprotection of Boc protecting groups were achieved by TFA/DCM/TIPS in 50/45/5 
ratio at room temperature for 1 hour. The deprotection product was precipitated by 







Scheme 5.9 Solid phase synthesis of B3KP. 20 was synthesized by coupling Nα-Fmoc-Nε-
Boc -L-lysine with 19 in scheme 5.8. Reagents and conditions are same as described 
above. 
5.2.5.4 Synthesis of Biotin-4lys-cys-pant (B4KP) 
The synthesis of B4KP was started with coupling one more Fmoc-Lys(Boc)-OH 
to 19. As positive charge from lysine amino group was hypothesized to aid in the uptake 
of these pantetheine analogs, B4KP was thought to have highest chance to get diffused 
across the bacterial plasma membrane. Resin 20 (90 mg, 100 micromoles) were swelled 
in 1 mL dry DMF for 30 minutes. Fmoc-Lys(Boc)-OH (140 mg, 400 micromoles) were 
activated by 0.9 equivalents of HCTU in 1 ml 20% NMM/DMF for 5 minutes and added 
into the resin. The coupling reaction was carried out for 30 minutes at room temperature. 
Fmoc was deprotected by 20% piperidine/DMF and used for the quantitation that showed 
near quantitative coupling yield. all other steps including cysteine coupling, fmoc 
deprotection, acetate coupling, stbu deprotection, 1,3-diiodopropane reaction and final 
pantetheine coupling were carried out as described above. Finally, the product B4KP was 
deprotected globally (from the trityl resin and N-Boc deprotection) by TFA/DCM/TIPS 
in 50/45/5 ratio at room temperature for 1 hour. The product from deprotection was 
precipitated by diethyl ether and dried to yield 104 mg (83%) B4KP as white gummy 





Scheme 5.10 Solid phase synthesis of B3KP. 23 was synthesized by coupling Nα-Fmoc-
Nε-Boc -L-lysine with 20 in scheme 5.8. Reagents and conditions are same as described 
above. 
 
5.2.6 Pantetheine analogs as PanK and PPAT substrates 
Pantetheine analogs B1KP, B2KP, B3KP and B4KP were tested for their ability to serve 
as substrates for CoA biosynthetic enzymes PanK and PPAT. Since PanK and PPAT was 
previously reported to have broad substrate tolerance by us and others, these analogs 
were expected to be accepted by CoA biosynthetic enzymes and get transformed into 
respective dephospho-CoA analogs [143, 157, 209]. We used the analogs B3KP and 
B4KP with +3 and +4 charges respectively assuming if the reaction works for B3KP and 
B2KP, it would work for B1KP and B2KP as well. The reaction was set up in 1x buffer 
containing 50 mM tris pH 7.0, 10 mM KCl, 5 mM MgCl2, 5 mM ATP and 2 Mm B3KP& 
B4KP. The reaction was initiated by adding PanK and PPAT enzymes and incubated for 









Figure 5.11 pantetheine analogs as PanK and PPAT substrates. B3KP and B4KP 
were tested for their ability to serve as PanK and PPAT substrates. The reaction 
products were separated by 20% denaturing PAGE pH 5.0 (acid gel 
electrophoresis). 0.1M Acetate buffer pH 5.0 was used as running buffer.   
As can be seen from figure 5.11, the enzymes successfully transformed B3KP and 
B4KP analogs into corresponding dephospho CoA analogs. As can be seen from figure, 
phosphorylation of B3KP and B4KP by PanK added one negative charge in these analogs 
that reduced their gel mobility during electrophoresis. The addition of another negative 
charge during adenylylation by the action of PPAT further slowed their mobility on the 
gel. These experiments confirmed that the synthesized pantetheine analogs have can be 
used by CoA-biosynthetic machinery as the substrates and can potentially label E coli 
CoA-RNA on vivo if bacteria uptake these analogs. 
In order to label bacterial CoA-RNA in vivo with these analogs, E. coli must uptake them 
from the media. E coli Top10 cells were grown to OD 0.6 in 10 mL LB. Pantetheine 
analogs B1KP, B2KP, B3KP, and B4KP were added to actively growing E. coli cells at 
10 µM to 100 µM final concentration. The cells were grown for one more hour, collected 
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by centrifugation and the radioactivity in the harvested cell were quantitated by 
scintillation counting. Uptake experiments were conducted in different conditions 
including higher cell density (1-5 OD at 600 nm), different media (M9 minimal media) 
and varying time (20 minutes to overnight). in all cases, only <1% of total 14-C labelled 
pantetheine was found to be associated with cell pellet. It wasn’t clear whether these 
analogs are interacting with negatively charged membrane or reached the cytosol. Even if 
all the radioactivity was coming from pantetheine analogs in the cytosol, less than <1% 
uptake was not enough to label CoA-RNA in vivo. More research is needed to evolve 
novel pantetheine transporter by applying gradual evolutionary pressure on E. coli and to 
synthesize pantetheine analogs conjugated to ligands having high transport efficiency in 
order to successfully label CoA-RNAs in vivo facilitating their capture.  
5.3 Conclusions 
In this study, we have attempted to develop two chemoenzymatic methods for 
CoA-RNA capture, but both methods could not successfully capture CoA-RNAs. In the 
first approach, we strived to use various metabolic enzymes of acyl-CoA ligase class to 
ligate CoA-RNA to biotinylated fatty acid. Acetyl CoA synthetase and succinyl CoA 
synthetase were very specific for their substrates and did not accept chemically modified 
analogs for the catalysis. Since ACS and SucCD play a key role in fatty acid metabolism 
and TCA cycle respectively that requires precise recognition of the substrates, their very 
high specificity for their substrate is understandable. However, malonyl/methylmalonyl 
CoA synthetase from S. coelicolor, an enzyme of polyketide biosynthetic pathway, was 
previously reported to be promiscuous toward wide range of substrates. This enzyme 
generates malonyl/ methylmalonyl CoA which serves as an extender unit in bacterial 
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polyketide synthesis pathway. Although malonate is the natural substrate for the reaction, 
a wide variety of malonate analogs can be accepted including ethyl malonate, propyl 
malonate, dimethyl malonate and other derivatives containing hydrocarbon side chains 
linked to the α-carbon of malonate [210]. The substrate- specificity of matB can also be 
broadened by introducing few mutations [211]. We synthesized a biotin labelled 
malonate analog by reacting 2-amino malonate with activated biotin.  Although MatB 
was shown to accept broad range of malonate analogs, biotinylated malonate was not 
accepted by the enzyme as its substrate. It is possible that the size of biotin is too big to 
fit in the enzyme’s active site. If the substrate binding pocket of the enzyme is widened 
by replacing the amino acids having bulkier side chains with amino acids having smaller 
side chains like glycine or alanine, it might create enough space for big molecules like 
biotin-malonate to fit in. However, such change may affect the enzyme activity as well. 
Considering the enzyme’s wide applications in creating the polyketide diversity, many of 
which are drug candidates, it may be worth trying to widen the enzyme’s malonate 
binding pocket so that broad range of modifications can be tolerated. 
Fatty acyl CoA synthetases are another class of acyl CoA ligase that catalyze the 
formation of thioester bond between CoA thiol and fatty acids. Medium chain fatty acid 
CoA ligase (FadK) is an E. coli enzyme that accepts 6-12 carbon fatty acids as its 
substrate [212]. As fatty acids with variable chain length serves as FadK substrates, we 
speculated that biotin and biotin-fatty acid conjugates might be accepted by the enzyme. 
However, we could not use FadK based CoA-RNA strategy due to the limitations 
experimental technique to analyze FadK activity. We briefly attempted to use AMP 
deaminase coupled assay to quantitate IMP, which is produced as a result of AMP 
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deamination. Further exploration is needed to develop an AMP-demainase based assay to 
analyze the activity of fatty acyl CoA ligases.  
Since we could not find any enzyme that is able to ligate biotinylated fatty acid 
even with CoA, we approached to label CoA-RNA in vivo by using pantetheine analogs. 
We designed the analogs based on four assumptions: 1) multiple positive charges on the 
analog help them to diffuse across the cell membrane. Since cell membrane is negatively 
charged, we assumed positively charged analogs may have better access to membrane 
and will go in by diffusion. 2) Presence of biotin as a purification handle make the 
purification possible by streptavidin beads. 3) presence of reporter tag allows to track the 
cellular uptake and localization of these analogs, and 4) presence of pantetheine with free 
hydroxyl group makes these analogs able to serve as PanK/PPAT substrate, transforming 
into dephospho-CoA analogs in vivo. Using solid phase synthetic strategy, we 
successfully synthesized four different analogs BKP, B2KP, B3KP, and B4KP having 
charge of +1, +2, +3 and +4 respectively. The application of solid phase synthesis 
significantly simplified the synthesis of these analogs by two different ways: 1) the 
reaction time is significantly shortened — most reactions were complete within 30 
minutes, and 2) the chromatographic purification after each coupling is not required since 
the excess reactants can easily be washed and drained. Although this synthetic strategy 
required 3-fold-5fold excess of the reactant to be coupled, benefits from the shortened 
reaction time and easy purification outcompeted the loss of excess reagents. 
 The synthesized analogs were accepted by E. coli CoA biosynthetic enzymes 
PanK and PPAT as their substrates, transforming them into phosphopantetheine analogs 
and dephospho-CoA analogs respectively. However, none of these analogs were able to 
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cross the cell membrane in high enough concentration to compete with cellular 
pantetheine/phosphopantetheine/ dephospho CoA and label CoA-RNA as biotin-C-14-
CoA-RNA. Although previous report showed that biotinylation facilitates the uptake of 
peptides by E. coli through biotin transporter [213], we did not observe such effect in our 
experiment. Further exploration on the delivery of these analogs - probably by 
conjugating with cell penetrating peptides or conjugating with small molecule ligand like 
glucose or other sugars having efficient membrane transporter- is needed for their 
applications to label CoA-RNA internally facilitating its capture 
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CHAPTER VI - POST-TRANSCRIPTIONAL BIOGENESIS OF 
COA-RNA IN E. COLI  
6.1 Introduction 
Eukaryotic messenger RNA transcripts contain an inverted 7-methylguanosine 
molecule linked to the first transcribed nucleotide by a 5’-5’ triphosphate bond. This 
structure is referred as 5’ cap, which is involved in many aspects of RNA metabolism 
including resistance to 5’→3’ exonuclease, pre-mRNA splicing, polyadenylation, nuclear 
export and translation initiation [214].  For example, the degradation of mRNA starts 
with removal of the 5’ cap structure by decapping enzymes, to expose the 5’ end of 
mRNA to 5’→3’ exoribonucleases [215]. The protection against 5’→3’ 
exoribonucleolytic degradation in capped transcripts makes them more stable than the 
triphosphate RNA.[216] Moreover, 5’ capping prevents the stimulation of innate immune 
system by RIG-I activation by 5’ triphosphate group, thus lowering the cytotoxicity of 
RNA [217]. Furthermore, eukaryotic translation initiation factor eIF4 requires capped 
mRNA transcripts to form the pre-initiation complex, where the mRNA transcript is 
linked  with the 43s pre-initiation complex via 7-methylguanosine cap [218]. Moreover, 
the 5’ cap not only inhibits off pathway binding of mRNA with eIF3, but also blocks the 
mRNA recruitment in the pre-initiation complex if the complete sets of initiation factors 
are not present [219]. 
In bacteria, the basic cellular processes including transcription, RNA processing, 
and translation are significantly different from their eukaryotic coiunterparts. For 
instance, bacterial RNAs do not undergo spliceosome mediated processing and do not 
contain 5’-cap as in eukaryotic system. However, some bacterial transcripts may be 
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processed through ribozyme-mediated splicing [220] [221] and may contain 3’ poly A 
tail[222]. It is interesting to note that the same features on RNA may have completely 
opposite functional roles in prokaryotes and eukaryotes. For example, 3’ poly A tail in 
eukaryotic mRNA protects it from 3’ exonucleases while the same modification 
facilitates the nuclease loading in RNA by adding a non-structured tail in case of bacterial 
mRNA [222]. The 5’ terminus of bacterial RNA is thought to contain no modifications 
although the phosphorylation state may vary. Bacterial primary transcripts contain 
triphosphate at their 5’ terminus as the transcription is initiated by nucleotide 
triphosphates. The triphosphate group on the 5’ end protects RNA from 5’→3’ 
degradation by RNase E as it requires unpaired RNA ends bearing 5’- monophosphate 
[223]. The RNA degradation in E. coli was perplexing until the discovery of RNA 
pyrophosphohydrolase RppH because the 3’ RNA end is protected by various stem-loop 
structure making it inaccessible to 3’→5’ exonucleases, the endonuclease RNAseE 
requires 5’- monophosphate and the dedicated 5’→3’ exonuclease is absent. Belasco and 
colleagues found that the activity of RppH generates 5’ monophoate RNA from 5’ 
triphosphate RNA, creating a substrate for RNaseE mediated decay [224, 225]. The same 
group later identified that triphosphorylated RNAs are first converted into 
diphosphosphorylated RNAs, which are the better substrates for RppH enzyme [226]. 
The biological significance of sequential 5’ phosphate removal to generate ppRNAs and 
pRNAs while having the ability to generate pRNA from pppRNA in a single step remains 
to be elucidated. 
The 5’ end feature of bacterial RNA is not limited to pppRNA, ppRNA and pRNA. In 
2009, David Liu’s group at Harvard discovered bacterial RNAs to have NAD, dephospho 
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CoA and its various thioesters at the 5’ end of E. coli and S. venezulae[113, 227] . They 
coupled size-exclusion chromatography with high resolution LC-MS to detect those 
cofactor molecules covalently linked to RNA 5’ end. Their search was inspired from the 
disparity between chemical diversity and functional diversity of RNA. While RNA is 
functionally very diverse in nature that participates in information storage, processing, 
transfer, catalysis and binding, the chemical diversity of RNA is limited to four canonical 
nucleotides. The identification of NAD, CoA and CoA thioesters covalently bound at 
RNA 5’ end expanded the RNA chemical diversity and opened up new questions in 
contemporary RNA function. As NAD, CoA and CoA-thioesters are thought to be 
evolved very early during evolution and are present since LUCA, these cofactor-linked 
RNA species could be the molecular fossils since RNA world. On the other hand, since 
CoA and NAD play a crucial role in contemporary metabolism as enzyme cofactors, such 
RNA species may have functional role in current biology that remains to be elucidated. 
Discovery of existence of cofactor-linked RNA species raised many questions about their 
function, metabolism and biogenesis including how these cofactors can be incorporated 
into RNA. The original study by David liu’s lab attempted to answer this question. They 
hypothesized that the modification should be post-transcriptional since E. coli RNAP was 
unable to initiate transcription with NAD and dephospho-CoA. However, later studies 
found transcriptional incorporation as the main mechanism of cofactor-RNA biogenesis 
[124, 228, 229]. However, since transcripts generated from post-transcriptional 
processing are found to contain cofactor caps, an alternative mechanism of cofactor 
linked RNA biogenesis can be speculated [166]. 
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In this study, we investigated the possibility of CoA-RNA biogenesis E. coli by the 
activity of PPAT. Since PPAT is known to have broad substrate tolerance for various 
phosphopantetheine analogs [209], we speculated such relaxed substrate specificity may 
exist for the second substrate ATP, allowing ATP-RNA to serve as a substrate. Such a 
reaction between phosphopantetheine and ATP-RNA catalyzed by PPAT would produce 
CoA-RNA, illuminating on the post-transcriptional mode of CoA-RNA biogenesis. For 
the convenience in product visualization and quantitation, we used synthetic pant-p 
analog B2KPP as the substrate in place of natural 4’-phosphopantetheine.    
6.2 Results and Discussion  
6.2.1 Synthesis of Biotin-2Lys-C14-Phosphopantetheine (B2KPP) 
The transfer of phosphopantetheine to pppA-RNA produces CoA linked RNA as 
shown in scheme 6.1. Although the CoA-RNA product can be separated from pppA-RNA 
using denaturing PAGE, the visualization of the product by EtBr staining would be 
problematic if the reaction yield is low. The internal radiolabeling of RNA by using ATP 
[α 32-P] is also not ideal as the gel mobility of CoA RNA-product is equivalent to N+1 
RNA, which may alternatively be generated by the transcription itself. Moreover, the 
high background of radiolabeled pppARNA that moves very close to CoA-RNA would 
further make it difficult to visualize and quantitate the product.  
 
Scheme 6.1 Mechanism of CoA-RNA biogenesis post-transcriptionally as a result of 
PPAT catalyzed phsosphopantetheine transfer to pppA-RNA 
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The use of ATP [γ 32-P] in PanK reaction to phosphorylate pantetheine is a good 
alternative, but the complete removal of ATP [γ 32-P] would be a challenging 
requirement as ATP, if present, would yield CoA analog instead of CoA-RNA analog. To 
address these problems, we designed a phosphopantetheine analog B2KPP having C-14 
acetate as a reporter tag and a biotin molecule as a purification handle (scheme 6.2).  
The synthesis of B2KPP was carried out by solid phase synthetic strategy because of its 
simplicity and speed. In most cases, the reaction was complete after 30 minutes of 
agitation that allowed to complete multiple steps in a single day. Furthermore, while 
using solid phase synthetic strategy, the chromatographic purification of the product is 
not needed after each coupling step. Commercially available trityl chloride resin was 
changed to amino functionalized resin by reacting with excess of ethylene diamine in 
DCM. The amino functionalized resin was then reacted with HCTU activated fmoc-
lys(biotin)-oh in DMF to install a biotin group as a purification handle. On-resin 
deprotection of Fmoc was carried out by reacting with 20% piperidine in DMF. The 
reactive amino group generated from Fmoc deprotection was used to react with HCTU 
activated Fmoc-Cys(stbu)-OH. The deprotection of Fmoc was carried out as before and 
HCTU activated C-14 sodium acetate was added to install a radiolabeled reporter tag. 
The S-tert butyl protecting group on cysteine thiol was deprotected by adding 1 M DTT 
in DMF at 60 °C. Diiodopropane was then coupled with stub- deprotected thiol to install 
an iodo-functional group which was reacted with pantetheine, synthesized by reducing 
commercially available pantethine. The final deprotection form the trityl beads was 
effected by 5% TFA in DCM. The crude product was purified by ether precipitation and 
dried to yield BK2P in 76% final yield. The phosphorylation was carried out by the 
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activity of Pantothenate kinase (PanK) that was expressed and purified recombinantly 
(scheme 6.2). Reverse phase HPLC purification was carried out to yield BK2PP in its 
highest purity. 
Scheme 6.2 Solid phase synthesis of phosphopantetheine analog B2KPP. Reagents and 
conditions: (i) ethylene diamine, DMF, 10 min, RT (ii) Nα-Fmoc-Nε-biotinyl-L-lysine, 
HCTU (iii) and (v)  20% piperidine in DMF, RT, 5 min (iv) fmoc-cys(stbu)-OH, HCTU 
(vi) [1-14C] NaoAc, HCTU (vii) 1M DTT, 60 ° C, 3 h (viii) 1,3-diiodopropane, DMF, RT, 30 
min (ix) pantetheine, DMF, RT, 30 min (x) 5% TFA/DCM, RT, 10 min. 
6.2.1.2 Amino Functionalization of Beads 
Trityl chloride resin, 0.96 grams/ 1.3 mmol capacity, from Chem Impex 
international (catalog number: 03902) was swelled in 10 mL dry DMF for 10 minutes at 
room temperature under Nitrogen environment. Excess of ethylene diamine (3 g) was 
added and agitated for 1 hour at room temperature. The solvent was drained, washed with 
2x5 mL DMF followed by 2x10 mL DCM. The beads were dried under a vacuum in a 
desiccator. The reaction yield was determined by coupling with fmoc-gly-oh as shown in 





Scheme 6.3 Use of Fmoc-Glycine to determine the reaction yield. Fmoc-Gly-OH was 
reacted with amino  functionalized resin, treated with piperidine  and the deprotection 
product was quantitated by UV-Vis at 300  nm. Reagents and conditions: (i) HCTU, 
NMM/DMF, RT, 30 min (ii) 20% piperidine/DMF, RT, 5 minutes. 
Trityl amino beads, 12 mg, were swelled in dry DMF for 30 minutes. Fmoc-Gly-
oh, 17.8 mg/ 60 micromoles, from Chem Impex international (catalog #: 02416) and 50 
micromoles/ 20 mg HCTU (chem impex international, catalog # 14260) was dissolved in 
0.2 mL 20% NMM/DMF. The HCTU activation of fmoc-Gly produced yellow colored 
solution when reacted for 5 minutes at room temperature. The activated fmoc Gly was 
added to the amino-beads and agitated for 40 minutes at room temperature. The solvent 
was drained followed by washing of the beads with 3x4 mL DMF. The deprotection of 
fmoc was carried out by adding 0.5 mL 20% piperidine in DMF at room temperature for 
5 minutes. The fmoc deprotection product was collected and quantitated by UV using 
extinction coefficient of 7.08 OD/micromoles at 300 nm. Quantitation by UV 
spectrometry yielded 14.5 micromoles of fmoc deprotection product which is equivalent 
to 1.2 mmol/g amino functionalization on the beads with a yield of ~90 %.  
6.2.1.3 Loading of fmoc-lys(biotin)-OH 
The synthesis of BK2PP was performed in 0.1 mmol scale. Amino functionalized 
resin (100 mg, 120 micomoles capacity) was swelled in dry DMF for 1 h. Commercially 
available Nα-Fmoc-Nε-biotinyl-L-lysine, 325 umol, 190 mg, (Chem impex international, 
catalog #04988) was activated by adding 130 mg/ 315 micromoles/0.96 equivalent of 
HCTU in 1 mL 20% NMM/DMF. The reaction produced yellow colored solution upon 
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incubation at room temperature for 5 minutes. It was added to the beads and agitated for 
30 minutes. The solvent was drained, and the resin was washed with 3x5 mL DMF. 
Unreacted amimo functional groups were capped by adding 100 ul/ 1 mmol acetic 
anhydride in 1 mL DMF into the beads followed by agitation at room temperature for 30 
minutes. 
The deprotection of Fmoc was carried out by adding 1 mL 20% piperidine in DMF into 
the beads. The reaction was incubated for 5 minutes at room temperature. The 
deprotection product was collected by draining the solvent and quantitated by UV 
spectrophotometer that showed nearly quantitative loading (~98%) of Fmoc-Lys(biotin)-
OH on the beads. 
6.2.1.4 Coupling of fmoc-cys(stbu)-OH 
The deprotected amino group was used to react with HCTU activated carboxyl group of 
Fmoc-L-Cys(stbu)-OH, forming an amide bond. Commercially available Fmoc-
Fys(Stbu)-OH (Chem Impex International, catalog number 02403) 172 mg, 400 
micromoles and 157 mg/ 380 micromoles HCTU was dissolved in 1 mL 20% 
NMM/DMF and allowed to react at room temperature for 5 minutes. It was then added 
into the beads and agitated for 1 hour at room temperature. The solvent was drained and 
3x2 mL DMF was used to wash the resin. Fmoc deprotection was carried out as before. 
Quantitation by UV spectrophotometry showed quantitative yield of the coupling 
reaction. 
6.2.1.5 Loading of C-14 acetate 
The reactive amino group generated through fmoc deprotection was used to install 
a radiolabeled acetate (C14 NaOAc) as a reporter tag. Acetic Acid, Sodium Salt, [1-14C] 
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was obtained as a generous gift from Dr. Philip Bates as 3 mCi/mL aqueous solution. Sodium 
acetate, 5 mg/ 60 micromoles, was dissolved in 0.6 mL water as 0.1 M solution and added 30 
ul Acetic Acid, Sodium Salt, [1-14C]. The solution was frozen and lyophilized to obtain 62 
micromoles of sodium acetate with 100 µCi radioactivity. HCTU 25 mg, 60 micromoles and 
0.5 mL 20% NMM/DMF was added to NaoAc to activate the carboxyl group. The reaction 
was vortexed at room temperature for 10 minutes until completely dissolved. The activated hot 
acetate was added into the beads and allowed to react for 1 hour with gentle agitation. Sodium 
acetate, 41 mg, was activated in the same way and added to the beads to cap the unreacted 
amino group. The solvent was drained and the radiolabeling yield was found to be ~70% as 
determined by liquid scintillation counting. 
6.2.1.6 Stbu deprotection 
The deprotection of stbu protection group was carried out by DTT mediated 
disulfide reduction. DTT (77 mg) was dissolved in 0.5 mL DMF and added to the beads. 
30 µL DIPEA was also added to create a basic environment for the reduction. The reaction was 
carried out at 60 ° C. A small portion of the beads were taken, deprotected and analyzed 
by HPLC to monitor the reaction progress. The reaction was completed after 2 hours of 
incubation at 60 °C as shown by HPLC analysis. The solvent was drained and 3x4 mL 
DMF was used to wash the resin.  
6.2.1.7 Coupling of 1,3-diiodopropane 
The reactive thiol group on the beads was reacted with 1,3 diiodopropane to yield 
Iodo-functional group on the beads. Commercially available 1,3 diiodopropane 
(Oakwood chemical, catalog # 003098), 191 mg/650 umol in 500 ul DMF was added into 
the beads and reacted at room temperature for 30 minutes with gentle agitation. The 
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excess of the solvent and unreacted diiodopropane were drained and the resin was 
washed with 3x4 mL DMF. The Iodo functional group generated this way was used to 
react with the pantetheine thiol as a final step of synthesis. 
6.2.1.8 Loading of Pantetheine  
Pantethine (Ox-Pant, Chem impex international, catalog number 00240) was 
reduced by DTT to yield pantetheine. Ox-pant, 150 mg/ 270 µmoles was dissolved in 2 mL 
DMF and added 63 mg/ 405 µmoles of DTT (Sigma Aldrich), The reduction was carried out 
at room temperature for 1 hour with gentle stirring. The pantetheine product was 
precipitated by adding 5 mL diethyl ether, washed and dried in desiccator. It was then 
dissolved in 1 ml DMF and added into the resin. The reaction was carried out at room 
temperature for 30 minutes with gentle agitation. The solvent was then drained and 3x2 
mL DMF was used to wash the resin that completed the solid phase synthesis of B2KP. 
6.2.1.9 Deprotection from the beads  
B2KP was deprotected form the trityl resin by adding 1 mL deprotection cocktail 
composed of TFA/DCM/TIPS in 1:18:1 ratio at room temperature for 10 minutes. The 
solution was drained directly in 10 mL ether to precipitate the product. Beads were 
washed with 3x0.5 mL DCM and drained into diethyl ether. The precipitate was collected 
by centrifugation and dried at reduced pressure in a desiccator to yield 78 mg (76% final 
yield) of B2KP. 
6.2.1.10 Phosphorylation by PanK  
The phosphorylation of BK2P was carried out by the pantothenate kinase (PanK) 
purified recombinantly from E. coli as shown in scheme 6.4. BK2P (7.8 mg, 10 
micromoles) was dissolved in 1 mL reaction buffer (50 mM tris pH 7.0, 10 mM KCl, 1 
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mM MgCl2) and 11 mg/ 20 micromoles ATP was added. The reaction was started by 
adding 0.2 mg PanK and incubated at 37 °C. The reaction progress was analyzed by 
HPLC and found to be completed in 2 hours. The activity of the enzyme on 
phosphorylating B2KP was found to be comparable to its natural substrate pantetheine. 
The BK2PP product was purified to its highest purity by reverse phase HPLC. The 
reaction was loaded into 4.6x250 mm C18 column equilibrated with 10% 40 mM 
KH2PO4 at flow-rate of 1 mL/min. The column was washed with 5% acetonitrile for 5 
minutes to remove ATP and ADP. The product was eluted with 50:50 MeCN: Water with 
no buffer. It was then dried under reduced pressure at 60 °C to yield 7.7 mg (90%) of 
pure B2KPP product. The concentration was further analyzed by liquid scintillation 
counting that showed 98 million CPM in total.  BK2PP was stored as 5 mM aqueous 
solution having radioactivity of ~50,000 CPM/µL. 
 
Scheme 6.4 Phosphorylation of pantetheine analog B2KP by E. coli Pantothenate kinase. 
The reaction product B2KPP was purified by reverse phase HPLC.   
6.2.2 Transfer of B2KPP to pppARNA by PPAT 
Our lab’s long history of research on the area of functional RNA selection and in 
vivo cloning has accumulated a lot of DNA oligos that can be repurposed according to 
our needs. We selected three DNA oligos Rar, Sp20 and T7GTr having T7 φ2.5 promoter 
that initiates transcription with an ATP at the 5’ end. We annealed Rar and Sp20 oligos 
with another oligo U2.5, which is complementary to the φ2.5 promoter to make the 
promoter region double stranded so that the transcription can occur. The third oligo 
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T7GTr was annealed to its complementary oligo T7GTf to get double stranded 
transcription template. The transcription of three above-mentioned templates- Rar, SP20 
and T7GTf/T7GTr by T7 RNA polymerase under standard conditions produced 20 mer, 
24 mer and 18 mer pppA-RNA respectively as shown in figure 6.1A. The secondary 
structures of Rar and SP20 RNAs were predicted by mfold RNA folding program. As can 
be seen from figure 6.1B, Rar RNA was predicted to fold into a single structure having 6 
free nucleotides hanging on the 5’ end and a loop of 7 nucleotides held by a stem of 3 
base pairs on 3’ end. On the other hand, SP20 RNA was predicted to fold into two 
equally favorable structures (figure 6.1C and 61D)- one having 10 free nucleotides on the 
5’ end and a loop of 5 nucleotides held by a stem of 4 base pairs on 3’ end (Fig 6.1 C) 
and another having a loop of 6 nucleotides held by a stem of 5 base pairs on 5’ end and a 
stretch of 8 nucleotides on the 3’ end (Figure 6.1 D). The TetG RNA, generated by 
transcription of T7GTf/T7GTr template, folds into a G quartet structure. 
Since all three RNAs have 5’ triphosphate followed by Adenosine, they can be 
considered as analogs of ATP with a long tail of nucleotides anchored through 3’-OH. 
We questioned whether 5’pppA-RNA can replace 5’ pppA (ATP) in the 
phosphopantetheinyl adenylyltrnasferase (PPAT) catalyzed reaction of CoA biosynthesis 
pathway. Such a reaction would produce CoA-linked RNA instead of dephospho 
Coenzyme A (Scheme 6.1). We recombinantly expressed PPAT enzyme from the 
plasmid encoding CoaD (a gift from Tadhg Begley & Erick Strauss, Addgene # 50388) 
and purified it by immobilized metal affinity chromatography (IMAC) as discussed in 
chapter IV. Phosphopantetheine analog BK2PP is an ideal substrate to test whether 
pppA-RNA is accepted by the enzyme as an ATP analog. If the enzyme catalyzes the 
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transfer of BK2PP to pppA-RNA, the resulting RNA product is radioactive which can be 
visualized on the gel. We set up a reaction containing 20 µM RNA and 50 µM B2KPP in 
a reaction buffer (50 mM tris pH 7.0, 10 mM KCl, 1 mM MgCl2) to investigate whether 
pppA-RNA serves as an ATP analog for PPAT enzyme. The reaction was initiated by 
adding PPAT in 1 µM concentration and incubated at 37 °C for 2 hours. The RNA was 
purified by Zymo RNA clean and concentrator kit (catalog number R1015) and the RNA 











Figure 6.1 pppA-RNA serves as an ATP analog in a PPAT catalyzed reaction. A: 
The sequences of RNA used in the study. All three RNAs were synthesized by in 
vitro transcription reaction under T7 φ2.5 promoter using partially double 
stranded (Rar and SP20) or fully double stranded (TetG) DNA as templates. B: 
mfold-predicted structure of Rar RNA. C & D: mfold-predicted structures of 
Sp20 RNA. E: Urea-PAGE analysis of PPAT catalyzed transfer of B2KPP to 
pppA-RNA. Both Sp20 RNA and Rar RNA served as ATP analogs in PPAT 
reaction while TetG RNA could not serve as a substrate for PPAT. F: 
Characterization of the PPAT reaction product by electrophoretic mobility shift 
assay (EMSA). Streptavidin was added into the Sp20RNA product after the 
reaction, and the electrophoretic mobility was analyzed by 12% urea PAGE. The 
retardation on the gel after the addition of streptavidin and the radioactivity on 
the RNA product confirmed that PPAT catalyzed the transfer of BK2PP into 
Sp20RNA 
After drying and exposing the gel on the phosphor screen for a week, two bands 
corresponding to Sp20 RNA and Rar RNA were visualized (Figure 6.1E). We spotted the 
known amount of BK2PP on the gel and exposed for the same time to determine the 
reaction yield. As an experimental control, a separate reaction was set using Sp20 RNA 
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as a substrate but without the addition of enzyme (Fig 6.1E). Densitometry analysis 
showed that ~2% of Sp20 and ~1% of Rar RNA (Lane 2, fig 6.1E) reacted with BK2PP 
to yield Biotin-CoA-RNA in our reaction condition. On the other hand, TetG RNA (lane 
3, fig 6.1E) did not work as an enzyme substrate. Based on the mfold-predicted structure, 
the reaction yield is expected to be higher for Rar RNA as it has single structure 
compared to two equally favored structures of SP20 RNA. However, the structure of Rar 
RNA contains an unstable loop of 7 nucleotides held by a stem of two G:C and a U: A 
base pairs. The instability of the loop might force Rar into different structures that may 
account for the lower yield than that of Sp20 RNA. 
The product of the PPAT reaction was further confirmed by electrophoretic 
mobility shift assay (EMSA). As can be seen from figure 61F, the electrophoretic 
mobility of the Sp20 RNA product was greatly retarded when streptavidin is added. This 
experiment clearly indicated that the Sp20 RNA is biotinylated and is radioactive after 
incubation with PPAT and BK2PP. Since both biotin and C-14 radiolabel are associated 
with BK2PP substrate, it is clear that PPAT catalyzed the transfer of BK2PP to Sp20 
RNA generating Biotin-C14-CoA-RNA as a reaction product. 
6.2.3 Effect of RNA structure 
Since Sp20 and Rar RNA served as substrates for PPAT enzyme but not the TetG 
RNA, we hypothesized that RNA secondary structure is the determining factor on 
whether pppA-RNA can serve as an ATP analog in a PPAT catalyzed reaction. If the 
RNA has unstructured 5’ pppA region, it can possibly access the enzyme’s active site. 
However, if 5’region has stable secondary structure, the availability of 5’ ATP for the 
PPAT catalyzed phosphopantetheine transfer would be limited. To test this hypothesis, 
 
169 
we designed six different 22 mer RNAs viz. D2, D3, D4, D5, D7, and D10 (figure 6.2A). 
Our design was guided by the predicted secondary structure by mfold RNA folding 
program. All four RNAs contain a stable GAAA loop held by a stem containing three 
C:G base pairs and one U:A base pair. We varied the number of unstructured nucleotides 
at the 5’ region of RNA to understand its effect on the reaction. As can be seen from 
figure 6.2 B, D2 RNA was predicted to fold into a stem loop structure having 2 
unstructured nucleotides at 5’ end and a stretch of 8 nucleotides on 3’ end. D5 RNA has 
five unstructured nucleotides on the 5’ end and a stretch of six nucleotide on 3’ end (fig 
6.2C). Similarly, the folding of D7 and D10 RNA contains 7 unstructured nucleotides (fig 
6.2D) and 10 unstructured nucleotides (fig 6.2E) respectively at the 5’ end. As the RNA 
sizes and the other structural features of D2, D5, D7 and D10 RNA are identical, the 
effect of 5’ unstructured region and the required number of 5’ unstructured nucleotides 
for can be determined by using these four RNAs as substrates using PPAT as enzyme and 













Figure 6.2  Effect of RNA 5’ unstructured region on the PPAT catalyzed CoA-
RNA biogenesis. (A) Sequences of RNAs having 2, 5, 7, and 10 nucleotides at 5’ 
unstructured region. (B-E): mfold-predicted structures of D2, D5, D7 and D10 
RNA. All RNAs share a stable stem-loop structure but the number of nucleotides 
in 5’ unstructured region varies. (F): PAGE analysis of PPAT catalyzed transfer 
of BK2PP into D2, D5, D5 and D10 RNAs. D2 RNA did not serve as a PPAT 
substrate while D5, D7, and D10 RNA acted as ATP analog in PPAT reaction. 
(G): PAGE analysis of D3, D4, and D5 RNA as PPAT substrates to determine 
the minimum number of unstructured nucleotides at RNA 5’ end.       
All four RNAs were synthesized by in vitro transcription reaction as pppA-RNAs 
using partially double stranded DNA templates. Zymo RNA clean and concentrator kit 
was used to remove the buffer, salt, enzyme, and NTPs from the reaction mixture. The 
purified RNAs were quantitated by UV spectrophotometer at 260 nm using calculated 
extinction coefficients as presented in table 6.1.  
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Table 6.1 Sequences, molecular weight, extinction coefficient and transcriptional yield of 
different RNAs used. 
 
They were then used as enzyme substrates in PPAT reaction where BK2PP was another 
substrate. As can be seen from figure 6.2H, RNAs that have ≥ 5 nucleotides at the 5’ 
unstructured region can replace ATP in PPAT reaction. D2 RNA that has two nucleotides 
‘AG’ at the 5’ unstructured region did not serve as an enzyme substrate. These results 
clearly indicated that the number of unstructured nucleotides at the pppA-RNA 5’ region 
is the key factor in determining whether pppA portion of RNA can access the enzymes’ 
active site. 
We next questioned what is the minimum number of ‘free’ nucleotides at 5’ unstructured 
region for a pppA-RNA to serve as a PPAT substrate. We designed two RNA sequences- 
D3, and D4 that have 3 and 4 nucleotides at 5’ unstructured region respectively while 
keeping other features including RNA size and a stable loop supported by a stem of four 
base pairs same. D3 and D4 RNAs in 10 µM concentration were incubated with PPAT (1 
µM) in 30 µL reaction buffer B2KPP (50 µM) for 3 hours at 37 °C. The reaction products 
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were purified in a same way as before, separated by 12% urea-PAGE, and exposed onto 
phosphor screen for a week after drying. We found that D4 RNA that has four 
nucleotides on the 5 ‘unstructured region can form CoA-RNA in vitro (Lane 2 figure 
6.2I). When the number of nucleotides at the 5’ non-structured region was reduced to 
three, the RNA did not work as a PPAT substrate (Lane 3 figure 6.2I). From these 
experiments, we determined that pppA-RNA can compete with ATP in a PPAT catalyzed 
reaction and form CoA-RNA when it has 5’ unstructured region with at least four ‘free’ 
nucleotides. 
6.2.4 Effect of 5’ free nucleotides on the reaction rate  
we next examined how the reaction rate is affected by the number of nucleotides 
at the 5’ unstructured region. We used D4 RNA that had minimum number of free 
nucleotides on the 5’ region and D10 RNA which had maximum number of 5’ 
unstructured nucleotides to study the reaction progress with time. Both the RNAs at 10 
µM concentration were incubated at 37 °C in a reaction buffer containing 50 µM B2KPP 
and 1 µM PPAT enzyme. The reaction (30 µL/300 pmoL total RNA) was quenched at 
three different time points- 1 h, 2h, and 3h by freezing at -20 °C. RNA was then 
precipitated by adding 3.3 µL 3 M NaOAc and 100 µL Ethanol followed by incubation at 
-20 °C for 1 h. glycogen (1 µg) was added as a carrier for precipitation. The products 
were separated form 12% urea-PAGE, dried, and visualized by phosphorimaging after 
one-week exposure (Figure 6.3A). The amount of CoA-RNA product for both D4 and 
D10 RNAs increased with time as expected (figure 6.3A and 6.3B). A standard amount 
of BK2PP was spotted on same gel to calculate the reaction yield by densitometry 
analysis. We found the reaction yield is ~1% at 1 h and increased to ~3.5% after 4 hours 
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of reaction (figure 6.3B). The reaction rate (v) was calculated as pmol of CoA-RNA 
formed per minute. Our data suggested that the reaction rate for both D4 and D10 RNA is 
similar that ranges from 0.013-0.032 pmol/min. The ratio of reaction rate for D10 and D4 
was in the range of 0.82-1.11 with an average of 0.94. These data clearly indicated that 
the rate of PPAT activity is independent to the number of free nucleotides at 5’ 
unstructured region. As long as the minimum requirement of ≥ 4 nucleotides at 5’ 
unstructured region is met, the reaction proceeds with the same speed regardless of the 





Figure 6.3 The effect of the number of nucleotides at 5’ unstructured region of 
pppA-RNA in reaction rate. Two representative RNAs- D4 and D10 having 4 and 
10 free nucleotides respectively at the 5’ region was used to study the PPAT 
kinetics. (A): D4 and D10 RNA were incubated with B2KPP and PPAT at 
specified time, separated by Urea-PAGE, and exposed to phosphor screen for 1 
week. The enzyme catalyzed the transfer of phosphopantetheine analog B2KPP 
to both D4 RNA and D10 RNA with a similar rate. (B): the ratio of CoA-RNA to 
total RNA was plotted against incubation time (minutes) to visualize the reaction 
progress over time. The amount of product increased linearly with time for both 
D4 and D10 RNA with similar speed. 
 
6.2.5 Effect of RNA concentration 
To determine the enzyme’s kinetic parameters including Km and Kcat for pppA-RNA, 
PPAT catalyzed B2KPP transfer reaction was carried out at different RNA 
concentrations. We designed a 10 mer RNA DN having sequence 
5’pppAGGAAUAGUA-OH-3’. It was synthesized by in vitro transcription from a double 
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stranded DNA template having T7 φ2.5 promoter and the resulting RNA was purified by 
20% denaturing PAGE. The yield was determined by UV spectrophotometer by using an 
extinction coefficient of 118,100 M-1Cm-1 at 260 nm. A total of 4.5 micrograms of 10 
mer DN RNA was obtained from standard 20 µL transcription. As DN was predicted to 
be a non-structured RNA by mfold RNA folding program, we expected that it would 
serve as a PPAT substrate. A reaction was set up to test whether DN-RNA can replace 
ATP in a PPAT catalyzed reaction. We incubated DN-RNA at 10 µM concentration in a 
reaction buffer containing 50 µM B2KPP and ~1 µM PPAT enzyme at 37 °C. The 
resulting RNA product was precipitated by 0.3 M NaOAc, 3 equivalents of Ethanol and 1 
µg glycogen as carrier at -20 °C. It was then separated by 20% urea-PAGE, dried and 
exposed to phosphor screen for a week and imaged (figure 6.4A). The enzyme catalyzed 
the transfer of B2KPP to DN-RNA as expected generating C14 labelled Biotin-CoA-
RNA. The reaction progress with time was quantitated using volume analysis tool of the 
Quantity one software. When the reaction time was doubled form 1 hour to 2 hours, the 
amount of radiolabeled RNA product was increased by 2.5-fold. When the incubation 
time was further doubled to 4 hours, the yield of the reaction only increased by 1.6-fold. 
This may be partly due to the RNA degradation at longer reaction time. 
 
After establishing a series of RNA substrates of different sizes (10 mer and 22 mer) and 
having different number of nucleotides at 5’ unstructured region (D4, D5, D7 and D10) 
that can replace ATP in PPAT catalyzed reaction to yield CoA-RNA in vitro, we used 
D10 RNA (22 mer) and DN RNA (10 mer) at three different concentrations so that Km 
and Vmax for pppA-RNA can be calculated. The use of two different RNAs as substrates 
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further allows us to compare how the enzyme kinetics is affected by RNA size. As can be 
seen from figure 6.4B, the yield of CoA-RNA product was increased with increase in 
substrate concentration and reaction time. We spotted a standard amount of BK2PP and 
determined the reaction yield by densitometry analysis using volume rect tool of Quantity 
one software. When the RNA concentration in the reaction was doubled from 5 µM to 10 
µM, the reaction yield was increased by ~ 2-fold -by 1.9-fold (2 h)-2.1 fold (4 h) in case 
of DN RNA and by1.6 fold (4 h)-1.8 fold (2 h) in case of D10 RNA. When the RNA 
concentration in the reaction was quadrupled to 20 µM, the CoA-RNA yield was 
increased by ~4 times (2 h)- ~5.7 times (4 h) in case of 10 mer DN-RNA and ~2.2 times 
(2h) to ~2.8 times (4 h) in case of 22 mer D-10 RNA. For both DN and D10 RNAs, a plot 
of RNA concentration vs average reaction rate (pmol/min) produced straight lines (figure 
6.4C). The reaction with shorter RNA (DN) appears to be faster than D10 as the slope of 
line representing DN kinetics is higher than that of D10 (figure 6.4C). From the graph, it 
is clear that the RNA concentration in the reaction is far below to reach the maximum 











               
 
Figure 6.4 kinetics of PPAT catalyzed B2KPP transfer to pppA-RNA. (A) 
Unstructured 10 mer DN-RNA as a substrate for PPAT enzyme. DN-RNA at 10 
µM concentration was incubated in a reaction buffer containing 50 µM B2KPP 
and 1 µM PPAT enzyme at 37 °C for specified time. The RNA was ethanol 
precipitated, separated by 20% urea-PAGE, dried and exposed to phosphor 
screen for 1 week before imaging. (B)  Effect of RNA concentration on the 
reaction rate. DN RNA and D10 RNA at specified concentrations were used as 
PPAT substrates for specified amount of time. (C) Graph of substrate 
concentration versus rate of the reaction (pmol of CoA-RNA/min). Rate 
increased linearly with increase in substrate concentration, but the reaction did 
not reach its maximum velocity as high concentrations of RNA in a reaction. 
6.2.6 Competition of pppA-RNA and ATP 
PPAT catalyzes the transfer of phosphopantetheine to ATP and forms dephosphospho 
CoA product as a fourth reaction in bacterial de novo CoA biosynthesis pathway. Since 
both ATP and pppA-RNA serve as enzyme’s substrate, we questioned how the enzyme’s 
activity toward pppA-RNA is affected by the presence of ATP in a PPAT reaction. In 
bacteria ATP is present in ≥1 mM concentration (ref) but pppA-RNA never reaches such 
a high concentration. For this reason, we speculated that PPAT might favor pppA-RNA 
over ATP for phosphopantetheine transfer. We used DN-RNA (10 µM) and BK2PP (50 
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µM) as enzyme substrates and the reaction was carried out in presence of 0-20 µM ATP 
at 37 °C for 3 h. RNA products after the reaction were precipitated and separated by 20% 
DN-PAGE. After drying and exposing the gel to phosphor screen for a week, we found 
that ATP is a strong inhibitor of PPAT catalyzed phsophopantetheine transfer to pppA-
RNA (fig 6.5A). When 2 µM ATP was used in a PPAT reaction containing 10 µM DN-
RNA, the CoA-RNA yield was reduced by ~16%. The CoA-RNA yield was further 
reduced by ~56% when ATP and pppA-RNA were present in 1:2 ratio. We observed 
~80% reduction of CoA-RNA product when equal concentration of ATP and pppA-RNA 
were present in the reaction. When the concentration of ATP was two times higher than 
that of pppA-RNA, the formation of CoA-RNA was still detected on the gel, but the yield 
was decreased by ~ 93%. When [ATP] was plotted against [CoA-RNA]/[total RNA], an 
exponential decrease in CoA-RNA formation in presence if ATP was observed (figure 
6.5B). Since ATP is present in much higher concentration than pppA-RNA in a bacterial 
cell, we carried out PPAT reaction using 10 µM RNA and 1 mM ATP to mimic the 
cellular environment. In this condition, we did not observe the formation of CoA-RNA in 
a detectable amount. These results imply that the cellular concentration of CoA-RNA 
would be extremely low if we consider post-transcriptional transfer of 
phosphopantetheine to 5’ unstructured pppA-RNA catalyzed by PPAT as a major 





Figure 6.5 Effect of RNA size on the PPAT catalyzed B2KPP transfer to pppA-
RNA. (A) three RNA with different sizes- RNAI (109 mer), D10 (22 mer) and DN 
(10 mer) were used as substrates for PPAT and reacted with B2KPP for 2-4 h. 
(B) plot of [CoA-RNA]/[Total RNA] vs reaction time for DN, D10 and RNAI. The 
rate of reaction decreased with increase in RNA size. 
 
6.2.7 E. coli RNA as a PPAT substrate 
We next questioned whether E. coli RNAs can be capped post-transcriptionally as 
CoA-RNA by the activity of PPAT. Several small RNAs in E. coli are found to be capped 
with another metabolic cofactor NAD and the sequences of such NAD capped RNAs are 
available. RNAI is one of such NAD-capped RNA encoded in ColE1 plasmid of E. coli. 
This small RNA was enriched >500 fold in NAD-captureseq that led to the estimation of 
~13% of RNAI in E. coli are NADlyated (ref). When we predicted the secondary 
structure of RNAI by mfold RNA folding program, it folded into two possible structures: 
one having 10 nucleotides long unstructured 5’ region (figure 6.6A) and another with 4 
nucleotides long unstructured 5’ region (figure 6-6B). Based on the predicted structure, 
we hypothesized that RNAI might be a good substrate for PPAT catalyzed 
phosphopantatheine transfer. A DNA template for in vitro transcription of RNAI was 
prepared by PCR. As can be seen from figure 6.6C, PCR amplification of pET28a 
plasmid by RNAI specific primer pair yielded a 127 bp RNAI DNA that can be used as a 
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template to synthesize 109 mer RNAI. The T7 φ2.5 promoter sequence followed by two 
nucleotides ‘AG’ were added at the 5’ of forward PCR primer to meet the requirements 
for transcription. The PCR product was purified by Zymo DNA clean and concentrator 
and used directly as a transcription template. Epicenter high yield transcription kit was 
used for RNA synthesis that yielded 85 µg RNAI form standard 20 µL transcription. 
 
Figure 6.6 E coli RNA as PPAT substrate. A and B: secondary structures of E. 
coli RNAI predicted by mfold. C: DNA Template preparation. RNAI from 
pET28a plasmid backbone was amplified by PCR using RNAI specific primer 
pairs. The PCR product was analyzed by 2% agarose gel. D) PPAT activity on 





The synthetic RNAI was next used as a substrate in PPAT reaction to examine 
whether this RNA can serve as an ATP analog and gets capped with BK2PP as a product 
of enzymatic reaction. The reaction was started by incubating 300 pmol RNAI in 30 µL 
reaction buffer containing 50 µM BK2PP and 1 µM PPAT at 37 °C for 2-4 h. It was then 
purified by Zymo RNA clean and concentrator kit, separated by 8% DN-PAGE, dried, 
and exposed for a week. As demonstrated in figure 6.6D, RNAI indeed served as a 
substrate for PPAT. C-14 labelled RNAI was detected on a gel as a result of PPAT 
catalyzed transfer of B2KCC to pppA-RNAI. The yield of the reaction was found to 
increase with increase in reaction time. When the reaction time was doubled from 2 hours 
to 4 hours, the CoA-RNA yield was increased by ~1.8 fold. If we assume the similar 
mechanism exists in vivo, CoA-RNA-at least some portion- are generated by non-specific 
and residual activity of PPAT toward ATP initiated RNAs that have ≥ 4 nucleotides at 5’ 
unstructured region.    
6.2.8 Effect of RNA size 
Next, we investigated the effect of RNA size in the reaction kinetics. As pppA-RNA can 
be considered as an ATP analog with a long tail of nucleotides, the size of the tail might 
affect how fast the reaction proceeds. when the RNA size gets bigger, there is a 
probability that unstructured 5’pppA region may not get an access to enzyme’s active site 
because of the steric hinderance. We used three different sized RNAs- DN (10 mer), D10 
(22 mer), and RNAI (109 mer) to study the rate of PPAT catalyzed B2KPP transfer. The 
reaction was set by incubating 10 µM RNAI, D10 and DN RNA in 30 µL reaction buffer 
containing 50 µM B2KPP and 1 µM PPAT enzyme for 2-4 h at 37 °C. The B2KPP-RNA 
products were precipitated, separated from the gel, and exposed to phosphor screen for a 
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week. A standard amount of BK2PP was spotted and exposed to determine the reaction 
yield by densitometry analysis. As evidenced in figure 6.7A, the reaction rate by affected 
by the RNA size. The conversion of pppA-RNA to B2KPPA-RNA (CoA-RNA analog) 
was fastest for DN-RNA (10 mer) and the rate of reaction decreased with the increase in 
RNA size (figure 6.7 A and B). The reaction rate was ~3-4 times faster for DN RNA than 
for D10 RNA.  
 
Figure 6.7 Effect of RNA size on the PPAT catalyzed B2KPP transfer to pppA-
RNA. (A) three RNA with different sizes- RNAI (109 mer), D10 (22 mer) and DN 
(10 mer) were used as substrates for PPAT and reacted with B2KPP for 2-4 h. 
(B) plot of [CoA-RNA]/ [total RNA] vs reaction time for DN, D10 and RNAI. The 
rate of reaction decreased with increase in RNA size 
While the rate of PPAT catalysis was faster for D10 RNA than for RNAI, the difference 
is smaller (1.5-fold) compared to DN-RNA vs D10 RNA. on the other hand, the reaction 
was ~5-7 times faster for DN-RNA than for RNAI. These data suggested that the rate of 
reaction is affected by both RNA size and its secondary structure. DN is a small RNA (10 
mer) with no secondary structure that possibly gives it an advantage to access enzyme’s 
active site more easily than long and structured RNA like D10 and RNAI.   
6.3 Molecular Basis of CoA-RNA generation by the activity of PPAT 
PPAT catalyzes the transfer of phosphopantetheine to ATP in CoA biosynthetic pathway 
generating dephospho CoA and pyrophosphate. The enzyme was previously expressed 
 
183 
recombinantly and the kinetic analysis was performed by using the reverse reaction ( 
dephospho-CoA + ppi→ATP + pant-p) [144]. The enzyme was found to exist as a 
homohexamer and catalyzed dephospho CoA synthesis by formation of ternary complex 
of enzyme and substrates. The possibility of CoA acting as a substrate for reverse 
reaction was investigated. PPAT did not catalyze the phosphohydrolysis of CoA, 
showing CoA cannot be generated directly by transferring phosphopantetheine to ATP-3’ 
phosphate. However, in our study we observed PPAT catalyzed transfer of pant-p analog 
B2KPP to ATP-RNA yielding B2KPP-RNA (analog of CoA-RNA) and ppi in forward 
reaction and pyrophosphorolysis of CoA-RNA analog to ATP-RNA and pant-p analog 
B2KPP. Since ATP-RNA can be considered as an analog of pppAp, the enzyme should 
treat both the substrate in a similar way. 
The molecular interactions during substrate binding and catalysis were revealed after 
determining enzyme’s high resolution crystal structure with dephospho-CoA, CoA, pant-
p and ATP [230, 231]. The structural data showed the enzyme to be a hexamer of two 
asymmetric units, having identical monomer within the trimer [230]. Furthermore, the 
dephospho-CoA product and pantp substrate were bound to only one trimer of the 
hexamer. ATP was bound to all six monomers but the electron density due to ATP was 
well resolved in one trimer only. The crystal structure with CoA had shown that CoA 
binds to all six monomers but its binding to the two trimers of hexamer is different. In 
one protomer, the binding of CoA is exactly same as dephospho CoA but no electron 
density was observed for ATP in this protomer [232]. In another protomer, the binding 
mode of CoA is different from that of dephospho CoA. In this protomer, both CoA and 
dephospho-CoA binds to the same binding pocket but the pantetheine arm bends in 
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opposite direction and the adenosine of CoA also does not bind to the adenylate binding 
site of PPAT (figure 6.8). As CoA binds to the enzyme in two distinct modes and no ATP 
electron density was observed in one protomer at CoA binding site, it can be speculated 
that CoA might be serving as PPAT substrate in one trimer unit and inhibitor in another 
trimer unit. 
 
Figure 6.8 Binding of CoA (Blue) and dephospho CoA (green) in one protomer 
of the PPAT hexamer. CoA and dephospho-CoA binds differently as the 
cysteamine part of pantetheine arm orients in opposite direction and CoA 
adenosine does not bind in the adenylate binding site of PPAT. These two 
ligands bind in a same way in another protomer, but ATP was not clearly 
detectable either due to enzyme’s pyrophospholysis or disorder. 
Two distinct ligand binding modes in case of CoA binding was further observed in 
another study conducted by Miller and colleagues [233]. It is not clear why CoA would 
bind in two distinct modes to achieve just a single role of enzyme inhibition. More 
experimental evidence is needed to establish that the two binding modes of CoA actually 
have different functional significances: binding to first promoter contributes to enzyme 
inhibition while binding to second protomer contributes to catalysis. No studies so far 
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have examined whether PPAT can catalyze pant-p + pppAp → CoA + ppi, although the 
reverse reaction was negative. As PPAT is catalyzing transfer of phosphopantetheine 
analog B2KPP to ATP-RNA yielding an analog of CoA-RNA, it will be worth examining 
whether it can generate CoA by catalyzing transfer of pant-p and its analog B2KPP to 
pppAp which is a closed analog of RNA. This experiment will establish whether RNA is 
playing any role to make the reaction happen and whether the synthetic Pant-p analog 
B2KPP and natural Pant-p are equivalent to PPAT enzyme. 
6.4 Conclusions 
Our results have shown that E. coli PPAT (coaD) catalyzes the transfer of 
4’phosphopantetheine analog B2KPP to pppRNA yielding CoA-RNA analog Biotin-
CoA-RNA in vitro. Since B2KPP is a synthetic analog of natural substrate pant-p, it was 
assumed that PPAT does not discriminate between pant-p and B2KPP considering its 
broad substrate tolerance. If assume PPAT catalyzes transfer of pant-p to pppRNA in 
vivo, our study established the mechanism of CoA-RNA biogenesis. We found that the 
structure of RNA at the 5’ end determines whether it can serve as a substrate for PPAT 
reaction. The substrate RNA must have at least four unstructured nucleotides at the 5’ 
end. The length of 5’ unstructured region did not affect the reaction kinetics as RNA with 
4 unstructured nucleotides and 10 unstructured nucleotides reacted with the similar rate. 
Furthermore, the reaction was independent to the size of RNA when tested with 10 mer, 
22 mer, and 109 mer. finally we have shown E. coli native RNA viz. RNAI can serve as a 





CHAPTER VII – CONCLUSION AND FUTURE DIRECTIONS 
The identification of cofactor linked RNA conjugates in 2009 realized many 
questions on RNA functions and roles of cofactors especially NAD, CoA, and CoA-
thioesters in contemporary biology. After seven years of their known existence, NAD-
RNA capture protocol was developed that allowed their capture and the study of their 
function, metabolism and diversity. However, such features of CoA-RNA and thioester-
CoA RNA are still a mystery as a specific CoA-RNA capture method from bacterial 
RNA is not available. Therefore, successful identification of CoA-RNA would uncover 
many unknown features of bacterial metabolism and RNA function. 
The first step toward developing such CoA-RNA capture protocol would be to make 
synthetic CoA-RNA easily accessible. While a method to make CoA-RNA by in vitro 
transcription was previously described by our lab, a major constraint in preparing 
synthetic CoA-RNA is the cost and availability of dephospho coenzyme A to initiate 
transcription. We solved this hurdle by developing a chemoenzymatic method to prepare 
dephospho-CoA and its various analogs including amino dephospho-CoA and biotin-
dephospho-CoA. Two enzyme of CoA biosynthetic pathway- PanK/ CoaA and PPAT/ 
CoaD were cloned in a single plasmid by using our in vivo recombinational cloning 
method. The enzymes were co-expressed in BL21(DE3) strain of E. coli and co-purified 
using Ni-NTA resin. The co-expression and co-purification of PanK and PPAT not only 
saved time and resources, but also provided the mixture of required enzymes in ~1:1 ratio 
in a single preparation step. The purified enzymes were used to synthesize dephospho-
CoA from commercially available and relatively cheap pantethine via two routes. A 
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simple chromatographic purification by reverse phase column at the end yielded 
dephospho-CoA in high purity. Furthermore, we extended this method to synthesis 
various dephospho-CoA analogs with chemical modifications on thiol. The precursor 
pantethine was reduced by TCEP and reacted to Bromoaminoethane to yield amino 
pantetheine, which was readily converted to amino-dephospho-CoA by PanK/PPAT 
cocktail. Moreover, Biotin-pantetheine was synthesized by using our previously reported 
method and was converted to Biotin-dephospho-CoA by the action of PanK/PPAT 
mixture. We further extended this method by inserting CoaE/DPCK in PanK/PPAT 
plasmid resulting entire CoA biosynthetic pathway (salvage pathway) in a single plasmid. 
All three CoA biosynthetic enzymes PanK/PPAT/DPCK were expressed and purified in a 
single step and used to synthesize CoA in one-pot procedure starting from pantetheine. 
The development of these methods will make dephospho-CoA, CoA, and CoA-RNA 
easily accessible to wide range of researchers working in biochemistry, bio-organic 
chemistry, molecular biology and biomedicine. 
After successfully developing a method to synthetize dephospho-CoA, synthetic CoA-
RNA became readily available for the development of CoA-RNA capture protocol. We 
designed two different strategies for their capture: 1) screening of substrate promiscuity 
of various acyl CoA ligases to find an enzyme that can ligate biotinylated fatty acid to 
CoA-RNA, facilitating their capture on streptavidin beads and 2) in vivo labelling of 
CoA-RNA with various pantetheine analogs containing biotin and C-14 tag. The first 
strategy failed as none of the screened enzymes were found to have such broad substrate 
tolerance. The second strategy also was not successful as those pantetheine analogs were 
unable to diffuse through the bacterial cell membrane. In course of developing a synthetic 
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route toward such pantetheine analogs, we discovered and characterized a simple and 
easy method for the selective desilylation of primary TBDMS ether in presence of their 
secondary counterparts by using low concentrations of formic acid in acetonitrile/water. 
Although E.coli could not uptake these pantetheine analogs in enough concentration so 
that CoA-RNA is labelled with these analogs, they may be useful to study various CoA-
related processes. Furthermore, since CoA in central to metabolism and these pantetheine 
analogs are readily accepted by CoA biosynthetic machinery as substrates, these analogs 
can be promising candidates to develop novel antibiotics targeting CoA biosynthetic and 
CoA utilizing enzymes. 
Although E. coli could not uptake these pantetheine analogs, we phosphorylated one of 
such analogs B2KP to B2KPP and used it to study the mechanism of CoA-RNA 
biogenesis. We studied whether PPAT can accommodate ATP-RNA in its ATP binding 
pocket. As B2KPP has radiolabel tag and biotin handle, the use of these analogs made the 
product visualization much easier compared to regular pant-p. Interestingly, PPAT was 
able to catalyze the transfer of B2KPP to ATP-RNA yielding CoA-RNA analog in vitro. 
If we assume pant-p and B2KPP are equivalent to PPAT, our study has shown for the 
first time that the capping of RNA with CoA occurs post-transcriptionally as a result of 
non-specific activity of CoaD on ATP RNA. Furthermore, we established the structural 
requirement of RNA to serve as a PPAT substrate and the effect of RNA size in the 
reaction. As it was previously speculated that some cofactor linked RNA may have been 
synthesized post-transcriptionally besides promotor dependent co-transcriptional 
incorporation by RNAP, our study has experimentally demonstrated such mechanism for 
the first time. 
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Although we established the post-transcriptional mechanism of CoA-RNA biogenesis by 
the action of PPAT on ATP-RNA, the biological significance of this method can be 
questioned. CoA-RNAs were estimated to be present in ~100 copies per E. coli cell. 
Since ATP in >100 µM concentration which is ~ 10-50 times lower than the actual 
cellular concentration completely inhibited the reaction, co-transcriptional incorporation 
of CoA by RNAP might be the major pathway of CoA-RNA biogenesis. However, the 
cellular conditions might be different from in vitro conditions as pant-p is continuously 
available in cell unlike in test tube conditions where pant-p analog B2KPP is readily 
consumed in presence of ATP to form CoA analog which is an inhibitor of enzyme. The 
proportion of CoA-RNA generated post-transcriptionally by the action of PPAT to CoA-
RNA generated co-transcriptionally by RNAP remains to be investigated. 
The sequences of CoA capped RNA in E. coli are still a mystery. Further investigations 
are needed to achieve the successful capture of CoA-RNA from total cellular RNA of E. 
coli. Our method of dephospho-CoA synthesis will be useful to develop such capture 
protocol in future. Furthermore, the design and synthesis of better analogs of pantetheine/ 
phosphopantetheine able to diffuse through the E coli membrane is another work that 
needs to be done in future. The successful synthesis of such analogs will probably make 
CoA-RNA capture possible by labelling them with biotin in vivo and may be promising 
candidates for novel antibiotic development targeting CoA biosynthetic or CoA utilizing 
pathways. 
The complexity of CoA-RNA is higher than NAD-RNA as the former was found to exist 
in four acylation states as free CoA-RNA, acetyl-CoA-RNA, methylmalonyl-CoA-RNA, 
and succinyl-CoA-RNA. These findings indicated that CoA-RNA can act as an acylation 
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substrate as that of free CoA. It can be argued that CoA-RNAs are not simply the 
molecular fossils from RNA world, rather they are functional in contemporary 
metabolism because of their existence in four acylation states. Acylation of CoA-RNA 
must occur post-transcriptionally as acyl-CoA cannot initiate transcription because of the 
presence of 3’ phosphate. Acyl dephospho-CoA can be used as transcription initiator but 
the presence of such metabolites hasn’t been reported yet. The mechanism of CoA-RNA 
acylation will be an interesting area for the future research. 
In addition to CoA and NAD cap, E. coli transcripts were recently found to contain 
another adenosine derivative FAD as a 5’ cap [234]. Since the cellular concentration of 
FAD is very low and it is usually associated with flavin binding proteins, the probability 
of FAD to initiate transcription by competing with ATP is very low. It is interesting to 
speculate that adenylyl transferases including PPAT, nicotinate-nucleotide 
adenylyltransferase (NADD), and FAD synthase (FADS) may be able to accommodate 
ATP-RNA in their ATP binding pocket. An exciting area of future research will be to 
investigate whether R-p + pppA-RNA → Rpp-RNA + ppi is universal for all adenylyl 
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